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Summary 
Yersinia enterocolitica is a foodborne pathogen comprising a versatile group of organisms, which 
cause yersiniosis with diverse clinical manifestations, are found all over the world, and survive in 
a variety of habitats, with high prevalence in animal and food sources. Molecular pathogenesis 
of yersiniosis and the strategies used by enteropathogenic Yersinia to overcome host defenses 
are well understood, especially for the mouse highly-virulent bioserotype 1B/O:8 strains. 
Nevertheless, Y. enterocolitica isolates from patients mainly belong to the mouse weakly-virulent 
serotypes O:3, O:9 and O:5,27. In particular, serotype O:3 strains are responsible for 80-90% of 
yersiniosis cases worldwide, and are frequently isolated from pigs, considered as their 
asymptomatic reservoir.  
Genomic investigations have been mainly performed using the reference genome of bioserotype 
1B/O:8 strain 8081 as representative of the highly-virulent group, typically detected in America. 
Beside strain 8081, another bioserotype 1B/O:8 strain, namely WA-314, is studied in respect of 
pathogenicity, and strains closely related to WA-314 have recently emerged in Europe. In this 
context, it is worthwhile to unravel the genome sequence of strain WA-314 and compare it with 
that of strain 8081, together with their pathogenic potential. Not only did strain WA-314 
overcome strain 8081 in mouse colonization, but also their genomes showed high variability, 
with evidences of recombination and horizontal gene transfer events, reflecting a population 
adapted to a broad range of niches. Discovered genetic differences in adhesion proteins and in 
genes encoded by the pYV virulence plasmid, together with the presence of a colicin cluster and 
differing prophages, may account for the higher virulence and fitness properties of strain 
WA-314 in comparison with strain 8081. 
Since a detailed characterization of the genetic variability within the whole Y. enterocolitica 
species is missing, the uncovered highly-virulent specific genetic features have been analyzed 
together with available sequences from other serotypes. Whole genome comparison stressed 
the importance of anaerobic respiration in the physiology of weakly-virulent and non-virulent 
strains, due to specific nitrite and DMSO reductases. Notably, autotransporters and fimbriae 
constitute the most relevant virulence determinants for weakly-virulent and non-virulent strains, 
confirming that pathogenesis-associated abilities of Y. enterocolitica are strongly dependent on 
adhesion to and interaction with host cells. Genome comparison made also possible the 
establishment of an efficient PCR-based method for Y. enterocolitica patho-serotyping, by 
identifying new O-antigen gene clusters and designing primers targeting serotype-specific 
genes. This test has proved to be especially useful for typing strains which lost expression of the 
O-antigen and could not be tested by conventional methods. 
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By means of phylogenetic and comparative analyses of 10 genomes, representing the broad 
diversity of Y. enterocolitica, the high genome variability of the entire species has been 
discovered. The open pan-genome of the whole still evolving species reflects the wide range of 
habitats where these versatile bacteria can proliferate, especially those belonging to the highly- 
and non-virulent groups, in contrast to the lower diversity within the lineage of the weakly-virulent 
strains, which occupy more specialized niches. In particular, analyzing additional 20 genomes of 
the pig-adapted serotype O:3 revealed an overall clonal-like microevolution, driven by genetic 
drift and gene loss, and proposed the definition of “genetically monomorphic” for Y. enterocolitica 
serotype O:3 strains. No apparent differences between pig and human isolates have been 
identified, while a SNP-based phylogeny showed more recent mutational events in the human 
strains. Together with the genetic isolation, these results are consistent with the assumed role of 
pig asymptomatic carriers as the main reservoir of human infections by serotype O:3 strains. 
Y. enterocolitica serotype O:3, therefore, can be regarded as a genetically monomorphic group 
of bacteria, corresponding to a lineage within a species of greater diversity, probably because of 
adaptation to its major host, the swine. 
Finally, since the patho-adaptation mechanisms of Y. enterocolitica serotype O:3 to humans and 
swine are not known, an immuno-based approach has been applied to identify genes specifically 
induced during in vivo growth. Confirming the findings from the genome comparison analyses, 
genes belonging to the anaerobic pathways of cobalamin synthesis, nitrogen and sulfur 
metabolisms revealed immunogenic reactions with human sera, as well as flagella and fimbrial 
genes. 
In conclusion, this study reinforces the role of physiology and adhesion properties during host 
colonization and adaptation of Y. enterocolitica to specific hosts or environmental niches. New 
insights into the evolution of Y. enterocolitica as whole species and of the serotype O:3 sub-
population support the heterogeneity of this species, with the broad-host-range highly- and non-
virulent strains on one side and the host-restricted weakly-virulent ones on the other. The basis 
for a more detailed epidemiological knowledge of Y. enterocolitica has been established and 
future developments are expected. 
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Zusammenfassung 
Yersinia enterocolitica ist ein Krankheitserreger, der durch den Konsum kontaminierter 
Lebensmittel übertragen wird und aus einer heterogenen Gruppe verschiedener Organismen 
besteht. Y. enterocolitica verursacht das Krankheitsbild einer Yersiniose, die durch 
verschiedenste klinische Manifestationen charakterisiert ist. Y. enterocolitica ist weltweit 
verbreitet und kann in einer Vielzahl unterschiedlicher Habitate überleben, vor allem aber in 
Tieren und tierischen Lebensmitteln. Der molekulare Pathogenitätsmechanismus der Yersiniose 
und die Strategien, mit denen enteropathogene Yersinien die Immunabwehr des 
Wirtsorganismus entkommen, sind gut erforscht. Dies gilt vor allem für den im Mausmodell 
verwendeten hoch-virulenten Bio-/Serotyp 1B/O:8 Stamm. Klinische Y. enterocolitica Isolate 
gehören hingegen meist zu den Serotypen O:3, O:9 und O:5,27, die im Mausmodell nur 
schwach-virulent sind. Weltweit werden 80-90% der Yersiniosen durch Serotyp O:3 Stämme 
verursacht. Diese werden häufig aus Schweinen isoliert, weshalb Schweine als 
asymptomatisches Hauptreservoir für Yersinien gelten. 
Genomische Untersuchungen wurden vor allem mit dem Bio-/Serotyp 1B/O:8 Referenzstamm 
8081 durchgeführt. Dieser Stamm gehört zur Gruppe der im Mausmodell hoch-virulenten 
Yersinia Spezies und wird vor allem in Amerika isoliert. Neben Stamm 8081 wird WA-314, ein 
weiterer Bio-/Serotyp 1B/O:8 Stamm, in Bezug auf sein Pathogenitätsverhalten untersucht. 
Stämme die nah verwandt mit WA-314 sind, breiten sich mittlerweile in Europa aus. Von daher 
ist es von besonderem Interesse, die Genomsequenz von Stamm WA-314 zu entschlüsseln und 
sowohl das Genom als auch sein Pathogenitätsverhalten mit Stamm 8081 zu vergleichen. In 
dieser Arbeit konnte gezeigt werden, dass Stamm WA-314 im Mausmodell eine bessere 
Kolonisierung als Stamm 8081 aufweist und dass eine starke Genomvariabilität zwischen diesen 
beiden Stämmen vorliegt. Spuren von Rekombinationsereignissen und horizontalem 
Gentransfer spiegeln somit eine Population wider, die an eine Vielzahl verschiedener 
ökologischer Nischen angepasst ist. Genetische Unterschiede von Adhäsionsproteinen und 
Genen, welche auf dem pYV Virulenzplasmid kodiert sind, sowie die Existenz eines Colicin 
Genclusters und verschiedener Prophagen, könnten für die starke Virulenz und die Fitness von 
Stamm WA-314 gegenüber Stamm 8081 im Mausmodel verantwortlich sein. 
Bislang fehlt eine detaillierte Charakterisierung der genetischen Variabilität innerhalb der 
gesamten Y. enterocolitica Spezies. Deshalb, wurden die entdeckten Genbereiche, die mit dem 
hoch-virulenten Phänotyp in Zusammenhang gebracht werden, mit vorhandenen 
Genomsequenzen anderer Serotypen verglichen. Gesamtgenomvergleiche zeigten die 
Bedeutung der anaeroben Atmung für die Physiologie der schwach-virulenten und nicht-
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virulenten Stämme. Dies ist auf das Vorhandensein von spezifischen Nitrit und DMSO 
Reduktasen zurückzuführen. Von besonderer Bedeutung für die Virulenz von schwach-
virulenten und nicht-virulenten Stämmen zeigten sich Gene kodierend für Autotransporter und 
Fimbrien. Damit konnte bestätigt werden, dass das Pathogenitätsverhalten von Y. enterocolitica 
stark von Adhäsion und der Interaktion mit der Wirtszelle abhängt. Weiterhin ermöglichten die 
Genomvergleiche, die Etablierung einer effizienten PCR-basierte Methode, zur Identifizierung 
verschiedener Yersinia Serotypen. Neue O-Antigen Gencluster wurden identifiziert, die mit 
entsprechend designten Primern amplifiziert werden können. Es zeigte sich, dass dieser Test 
besonders geeignet ist, um Stämme zu identifizieren, die das O-Antigen nicht mehr exprimieren 
können. Diese Stämme konnten bislang nicht mit konventionellen Methoden erfasst werden. 
Durch die phylogenetische und vergleichende Analyse von 10 verschiedenen Y. enterocolitica 
Genomsequenzen konnte die hohe Genomvariabilität innerhalb der gesamten Spezies gezeigt 
werden. Das Pangenom dieser gesamten sich weiterhin entwickelnden Spezies spiegelt die 
verschiedenen Habitate wider, wo sich diese Bakterien vermehren können. Diese Variabilität ist 
besonders bei jenen Stämmen ausgeprägt, die zur Gruppe der hoch-virulenten und nicht-
virulenten Gruppen gehören. Im Gegensatz dazu ist das Genom der schwach-virulenten 
Stämme weniger variabel, welches mit der Spezialisierung auf bestimme ökologische Nischen 
zu erklären ist. Die Analyse von 20 weiteren Genomen von Schwein-adaptierten Serotyp O:3 
Stämmen ergab eine Art übergeordnete, klonähnliche Mikroevolution, die durch Gendrift und 
Genverlust entstanden ist. Daher, führt dieses zu der Definition „genetisch monomorphen“ 
Y. enterocolitica Serotyp O:3 Stämmen. Es konnten keine genetischen Unterschiede zwischen 
Yersinia Isolaten aus Schwein und Mensch identifiziert werden. SNP-basierte phylogenetische 
Untersuchungen hingegen zeigten, dass kürzlich ereignete Mutationen vor allem in den Isolaten 
vom Menschen zu finden sind. Zusammen mit der genetischen Isolierung unterstützen diese 
Ergebnisse die Hypothese, dass asymptomatische Schweine das Hauptreservoir für  Infektionen 
von Menschen mit Serotyp O:3 Stämmen darstellen. Aufgrund dessen können Y. enterocolitica 
Serotyp O:3 Stämme als eine genetisch monomorphe Gruppe innerhalb einer Spezies mit 
größerer genetischer Variabilität angesehen werden. Dies ist vermutlich auf die Adaption an 
ihren Hauptwirt, das Schwein, zurückzuführen.  
Der Pathogenitätsmechanismus, wie Y. enterocolitica Serotyp O:3 sich Menschen oder 
Schweinen anpasst ist bislang nicht bekannt. Demzufolge wurde in dieser Arbeit ein 
immunologischer Ansatz verwendet, um Gene zu identifizieren, die während des Wachstums in 
vivo induziert werden. Gene die mit dem anaeroben Weg der Cobalamin Synthese, des Nitrit 
oder Sulfat Metabolismus, sowie Flagellen und Fimbrien assozierte Gene zeigten 
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immunologische Reaktionen gegenüber Humanserum. Dieser Zusammenhang ergab sich 
bereits aus den Ergebnissen der Genomvergleiche. 
Zusammenfassend bestärkt diese Arbeit die Rolle der Physiologie und der adhäsiven 
Eigenschaften von Y. enterocolitica während der Kolonisierung des Wirts und der Anpassung an 
spezifische Wirtseigenschaften bzw. an ökologische Nischen. Neue Einblicke in die Evolution 
von Y. enterocolitica als gesamte Spezies sowie der Serotyp O:3 Subpopulation untermauern 
die Hypothese der Heterogenität dieser Spezies: auf der einen Seite die hoch-virulenten und 
nicht-virulenten Stämme mit einem breiten Wirtsspektrum und auf der anderen Seite die 
schwach-virulenten Stämme mit einer eingeschränkten Wirtsspezifität. Mit dieser Arbeit wurde 
die Basis für detailliertere epidemiologische Erkenntnisse von Y. enterocolitica geschaffen und 
wird zukünftige Entwicklungen vorantreiben. 
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1. Introduction 
1.1. Yersinia enterocolitica taxonomy, classification and ecology 
Yersinia enterocolitica (YE) is a member of the genus Yersinia in the family Enterobacteriaceae, 
class gamma-proteobacteria. Together with Y. pseudotuberculosis and Y. pestis, YE is one of 
the three Yersinia species documented as virulent for humans, whereas the remaining 14 
species (Y. aldovae, Y. aleksiciae, Y. bercovieri, Y. entomophaga, Y. frederiksenii, 
Y. intermedia, Y. kristensenii, Y. massiliensis, Y. mollaretii, Y. nurmii, Y. pekkanenii, Y. rohdei, 
Y. ruckeri, and Y. similis) are mostly environmental and rarely associated with human disease 
(Merhej et al., 2011; Murros-Kontiainen et al., 2011a; Murros-Kontiainen et al., 2011b; Sprague 
and Neubauer, 2005; Sprague et al., 2008; Sulakvelidze, 2000).  
Y. enterocolitica is a gram-negative facultative anaerobe rod-shaped bacterium, which is able to 
survive and actively proliferate at low temperatures (1-4 °C). YE is flagellated and motile at 
25 °C, while it is non-flagellated, hence non-motile, at 37 °C (Bottone, 1999). YE is a highly 
heterogeneous group of organisms that can be classified into 6 biotypes according to 
biochemical reactions as regards to metabolism (Bottone, 1997) (Table 1), while antigenic 
variations in the O-antigen molecule of the lipopolysaccharide (LPS) allows differentiation of 
more than 70 serotypes (Wauters et al., 1987) (section 1.1.1). A common nomenclature based 
on the geographical origin of the first isolation in Europe/Japan or North America allows a further 
classification of the isolates into “Old World” and “New World” strains, respectively. Moreover, 
grouping of YE into 2 subspecies, palearctica (YEP) and enterocolitica (YEE), have been 
justified by differences in the 16S rRNA gene sequences  (Neubauer et al., 2000a). Based on 
the bacterial virulence in the mouse model, YE can be also classified into 3 groups: mouse- or 
highly-virulent, weakly-virulent and non-virulent (Table 2). 
Y. enterocolitica is a ubiquitous microorganism, which has been isolated from animals, water, 
soil, food, environment and humans, and especially swine serve as main reservoir for human 
pathogenic strains (Bottone, 1999). Interestingly, there is a close association between the 
bioserotype of the isolates and their ecological niches. Even though the facultative-pathogenic 
and opportunistic biotype 1A strains are the ones most frequently recovered from the 
environment, also pathogenic strains of biotype 1B have been isolated from water. Bioserotype 
4/O:3 strains colonize pigs with high frequency, while strains of bioserotype 2/O:9 are isolated 
from goats and cows. Strains of the very rare bioserotype 5/O:2,3 are isolated from sheep, hares 
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and goats, and bioserotype 3/O:1,2a,3 strains from chinchillas (Rahman et al., 2011). These 
data suggest that animals are the origin of YE human infections. 
Table 1 Biotyping scheme of Y. enterocolitica. Adapted from (Bottone, 1997). 
 Biotype reaction 
Test 1A 1B 2 3 4 5 
Esculin hydrolysis (24 h) +/- - - - - - 
Pyrazinamidase activity + - - - - - 
Salicin (acid production in 24 h) + - - - - - 
Lipase activity + + - - - - 
Indole production + + v - - - 
Xylose (acid production) + + + + - v 
Trehalose (acid production) + + + + + - 
Sorbitol (acid production) + + + + + - 
Nitrate reduction + + + + + - 
Ornithine decarboxylase + + + + + +(+) 
Symbols: +, positive result (detected activity); -, negative result (no activity); (+), delayed positive; v, 
variable, depends on the examined bacterial strain. 
Table 2 Classification of Yersinia enterocolitica isolates (Bottone, 1997; Sabina et al., 2011). 
Group Subspecies Geographical 
origin Biotype Serotype 
Highly-virulent 
(mouse-virulent)a 
enterocolitica 
(YEE) 
North America  
(“New World” 
strains) 
1B 
O:4,32; O:8; O:13a,13b; O:16; 
O:18; O:20; O:21; O:25; O:41,42; 
NTb 
Weakly-virulent 
palearctica 
(YEP) 
Europe and 
Japan 
(“Old world” 
strains) 
2 O:9; O:5,27; O:27 
3 O:1,2,3; O:5,27; O:3 
4 O:3 
5 O:2,3 
Non-virulent 1Ac 
O:4; O:5; O:6,30; O:6,31; O:7,8; 
O:7,13; O:10; O:14; O:16; O:21; 
O:22; O:25; O:37; O:41,42; O:46; 
O:47; O:57; NTb 
a
 In this thesis, the high-virulence pathotype refers to mouse-virulence and will be used in this sense. 
b NT: non-typeable. 
c Growing evidences support the idea that Y. enterocolitica 1A isolates are opportunistic pathogens in 
patients with underlying medical disorders and immune deficiencies. 
1.1.1. Y. enterocolitica O-antigens and serotypes 
Serotype-based classification of Y. enterocolitica was first applied in 1967 (Winblad, 1973). The 
serotyping scheme is mainly defined by the variability of the O-antigen (O-ag), allowing 
determination of more than 70 serotypes in YE and related species (Wauters et al., 1991), with 
biotype 1A strains being the more heterogeneous and belonging to at least 17 serotypes 
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(Bhagat and Virdi, 2011). Serological classification is performed by agglutination of strains with 
serotype-specific antisera, produced by immunized rabbits, after injection of heat-killed bacterial 
antigenic saline suspension (Aleksic et al., 1986). The O-ag epitopes are determined by the type 
and arrangement of sugar residues in the repeated O-units that compose the LPS. O-ags can be 
classified as homopolymeric, when the repeating unit is a single sugar, or heteropolymeric, if it is 
composed of two or more different sugar residues (Figure 1). Chemical approaches have 
elucidated the structures of a number of YE O-ags (Gorshkova et al., 1985, 1986; Ovodov et al., 
1992; Radziejewska-Lebrecht et al., 1994; Skurnik, 2006). Interestingly, in YE serotypes O:3 and 
O:9 the O-ag and the outer-core hexasaccharide are both attached to the inner core, forming a 
short branch in the LPS molecule, a peculiarity rarely seen in other enterobacteria (Skurnik and 
Bengoechea, 2003). The genetic cluster and genomic location of YE O-ags are partly solely 
known for serotypes O:3, O:9 and O:8. The O-ag gene cluster of serotype O:8 is located 
between the hemH (ferrochelatase) and gsk (inosine-guanosine kinase) genes, similarly to 
Y. pestis and Y. pseudotuberculosis. This locus is occupied by the outer core gene cluster in YE 
serotypes O:3 and O:9, while the genomic location of their O-ag clusters was unknown (Skurnik 
and Bengoechea, 2003) before this thesis. 
 
Figure 1 Schematic structure of the lipopolysaccharide of Y. enterocolitica. 
LPS of serotype O:3 (A) and serotype O:8 (B) are shown as example of homopolymeric and 
heteropolymeric O-antigens, respectively. Modified from (Skurnik, 2004). 
Serotyping of YE is a first approach for diagnostics, prognosis of disease and epidemiological 
studies (section 1.3.1). In fact, only 11 serotypes have been associated with human yersiniosis, 
namely O:8, O:3, O:9, O:5,27, O:13a,13b, O:4, O:18, O:20, O:21, O:1,2,3, O:2,3 (Bottone, 
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1997). In particular, pathogenic strains mainly belong to a restricted group of serotypes (O:8, 
O:3, O:9 and O:5,27) and their mouse virulence varies, as serotype O:8 strains are more virulent 
than O:3 or O:9 strains. Notably, in vitro binding and invasion of different host cells have been 
recently shown to possess serotype-specific characteristics (Schaake et al., 2013). Transfusion-
associated YE bacteremia have been related to few serotypes, O:3, O:9, O:5,27, O:1,2,3, and 
O:20, whereas secondary sequelae of acute YE infection have been correlated to serotypes O:8, 
O:3 and O:9 (Bottone, 1997). 
1.2. Pathogenesis of Yersinia enterocolitica 
1.2.1. Pathogenesis model and clinical manifestations 
Y. enterocolitica is a foodborne pathogen, which causes human infections after ingestion of food 
or contaminated water (Black et al., 1978; Keet, 1974). Once ingested, the bacteria colonize the 
intestinal tract, especially the terminal ileum and proximal colon, where they cross the mucus 
layer covering the mucosal epithelial cells via binding to M cells of the Peyer’s patches. 
Attachment to M cells, mediated by interaction between the bacterial outer membrane protein 
Inv (invasin) and β1 integrins, leads to internalization and translocation of YE by the M cells 
across the mucosal barrier. Bacteria are then expelled from the basolateral side of the M cells 
into the dome region of the follicle-associated epithelium (FAE) and are phagocyted by dendritic 
cells, macrophages and lymphocytes (Autenrieth and Firsching, 1996; Schulte et al., 2000). 
Through phagocyte migration, YE gain access to the subjacent tissues, disseminating to the 
mesenteric lymph nodes, liver, and spleen, where it proliferates in an extracellular form within 
micro-abscesses (Dube, 2009) (Figure 2). Invasion and survival of YE within different host 
tissues are multifactorial processes which require a large set of virulence factors encoded by the 
chromosome and by the Yersinia virulence plasmid (pYV) (Cornelis et al., 1998; Revell and 
Miller, 2001) (sections 1.2.2 and 1.2.3 and Table 3). 
Illness usually begins within 24-72 hours after infection with YE, causing mainly gastrointestinal 
disease, as well as extra-intestinal disorders, under defined host conditions (Revell and Miller, 
2001). The manifestation of different intestinal syndromes is associated with serotype of the 
invading strain, age of host, and host status. In children, acute enteritis, fever and diarrhea are 
the most frequent occurrences, while in young adults acute terminal ileitis and mesenteric 
lymphadenitis mimicking appendicitis are more common clinical symptoms (Black et al., 1978; 
Chandler and Parisi, 1994). The disease generally evolves as a self-limiting gastroenteritis, 
which may rarely results in fatal septicemia and abscesses formation in deep organs (Savin and 
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Carniel, 2008). Reactive arthritis is a post-infection phenomenon highly associated with YE; 
glomerulonephritis, endocarditis, erythema nodosum, uveitis and thyroid disorders are 
suggested to be secondary immunologically-induced diseases rarely occurring (Simonet, 1999). 
 
Figure 2 Pathogenesis model of Y. enterocolitica infections. 
After adhesion to M cells, bacteria are internalized and transported towards the basolateral side of the M 
cell, where they are expelled into the sub-mucosa to gain access to and multiply in subjacent tissues.  
Adapted from (Sabina et al., 2011). 
1.2.2. Plasmid-encoded virulence factors 
The presence of the pYV virulence plasmid, common to all the three pathogenic Yersinia 
species, is a critical element for the manifestation of a pathogenic phenotype in Y. enterocolitica. 
In fact, virulent strains of both subsp. enterocolitica and palearctica (biotypes 1B and 2-5) carry 
this plasmid, while the non-virulent biotype 1A strains do not have it. The 70-kb pYV plasmid 
governs the synthesis of a set of effector proteins called Yops (Yersinia outer membrane 
proteins), which are secreted by a type 3 secretion system (T3SS), namely the Yersinia 
secretion (Ysc-T3SS) locus, also encoded by the pYV plasmid. The adhesion protein YadA is 
another major virulence determinant synthetized by a pYV-encoded gene (see below). 
The Ysc-T3SS secretion machinery inhibits the host immune defenses by injecting cytotoxic 
Yops into the host cell cytosol, after contact between Yersinia and eukaryotic target cells 
(Cornelis, 2010). The Ysc-T3SS, whose basal structure resembles the bacterial flagellum, is 
composed of scaffold proteins, export apparatus proteins, ATPase complex, cytoplasmic 
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components, needle and translocator complex (Dewoody et al., 2013b). The complete 
injectisome  comprised a basal body, a needle and a translocator complex, which span the 
cytoplasmic membrane,  the peptidoglycan layer, and the outer membrane of the bacterium, 
extend to the extracellular milieu, and inserts into the host cell cytoplasmic membrane (Cornelis, 
2002). The efficient translocation of effector Yops into the cytosol of target cells requires the 
three translocator proteins, YopB, YopD and LcrV, which form a pore in the host cell membrane 
(Håkansson et al., 1993; Pettersson et al., 1999). The Yop translocation is tightly regulated in 
order to optimize the infectious process by Yersinia. In vitro, a temperature shift from 26 °C to 
37 °C and low calcium levels activate the Ysc-T3SS, whereas in vivo a physical contact with 
host cells is necessary (Heesemann et al., 1986a; Rosqvist et al., 1994). 
Once translocated into the host cell, Yop effector proteins enable survival of the invading 
Yersinia and their proliferation in lymphoid tissues (Table 4). The seven Yop effectors identified 
so far impair the dynamics of the cytoskeleton, therefore blocking phagocytosis by macrophages 
and polymorphonuclear leukocytes (YopH, YopT, YopE and YopO/YpkA); induce apoptosis in 
macrophages (YopP/YopJ); and interfere with the production of pro-inflammatory cytokines, 
chemokines and adhesion molecules (YopH) (Cornelis and Wolf-Watz, 1997). YopQ/YopK 
mainly regulates the translocation rate of Yop effectors into host cells and probably prevents the 
inflammasome activation (Brodsky et al., 2010; Dewoody et al., 2013a; Holmström et al., 1997; 
Thorslund et al., 2013). YopM, whose function still remains unclear, is the only effector detected 
into the nucleus of target cells (Skrzypek et al., 1998) and has been shown to be necessary for 
virulence in a mouse model (Leung et al., 1990). 
The non-fimbrial homotrimeric adhesin YadA plays a significant role in adherence and invasion 
of target cells by YE (Heesemann and Grüter, 1987; Pepe et al., 1995). YadA interacts with 
extracellular matrix proteins, such as cellular fibronectin, collagen and laminin (El Tahir and 
Skurnik, 2001), and protects the bacteria against the innate immune response of the host (Heise 
and Dersch, 2006). Transcription of yadA is controlled by two regulators, the plasmid-borne VirF 
and the chromosome-encoded YmoA, and yadA expression is upregulated at 37 °C. Osmolarity, 
pH, Fe3+ ion concentration and contact between bacterium and target cell also affect yadA 
transcription (Portnoy et al., 1984).  
1.2.3. Chromosome-encoded virulence factors 
Besides the important role played by the pYV plasmid, numerous chromosomal factors 
contribute to the virulence of Y. enterocolitica. Importantly, as summarized in Table 3, 
differences in the distribution of virulence determinants exist among the five YE biotypes. 
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Virulence factors found in all isolates include the invasin InvA, the LPS molecule, the Myf 
antigen, the Yst toxin, the urease and the flagella clusters. The Ail protein is present in 
pathogenic biotypes (1B and 2-5), whereas the high pathogenicity island HPI, the Ysa-T3SS and 
the Yts1-T2SS are harbored only by highly-virulent strains of biotype 1B. Lastly, the weakly-
virulent group of biotypes 2-5 specifically carries the Ysp/Ysa2-T3SS, Flag-2, Rtx and Tc 
clusters (Table 3). 
The invasin InvA is a 92 kDa outer membrane protein required for the entry of bacteria into the 
intestinal epithelial cells, by attachment to β1 integrins and stimulation of remodeling of actin 
filaments in the cytoskeleton of M cells (Miller et al., 1988; Pepe and Miller, 1993). Additionally, 
InvA is able to induce phagocytosis of Yersiniae by macrophages (Deuretzbacher et al., 2009). 
Temperature, pH and growth phase have a great influence on invA expression, which is 
significantly reduced at 37 °C (Pepe and Miller, 1993; Uliczka et al., 2011). InvA production has 
been shown to be different among various YE serotypes. Strains of serotypes O:8 and O:9 
efficiently express invA at environmental temperatures, while InvA is constitutively produced at 
both 22 °C and 37 °C in serotype O:3 strains (Uliczka et al., 2011). 
The lipopolysaccharide (LPS) is a major component of the membrane in gram-negative bacteria. 
Composed of lipid A, core and O-antigen, its completeness is necessary for full virulence of YE 
and the outer core of serotype O:3 has demonstrated virulence activity (al-Hendy et al., 1992; 
Skurnik et al., 1999; Zhang et al., 1997). Mutations in the O-ag gene cluster of YE serotype O:8 
were frequent in signature-tagged-mutagenesis screens, indicating a critical role for the O-ag 
during infection (Gort and Miller, 2000; Young and Miller, 1997). 
The Myf antigen, encoded by several myf genes, constitutes a fibrillar structure, with MyfA being 
the main subunit. The other proteins of the cluster include MyfB, a putative chaperone, MyfC, the 
membrane usher protein, and two transcriptional regulators, MyfE and MyfF (Iriarte et al., 1993). 
MyfA shows high similarity to the pH 6 antigen Psa, whose role in thermo-inducible binding and 
haemagglutination in Y. pseudotuberculosis is uncertain (Yang et al., 1996). In YE, however, the 
myf operon is not able to mediate haemagglutination and, therefore, its role in pathogenesis has 
to be clarified. 
YE is able to synthetize three highly identical heat-stable enterotoxins, encoded by the genes 
ystA, ystB and ystC. YstA, which is specifically produced by virulent strains, has a controversial 
role in YE pathogenesis. It induces fluid accumulation by increasing the concentration of cyclic 
GMP levels within intestinal epithelial cells (Robins-Browne et al., 1979), and stimulates both the 
nuclear and cytosolic levels of calcium and inositol triphosphate in rat intestinal epithelial cells, 
acting as causative agent of secretory diarrhea (Saha et al., 2009). On the other hand, a YE 
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serotype O:3 ystA-mutant maintained its virulence in a piglet model, and no toxin production was 
detected in diarrheal stool samples of experimental animals with YE-induced diarrhea (Robins-
Browne et al., 1985). The enterotoxin YstB is detected in isolates of the non-virulent biotype 1A 
(Ramamurthy et al., 1997), whereas YstC, whose gene is present in both virulent and non-
virulent isolates (Ramamurthy et al., 1997), demonstrated the highest toxicity of the three 
enterotoxins (Yoshino et al., 1995). 
Table 3 Relevant Y. enterocolitica virulence determinants and comparison among the three virulent 
groups. Modified from (Rakin et al., 2015). 
Genomic region / 
Gene cluster 
Function Highly-virulent  
(biotype 1B) 
Weakly-virulent 
(biotypes 2-5) 
Non-virulent 
(biotype 1A) 
pYV plasmid 
(Yop, Ysc, YadA) 
Invasion of the 
host 
+ + - 
InvA Invasion + + + 
Myf cluster Fibrillious 
adhesins 
+ + + 
Urease cluster Protection from 
acidic 
environment 
+ + + 
Flag-1 Motility + + + 
T2SS yts2 GSP + + + 
Ail Attachment and 
invasion 
+ + - 
YstA Enterotoxin + + - 
YstB Enterotoxin - - + 
HPI-PZ 
(Yersiniabactin) 
Dissemination in 
the host 
+ - - 
T3SS ysa-PZ Colonization of  
GI tract 
+ - - 
T2SS yts1-PZ GSP + - - 
T3SS ysp/ysa2 GSP - + + 
Rtx cluster Toxin - + +/-a 
Flag-2-PZ Motility - + - 
Tc proteins Insecticidal toxin - + - 
a+/-: detected in one 1A genome with low protein homology to the cluster of biotype 2-5 strains. 
Abbreviations: Ail, attachment invasion locus; GI, gastrointestinal; GSP, general secretion pathway; HPI, 
high pathogenicity island; Myf, mucoid Yersinia factor; pYV, Yersinia virulence plasmid; PZ, Plasticity 
zone; RTX, Repeats in Toxin; T2SS, type II secretion system; T3SS, type III secretion system; Tc, toxin 
complex; Yop, Yersinia outer membrane protein; ysa, Yersinia secretion apparatus; Ysc, Yop secretion; 
yts, Yersinia type II secretion; Yst, Yersinia heat-stable toxin. 
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Table 4 Yersinia Yop effectors and their functions during human infection. Modified from (Rakin et al., 
2015). 
Effector Biological activity Target Effect/feature 
YopE GAP Rac1, RhoG Actin depolymerization, inhibition of 
phagocytosis, of reactive oxygen species 
(ROS) production, and of the 
inflammatory response 
YopT Cysteine protease Rac, RhoA, 
Cdc42 
Actin depolymerization, inhibition of 
phagocytosis 
YopO/YpkA Ser/Thr kinase, GDI Gαq, RhoA, Rac Actin depolymerization, inhibition of 
phagocytosis 
YopH PTPase P130Cas, FAK, 
Paxillin, Fyb, 
SKAP-HOM, p85, 
Lck 
Disruption of peripheral focal complexes, 
impairing of T- and B-cell activation, 
inhibition of phagocytosis, of reactive 
oxygen species (ROS) production, and of 
the inflammatory response 
YopP/YopJ Cysteine protease 
Acetyltransferase ? 
MAKKs,  IKKβ, 
TRAF2, TRAF6, 
IKKα, IKKβ, and 
IkBα  
Prevention of NF-kB and MAPK 
activation, inhibition of inflammatory 
response, apoptosis in macrophages and 
dendritic cells 
YopM LRR protein PRK2, RSK1 Disruption of inflammasome formation 
and caspase-1 activation, depletion of NK 
cells, induction of IL-10 production 
YopQ/YopK Unknown Inflammasome Inhibition of inflammasome activation by 
regulating the rate of Yops translocation 
and preventing detection of T3SS by 
innate immune system  
Abbreviations: GAP, GTPase activating protein; GDI, guanine nucleotide dissociation inhibitor; PTPase, 
protein tyrosine phosphatase; FAK, focal adhesion kinase; Fyb, Fyn-binding protein; MAKK, mitogen-
activated kinase kinase; IKKβ, inhibitor-kappa B kinase β; NF-kB, nuclear factor kB; MAPK, mitogen-
activated protein kinase; LRR, leucine-rich repeat; PRK2, protein kinase C-like 2; RSK1, ribosomal S6 
protein kinase 1; NK, natural killer. 
All Yersinia species, except Y. pestis, show a positive phenotype for urease, a trimeric cytosolic 
enzyme able to hydrolyze urea to ammonia and carbon dioxide (de Koning-Ward and Robins-
Browne, 1996). The gene cluster is homologous between the three pathogenic Yersinia species 
and it comprises structural (ureA, ureB, ureC) and accessory (ureE, ureF, ureG, ureD) genes (de 
Koning-Ward et al., 1994). It is suggested that these genes are arranged in an operon-like 
manner, but whether they form a single unit (ureABCEFGD) or two polycistronic units (ureABC 
and ureEFGD) is not understood. Importantly, YE biotype 1A strains harbor a smaller ureB gene 
and larger intergenic regions (Bhagat and Virdi, 2009). Yersinia urease is a novel type of 
bacterial urease, since it is optimally active at acidic pH, it is maximally expressed at 28 °C 
rather than 37 °C, and it has a high affinity for urea (de Koning-Ward and Robins-Browne, 1997). 
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Yersinia may primarily use urease to live as saprophytes, degrading urea from soil and water. 
Urease may also contribute to the pathogenesis of YE by protecting the bacteria during their 
passage through the stomach, as supported by the fact that serotype O:3 and O:8 strains 
require urease to be fully virulent in infection models (Gripenberg-Lerche et al., 2000). 
Flagella are organelles that provide means for motility and for the export of proteins to the 
environment. The ability to produce flagella distinguishes the gastrointestinal pathogens YE and 
Y. pseudotuberculosis from Y. pestis, which has permanently lost this capability by mutations in 
the gene cluster (Young, 2004). Flagellum biosynthesis involves circa 50 genes, organized in the 
flagellar system 1 (Flag-1), which are expressed in a hierarchical cascade in three major flagellar 
gene classes. Class I genes consist of the flhDC operon and encode the transcriptional 
activators FlhD and FlhC, which are required for induction of all other flagellar genes (Young et 
al., 1999). Class II genes encode basal body and hook structural proteins as well as two 
regulatory components, FlgM and FliA (Iriarte et al., 1995; Kapatral et al., 1996). Class III genes 
encode proteins necessary for formation of the flagellum and chemosensory system. The 
production of flagella is regulated by environmental stimuli, such as temperature and salt 
concentration (Kapatral and Minnich, 1995; Kapatral et al., 1996; Young et al., 1999). Flagella 
may contribute to disease pathogenesis by initiating host cell invasion, helping the bacteria to 
migrate and attach to epithelial cells (Young et al., 2000). Experimental evidences support a 
reverse co-regulation of Inv and flagella expression, so that Yersinia are not motile after 
attachment to the host gut tissues (Badger and Miller, 1998). 
The attachment invasion locus (Ail) protein is a 17 kDa adhesin highly correlated with virulence, 
as it is present only in pathogenic strains. Its expression occurs exclusively at 37 °C and is 
affected by pH and oxygen level (Pederson and Pierson, 1995). Ail is a polypeptide folded into 
eight amphipathic β-sheets in the bacterial outer membrane (Miller et al., 1990). Ail is involved in 
adhesion to and invasion of tissue culture cells, as well as in resistance to serum, together with 
the pYV-encoded YadA (Miller et al., 2001). 
Presence of the High-Pathogenicity Island (HPI), encoding an iron acquisition system, is a main 
prerequisite for the highly pathogenic phenotype in Yersinia, as loss or inactivation of this 
system results in significant virulence attenuation in a mouse model (Heesemann et al., 1993; 
Perry and Fetherston, 2011). The HPI is restricted to some subgroups of the three pathogenic 
Yersinia species: serotypes O:1 and partly O:3 of Y. pseudotuberculosis, biotype 1B of YE, and 
all three biotypes of Y. pestis (de Almeida et al., 1993; Rakin and Garzetti, 2013; Rakin and 
Heesemann, 1995). The YE HPI genomic region is 43.1 kb long and can be divided into two 
distinct parts: the highly conserved right-hand part, named the “yersiniabactin” locus, and the 
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variable left-hand part (Rakin et al., 1999). The genetic locus of the high-affinity, iron-chelating 
system yersiniabactin is composed of 11 genes, organized in four operons, which can be divided 
into three functional parts, namely biosynthesis, transport into the bacterial cell, and regulation 
(Pelludat et al., 1998). Yersiniabactin biosynthesis is strictly regulated by the transcriptional 
regulator YbtA and the FurA repressor (Perry et al., 1999). The left-hand part of YE biotype 1B 
HPI contains a cluster of four IS elements and seven other ORFs that have no significant 
similarity to any known gene (Carniel et al., 1996; Rakin et al., 1999). The HPI confers on the 
bacteria the ability to capture iron ions bound to eukaryotic molecules (such as hemoglobin, 
transferrin, ferritin and myoglobin) via the yersiniabactin, and subsequently to disseminate in 
mammalian hosts and to cause systemic infections. Therefore, the ability of YE biotype 1B 
strains to proliferate and be virulent in mice strongly correlate with the capability to capture iron 
from host tissues through yersiniabactin (Heesemann, 1987). 
Besides the pYV-encoded Ysc T3SS, to colonize the GI tract YE biotype 1B can utilize a 
chromosomal T3SS, named Ysa-T3SS (Yersinia secretion apparatus) (Haller et al., 2000). The 
Ysa-T3SS genetic cluster is located within the so called “plasticity zone” (PZ) region in serotype 
O:8 strains (Thomson et al., 2006) and resembles the T3SS-1 encoded within the Salmonella 
enterica SPI-1 and the Shigella Mxi-Spa T3SS (Foultier et al., 2002). Eight Ysp (Yersinia 
secreted protein) effectors have been so far identified: YspA, YspE, YspF, YspI, YspK, YspL, 
YspM, and YspP (Foultier et al., 2003); however, functional activity has been clarified for only 
few of them (Matsumoto and Young, 2006, 2009). The Ysa-T3SS has been shown to play an 
important role during the earliest stages of infection in the GI tract, and to facilitate the 
overcoming of the host immune barriers (Venecia and Young, 2005). 
Two T2SS, Yts1 and Yts2, have been identified in YE (von Tils et al., 2012). Yts2 is present in all 
YE isolates, while Yts1 can be found only in highly-virulent YEE strains, as part of the PZ (Iwobi 
et al., 2003; Thomson et al., 2006). Yts1, mainly active at low temperatures and in presence of 
high concentrations of Mg2+, is involved in dissemination and colonization of deeper tissues, 
such as liver and spleen (von Tils et al., 2012). Additionally, a role of the Yts1 system in survival 
of the bacteria in an environmental habitat has been suggested by in vitro functional 
characterization of the Ysp secreted proteins (Shutinoski et al., 2010). Concerning the Yst2 
T2SS, its biological function is still unknown. 
Y. enterocolitica subsp. palearctica lack the HPI and the two Ysa and Yts1 secretion systems 
specifically present in the highly-virulent YEE strains. Nevertheless, strains of biotypes 1A and 2-
5 carry additional factors, potentially associated with their adaptation to the host. The Ysp/Ysa2-
T3SS, homologous to the SPI-2 T3SS in Salmonella and collinear to respective regions in 
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Y. intermedia and Y. frederiksenii, lack identified effector proteins (Batzilla et al., 2011a). Its 
biological activity and, therefore, its possible role in YEP pathogenesis require a better 
characterization. 
An Rtx cluster, detected in biotypes 2-5 and in some biotype 1A genomes, encodes an RtxC 
activator, an RtxH peptide chain release factor, and a large RtxA cytotoxin (Batzilla et al., 2011a; 
Fuchs et al., 2011; Wang et al., 2011). This toxin may contribute to YE pathogenesis, by forming 
pores in the host cell membranes and/or inducing Ca2+ release, as it has been demonstrated for 
Rtx toxins produced by other Gram-negative bacteria (Linhartová et al., 2010; Liu et al., 2009; Lo 
et al., 2011). 
For another toxin complex, the insecticidal toxin cluster (Tc), biological activity has been 
demonstrated in a weakly-virulent YE serotype O:9 strain, which showed higher toxicity toward 
the larvae M. sexta, compared to toxin-depleted strains (Fuchs et al., 2008). However, a function 
of the insecticidal Tc toxin in Yersinia virulence to mammals cannot be excluded. 
A second flagellar cluster, Flag-2, absent from biotypes 1A and 1B strains, may contribute to 
motility of weakly-virulent strains. Functionality of the genes from a YE serotype O:9 strain has 
been proved by swarming assay, and their expression was high at 20 °C and dependent on the 
Flag-1 master regulator FlhC (Bresolin et al., 2008). The possible role of this cluster in virulence 
and host cell invasion is still unproven. 
1.3. Isolation and diagnosis of Yersinia enterocolitica 
1.3.1. Culture-based methods and serotyping 
Cultivation and isolation of Y. enterocolitica from clinical, food and environmental samples is the 
first step for identification of pathogenic strains and diagnosis of yersiniosis, whose causative 
agents include not only YE but also Y. pseudotuberculosis (EFSA and ECDC, 2013). Isolation 
methods are affected by the source and stage of infection. Direct plating of samples on 
conventional enteric media is usually successful for pathogenic strains from patients with acute 
gastroenteritis or organ abscesses, where YE is the dominant bacterium. On the other hand, in 
asymptomatic carriers, food or environmental samples, this method is rarely successful and 
enrichment in liquid media before isolation on solid media is necessary (Fredriksson-Ahomaa 
and Korkeala, 2003). Cold enrichment (Aulisio et al., 1980) takes advantage of the 
psychrotrophic nature of YE. It is performed incubating the specimens at 4 °C for 1-3 weeks in 
phosphate buffer or in phosphate-buffered saline (PBS) with sorbitol and bile salts (PSB), with or 
without treatment with potassium hydroxide, and plating the inoculum onto selective agar plates, 
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such as CIN (Cefsulodin-irgasan-novobiocin) or SSDC (Salmonella-Shigella deoxycholate 
calcium chloride) agar (Schiemann, 1979; Wauters, 1973). Alternatively, selective enrichment in 
media culture with antimicrobial agents can be used. Several media have been reported: MRB 
(modified Rappaport broth) and ITC (irgasan, ticarcilin, and chlorate) media successfully 
recovered YE strains of bioserotype 4/O:3 (de Boer, 1992), while the BOS (bile-oxalate-sorbose) 
medium is particularly useful for bioserotype 1B/O:8 (Schiemann, 1982). Enrichment in PSB 
broth has shown to give better results for non-pathogenic strains, whereas for pathogenic strains 
enrichment in ITC broth is more efficient (Wauters et al., 1988). Identification of YE from colonies 
on CIN agar plates is then carried out by biochemical tests such as fermentation of sucrose, 
rhamnose, and melibiose. Commercial systems like API 20E and ID 32E provide reliable 
alternatives to conventional tube tests (Manafi and Holzhammer, 1994; Neubauer et al., 1998). 
Pathogenicity of YE isolates can be assessed by the pyrazinamidase and autoagglutination tests 
(Kandolo and Wauters, 1985; Laird and Cavanaugh, 1980). The pyrazinamidase test allows 
differentiation between potentially pathogenic and nonpathogenic strains, showing negative and 
positive reactions, respectively. Autoagglutination at 37 °C is a phenotypic characteristic 
associated with the virulence plasmid, and in particular with the YadA protein, together with 
calcium dependence and uptake of Congo red and crystal violet, which are all indirect markers 
used to identify pathogenic YE isolates. Notably, the pYV plasmid can be lost after a few 
subcultures, especially at 37 °C, of YE strains, thus showing negative reactions in tests fro pYV-
associated phenotypes (Fukushima et al., 2011). Therefore, direct methods are required to 
assess the potential pathogenicity of a strain, even if pYV-negative. 
Since a correlation exists between the serotype of YE isolates and their ability to cause infection, 
serotyping is an important diagnostic tool for this species (see section 1.1.1). Classical 
serotyping of YE is performed by slide agglutination with O-antigen specific typing antisera. 
Commercial monovalent (serotypes O:3, O:8, O:9, O:5) or polyvalent (serotypes O:1 and O:2) 
antisera from immunized rabbits are nowadays extensively used. If the tested YE strain 
possesses the O-ag recognized by the antisera antibody, a clear agglutination reaction of the 
bacterial mass will appear. Despite the feasibility and simplicity of this method, it has several 
drawbacks: isolates which do not express the O-ag (rough LPS) in experimental conditions 
cannot be typed with the traditional agglutination test; cross-reactions may occur, as between 
YE serotype O:9 and Brucella sp. (Godfroid et al., 2002); it is not possible to infer virulence by 
serotyping itself, since, for example, some strains of serotype O:8, frequently O:8,7, belong to 
the non-virulent group 1A (Bottone, 1997); subjective interpretation of the results is required. 
Even though a PCR-based O-genotyping method has been developed for identification and 
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serotyping of Y. pseudotuberculosis and Y. pestis (Bogdanovich et al., 2003), such a test is not 
yet available for Y. enterocolitica. 
1.3.2. Molecular methods for Y. enterocolitica detection 
With the conventional culture-dependent methods, identification of Y. enterocolitica can be 
supposedly done in 36-48 hours, but confirmation may take more than 14-21 days. Moreover, 
biochemical reactions do not guarantee good identification at species level. In the past decades, 
researchers have attempted to develop rapid and reliable molecular methods for detecting YE 
directly in natural samples (Fredriksson-Ahomaa et al., 2006). Nucleic acid-based methods 
permit fast detection of DNA with high specificity and sensitivity. Several PCR, real-time PCR 
and colony hybridization assays have been designed to verify the pathogenicity of YE isolates, 
targeting specific region of the virulence plasmid and/or the chromosome (Fredriksson-Ahomaa 
and Korkeala, 2003). The most used pYV-encoded genetic targets are yadA, encoding the 
essential virulence protein YadA, and virF, a regulatory gene involved in the coordinated thermal 
induction of virulence determinants (Brubaker, 1991). Due to the possible plasmid loss during 
laboratory subculturing, chromosomal gene targets, including ail, inv, yst and Yersinia-specific 
region of the 16S rRNA gene, have been applied to molecular diagnosis of YE (Fredriksson-
Ahomaa and Korkeala, 2003). Multiplex PCR assays able to detect various genotypic features 
have been also designed, combining pYV- and chromosome-encoded determinants (Harnett et 
al., 1996; Kaneko et al., 1995). Single PCR assays targeting the rfbC (dTDP-4-deoxyrhamnose-
3,5-epimerase) and per (perosamine synthetase) genes of the O-antigen clusters have allowed 
differentiation of YE serotypes O:3 and O:9, respectively, from other pathogenic serotypes 
(Jacobsen et al., 2005; Thisted Lambertz and Danielsson-Tham, 2005). Importantly, due to the 
complex composition of natural samples such as blood, feces, meat and soil, PCR inhibitory 
compounds may be present and sensitivity of the test reduced (Rossen et al., 1992). Therefore, 
sample preparation steps prior PCR are recommended, including enrichment, dilution, filtration, 
centrifugation, and adsorption (Fredriksson-Ahomaa and Korkeala, 2003).  
1.4.  Epidemiology of Yersinia enterocolitica 
In Europe, yersiniosis is the third most frequently reported zoonotic gastrointestinal disease in 
humans, after campylobacteriosis and salmonellosis (ECDC, 2013). The number of yersiniosis 
cases has dropped with a statistically significant five-year trend in 2007-2011 (Figure 3). In 
particular, six countries reported this reduction (Denmark, Germany, Lithuania, Slovenia, Spain 
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and Sweden), while an increasing trend was noted in Hungary, Romania and Slovakia (EFSA 
and ECDC, 2013). 
 
Figure 3 Trend of confirmed cases of yersiniosis reported in Europe. Modified from (ECDC, 2013). 
In 2011, a total of new 7,041 confirmed cases (2.20 cases per 100,000) of human yersiniosis 
were reported in the EU, increasing by 2% on 2010 (ECDC, 2013). In the same year in the USA 
the number of newly confirmed Yersinia infections was 163 (0.34 per 100,000 population) (CDC, 
2012), indicating a clearly higher incidence of YE foodborne infections in European countries 
compared to USA. Importantly, yersiniosis cases in Germany accounted for almost half of all 
reported European yersiniosis events (47.5%, 3,345 confirmed cases), while Lithuania and 
Finland showed the greatest notification rates (11.40 and 10.31 cases per 100,000 population, 
respectively) (ECDC, 2013), supporting the high incidence of yersiniosis in temperate and cold 
countries. High numbers of cases of gastrointestinal illness due to yersiniosis have been also 
observed in many developing countries like Bangladesh, Iraq, Iran, and Nigeria, indicating 
probable food safety problems (Rahman et al., 2011). Overall, Y. enterocolitica has been 
isolated in various countries on all continents (Carniel, 2006), and account for 98.4% of 
confirmed yersiniosis cases (Y. pseudotuberculosis represents circa 1%) (EFSA and ECDC, 
2013). Biotype 4 is the most prevalent biotype isolated from humans, followed by biotype 2 and 
biotype 3, with serotype O:3 predominating in Europe, Japan and North America, serotype O:9 
in England and serotype O:5,27 in Russia (Griffin, 2008). Also biotype 1A strains, even though 
lacking most of the classical virulence markers, have been isolated from patients with diarrhea, 
supporting the pathogenicity of some biotype 1A strains (Burnens et al., 1996; Greenwood and 
Hooper, 1987; Huovinen et al., 2010; Ratnam et al., 1982). 
Human infections most frequently occur as sporadic cases or, rarely, as small outbreaks. Direct 
person-to-person contact has been suspected as source of infection in a nosocomial outbreak 
due to YE bioserotype 1A/O:5 in hospitalized patients (Ratnam et al., 1982), and indirect person-
Introduction  16 
to-person transmission by transfusion of blood products from donors suffering from latent 
yersiniosis has often occurred (Bottone, 1999). However, transmission of YE occurs most 
commonly by the fecal-oral route. Although transmission of pathogenic YE from pigs to humans 
has not been proven, the main sources of human infection are thought to be through the 
handling of swine and the consumption of raw pork meat. Pigs do not develop diseases, but are 
known to carry the bacteria in their oropharynx, nasopharynx and their intestine (Nesbakken et 
al., 2003; Thibodeau et al., 1999). Consumption of contaminated and inadequately heated food 
has been suggested as the most common source of intestinal yersiniosis, even though 
pathogenic isolates have rarely been recovered from food samples (Prpic et al., 1985), probably 
due to limited sensitivity of culture methods (Fredriksson-Ahomaa and Korkeala, 2003). 
Nevertheless, YE has been detected in milk and milk products, egg products, beef, pork, lamb 
and poultry meats, vegetables, and other food products (Rahman et al., 2011). Drinking water 
has been reported as a source of YE biotype 1B infection (Ostroff et al., 1994). Overall, the 
majority of YE isolates recovered from environmental samples, such as from slaughterhouses, 
soil, and water, belong to the non-virulent biotype 1A (Berzero et al., 1991; Cork et al., 1995). 
Y. enterocolitica is able to endure repeated freezing and thawing cycles and to survive in frozen 
foods (Bhaduri, 2006), making refrigerated aliments potential vehicles for infection. Additionally, 
YE grows, even though with low efficiency, at refrigeration temperatures thanks to its 
psychotropic nature. Notably, poor sanitation, inadequate sterilization techniques and improper 
storage may contribute to food contamination. Therefore, general food hygiene guidelines, like 
accurate washing of raw fruits and vegetables, adequate food cooking, and consumption of 
pasteurized milk, might significantly reduce the risk of YE contamination (Kapperud, 1991; 
Lampel et al., 2009). 
1.4.1. Molecular subtyping of Yersinia enterocolitica 
Subtyping is an important tool in epidemiology for recognizing outbreaks, detecting cross-
transmission of pathogens and determining the source of an infection. Y. enterocolitica strain 
differentiation has typically relied on phenotypic characteristics, such as biotype, serotype, 
phage type and antibiogram type. These methods have provided valuable information on the 
epidemiology and taxonomy of this microorganism; however, they have some limitations. The 
biotyping scheme well correlates with the pathogenicity of YE, but atypical strains are frequent. 
Preparing monospecific antisera for serotyping is tedious and technically laborious; moreover, 
commercial antisera are available for only some serotypes, and a complete set of antisera is 
accessible in few laboratories in the world. Phage typing, being also a technically demanding 
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procedure, is performed in specialized laboratories and is not commonly used. Antibiotic 
susceptibility tests have demonstrated limited efficacy in assessing heterogeneity among YE 
isolates (Virdi and Sachdeva, 2005). Therefore, also due to technological advances in molecular 
techniques, genotyping methods have recently become more reliable typing tools. Molecular 
subtyping of YE has been performed by different approaches, allowing characterization of 
strains belonging to the same bioserotype and, consequently, tracking the spread of clones and 
the source of an infection (Table 5). 
Multi-locus enzyme electrophoresis (MLEE) relies on the relative electrophoretic mobility of a 
large number of intracellular enzymes. Differences in mobility are directly related to amino acid 
substitutions, caused by mutations at the corresponding gene locus, which affect the net charge 
of the protein. The unique profile produced by each strain is called electromorph type (ET). 
Application of MLEE for YE subtyping has shown clustering of strains into two groups, 
represented by serotypes O:1,2, O:3, O:5,27 and O:9 on one side, and O:8, O:13 and O:21 on 
the other (Caugant et al., 1989). Other studies have indicated that YE strains belong to one 
cluster, and subgroups within this cluster most often equal the bioserotypes of the isolates 
(Dolina and Peduzzi, 1993; Goullet and Picard, 1988). However, within one bioserotype the 
discriminatory power was not enough satisfactory, as strains of different serotypes could have 
the same ET. 
Restriction endonuclease analysis of chromosome (REAC) requires cleavage of genomic DNA 
by restriction enzymes and separation of the resulting fragments by gel electrophoresis. REAC 
has been used to study polymorphisms among YE strains belonging to different bioserotypes, 
resulting in 22 bioserotype-specific distinct fragment patterns amongst 72 Yersinia strains 
(Kapperud et al., 1990). Some DNA profiles also varied within the same bioserotype. This 
method showed the best discriminatory power within bioserotype 1B/O:8 strains, whereas 
bioserotypes 3/O:3, 4/O:3, 2/O:5,27 and 2/O:9 were more homogeneous. Moreover, most of the 
strains of bioserotype 4/O:3 isolated in Norway could not be distinguished, indicating an overall 
genetic homogeneity. The interpretation of complex profiles, consisting of hundreds of 
unresolved and overlapping bands, is a major limitation of this technique. Restriction 
endonuclease analysis of the plasmid (REAP) is based on the comparison of banding patterns 
which result from extraction and endonuclease-digestion of the pYV virulence plasmid present in 
pathogenic YE strains. Mostly, REAP studies have demonstrated serotype-specific profiles, with 
O:8 strains displaying the highest degree of polymorphism, and O:3 and O:9 strains exhibiting 
low diversity (Iteman et al., 1996; Kapperud et al., 1990; Kwaga and Iversen, 1993; Nesbakken 
et al., 1987). Another study reported close correlation between REAC and REAP patterns of 
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serotype O:5,27 strains (Fukushima et al., 1993). The REAP method is rapid and easy to 
perform, but it is not applicable to non-virulent strains or to virulent strains cured of their plasmid. 
Overall, it appears that the use of REAC and REAP for molecular epidemiological tracing of YE 
might not bring valuable information. 
Ribotyping refers to the analysis of the restriction fragment length polymorphisms generated 
after hybridization of digested bacterial genomic DNA with a ribosomal probe. Strain-specific 
fingerprints can be obtained based on the number and position of the rRNA operons. Several 
studies have applied this technique to YE typing, but the results are not comparable since 
different enzymes have been used (Fukushima et al., 1998; Lobato et al., 1998; Mendoza et al., 
1996). In these analyses ribotyping has partly allowed the distinction of subtypes within a certain 
bioserotype, with good correlation between phenotypic and ribotypic traits. However, ribotypic 
polymorphisms appeared to be higher for biotype 1A or 1B strains detected in the environment, 
than for those adapted to animal hosts, such as bioserotypes 4/O:3 and 2/O:9. This technique 
could therefore be useful to trace the spread of YE over the world but it has limited interest for 
outbreak investigations. Moreover, the use of ribotyping on routine basis is hindered by technical 
unfeasibility, long experimental time and costs. 
Pulsed-field gel electrophoresis (PFGE) is considered the gold-standard for different bacteria 
molecular subtyping. It permits analysis of the whole bacterial genome, using various rare-
cutting restriction enzymes and separation of the resulting large-size DNA fragments by special 
electrophoretic apparatus. This technique has shown the highest discriminatory power for YE 
epidemiological tracing (Iteman et al., 1996). In different studies, strains demonstrated low 
genomic variability within each bioserotype, and therefore major serotype-specific pulsotypes 
could be delineated (Asplund et al., 1998; Najdenski et al., 1994, 1995; Saken et al., 1994). 
Pulsotypes seemed also to be more closely related to the biotype than to the serotype 
(Buchrieser et al., 1994; Najdenski et al., 1994). PFGE produces highly reproducible restriction 
profiles that usually show distinct and well-resolved fragments. However, optimal enzyme and 
gel electrophoresis conditions have not yet been established; the enzymes produce a large 
number of closely spaced restriction fragments, which make analysis of patterns difficult. 
PCR is a versatile technique that has been used in several variations for molecular genotyping 
of bacteria. The randomly amplified polymorphic DNA (RAPD) assay makes use of the random 
amplification of genomic DNA at low annealing temperatures with arbitrarily selected primers, 
which do not target any specific bacterial sequence. Studies that used RAPD for typing YE 
strains showed a relatively weak correlation between their RAPD clusters and bioserotypes, and 
only in some cases the technique was able to efficiently discriminate among isolates belonging 
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to the same bioserotype (Leal et al., 1999; Odinot et al., 1995; Rasmussen et al., 1994). RAPD-
defined subtypes of pathogenic YE strains correlated well with the geographical origin (Blixt et 
al., 2003). RAPD is an easy and quick technique, but has low reproducibility and standardization 
of the technique is difficult. Repetitive element PCR (rep-PCR) is based on primers targeting 
interspersed repetitive DNA elements spread through the whole bacterial genome to generate 
specific genomic fingerprints. Two families of repetitive elements, the repetitive extragenic 
palindromic (REP) and enterobacterial repetitive intergenic consensus (ERIC) sequences, have 
been used to differentiate YE strains (Sachdeva and Virdi, 2004; Wojciech et al., 2004). YE 
isolates with different serotypes produced identical rep-profiles, indicating limited genetic 
heterogeneity. Overall, although both REP and ERIC genotyping gave comparable results, REP-
PCR proved to be more discriminatory than ERIC-PCR. PCR ribotyping, or 16S–23S intergenic 
spacer region typing, takes advantage of variations in the number of copies and sizes of 16S–
23S spacer region of the rrn operon. DNA is amplified by PCR with defined primers, the PCR 
products are digested with a restriction enzyme, and the resulting fragments electrophoretically 
resolved. YE strains with similar ribotypes have been differentiated into specific sub-types with 
this method, even though same PCR-ribopatterns resulted from strains belonging to different 
serotypes (Lobato et al., 1998). The discriminatory power of PCR-ribotyping was shown to be 
similar to ERIC-PCR but lower than REP-PCR when strains of different bioserotypes were 
analyzed (Wojciech et al., 2004). 
Variable number tandem repeats (VNTRs) are short nucleotide sequences repeated in tandem 
in variable numbers, causing polymorphisms in these loci. VNTR-based typing is considered a 
valuable epidemiological tool to characterize bacterial species, especially if genetically 
homogeneous and difficult to type with other techniques (van Belkum, 1999). A VNTR locus 
identified and characterized in several strains of YE was found to be polymorphic in strains of 
bioserotype 4/O:3 (de Benito et al., 2004). Interestingly, analysis of this locus in eight strains 
belonging to the same pulsotype showed seven different alleles, improving the discriminatory 
power of PFGE. Multi-Locus VNTR (MLVA) approaches have proved to be a promising tool for 
YE outbreak investigations, due to their high discriminatory power (Gierczyński et al., 2007; 
Sihvonen et al., 2011; Virtanen et al., 2013). One study, specific for strains of YEP, could 
distinguish 76 genotypes among 91 isolates of different bioserotypes and geographical origins, 
and 41 genotypes among 51 bioserotype 4/O:3 isolates, demonstrating high resolution power. A 
minor correlation between genotypes and serotypes was observed. A more recent MLVA 
method has detected 312 different MLVA patterns when genotyping 379 YE isolates from human 
patients, pigs at slaughterhouses, and pork samples from meat stores. The method was 
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applicable for serotypes O:3, O:5,27, and O:9 and appeared to be a highly discriminating tool for 
distinguishing sporadic and outbreak-related strains. 
Amplified fragment length polymorphism (AFLP) is an approach based on selective PCR 
amplification of restriction fragments from digested genomic DNA. Its steps require restriction of 
DNA, ligation of oligonucleotide adapters, selective amplification of sets of restriction fragments, 
and gel analysis of the amplified products. AFLP is normally performed with a combination of a 
6-base-specific and a 4-base-specific restriction enzyme and fluorescent-labelled primers. 
Results are interpreted using gene scan analysis software, rendering AFLP an effective means 
of DNA fingerprinting for bacterial DNA. YE studied by an AFLP method (Fearnley et al., 2005), 
which included 70 strains belonging to different bioserotypes and sources, showed clustering of 
strains into two groups, biotypes 2–5 and biotypes 1A and 1B, respectively. AFLP profiles further 
differentiated strains within these two clusters and within the resulting serotype-related 
subclusters, indicating a high discriminatory power of this method for YE. Another recent AFLP 
genotyping study demonstrated high clonality of strains isolated from American pigs, regardless 
of geographical origin or production system (Tadesse et al., 2013). In some cases, genetic 
diversity was observed in isolates that originated from the same farm with the same phenotype. 
Rapid development of cost-effective NGS (next generation sequencing) techniques has recently 
made sequencing a good alternative method for genotyping bacterial isolates. A PCR strategy 
based on 16S rRNA gene sequencing, for example, has been developed for unambiguous 
identification of isolates identified as YE by biochemical tests (Neubauer et al., 2000b). 
Moreover, based on the sequencing of specific housekeeping genes, multilocus sequence typing 
(MLST) methods have been developed for Yersinia typing (Duan et al., 2014; Kotetishvili et al., 
2005; Laukkanen-Ninios et al., 2011). YE strains showed some polymorphisms between 
different bioserotypes and within the same bioserotype; however, the pathogenic YE strains 
formed a relatively conserved group, with serotypes O:3, O:8, and O:9 separated into three 
distinct blocks. 
To conclude, PFGE typing is highly effective in molecular epidemiological studies of 
Y. enterocolitica and is more efficient than other molecular methods in discriminating among 
isolates of the same bioserotype. The highly-discriminatory AFLP and MLST techniques could 
provide a means of differentiating YE strains detected as identical with other genotyping tools. 
The recent progresses in sequencing technologies will allow rapid strain comparison on a single 
nucleotide level (e.g. SNPs), providing higher sensitivity and discriminatory power for strains 
within the same serotype. 
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Table 5 Comparison of methods for molecular subtyping of Y. enterocolitica isolates. 
Modified from (Fredriksson-Ahomaa et al., 2006; Virdi and Sachdeva, 2005). 
Method Typeability Reproducibility Discriminatory power Use Interpretation 
MLEE Excellent Good Good Moderate Moderate 
REAP Variable Good Poor Easy Easy 
REAC Excellent Moderate Moderate Easy Difficult 
Ribotyping Excellent Excellent Variable Moderate Easy 
PFGE Excellent Excellent Good Moderate Easy 
PCR Excellent Moderate Variable Easy Moderate 
VNTR Variable Good Moderate Moderate Moderate 
AFLP Excellent Good Good Moderate Moderate 
DNA 
sequencing Excellent Excellent Good Difficult Moderate 
 
1.4.2. Yersinia enterocolitica bioserotype 4/O:3 
In Europe, Japan and Canada, Y. enterocolitica strains most frequently isolated from human 
patients belong to bioserotype 4/O:3 (80 to 90%); even though in USA bioserotype 1B/O:8 has 
traditionally been the most predominant, recently 4/O:3 strains have also emerged (Fredriksson-
Ahomaa, 2007). YE serotype O:3 has been responsible for several outbreaks in different 
countries, but the source of infections remained undetected (Jones, 2003; Lee et al., 1990; 
Maruyama, 1987; Olsovsky et al., 1975). In general, outbreaks of YE O:3 gastroenteritis are 
more uncommon than sporadic infections (Fredriksson-Ahomaa, 2007). YE bioserotype 4/O:3 
strains pathogenic for humans have been isolated from mostly asymptomatic pigs, which are 
recognized as the main reservoir of this bioserotype (Kapperud, 1991). The bacteria mainly 
colonize tonsils, pharynx and intestinal tract of the pigs without inducing disease (Nesbakken et 
al., 2003). The prevalence of this bioserotype in pig slaughterhouses has been reported to be 
higher than 50% in Finland (Korte et al., 2004) and in southern Germany (Fredriksson-Ahomaa 
et al., 2001). Moreover, serotype O:3 is predominant among isolates recovered from slaughter 
pigs in the USA (Bhaduri et al., 2005; Tadesse et al., 2013) and in Brazil (Paixao et al., 2013a). 
Consumption of contaminated pork products has been often suspected to be the main source of 
YE bioserotype 4/O:3 infections, but the connection between human and animal isolates is not 
well understood. Contamination of meat with YE probably occurs during slaughtering and 
processing of carcasses (Laukkanen et al., 2009). Bioserotype 4/O:3 strains have been detected 
from raw pork products, such as pig tongues and minced pork, at retail level (Bucher et al., 
2008; Fredriksson-Ahomaa et al., 1999; Messelhausser et al., 2011). Moreover, YE bioserotype 
4/O:3 is able to grow in modified atmosphere-packed pig cheek meat at 6 °C (Fredriksson-
Ahomaa et al., 2012). 
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Several DNA fingerprinting approaches have been used to study genotypic diversity among 
bioserotype 4/O:3 strains, indicating a general limited genetic diversity and a high similarity 
between human and pig isolates (Fredriksson-Ahomaa et al., 2006). In particular, the pulsotypes 
obtained from PFGE analyses on YE bioserotype 4/O:3 strains have shown high homogeneity 
(Asplund et al., 1998; Iteman et al., 1996; Najdenski et al., 1994; Saken et al., 1994). PFGE 
characterization of bioserotype 4/O:3 strains recovered from tonsils of Bavarian slaughter pigs 
revealed the presence of one genotype common to most of the farms (Fredriksson-Ahomaa et 
al., 2010). However, PFGE genotypes differed from German and Finnish strains, indicating a 
different geographical distribution (Fredriksson-Ahomaa et al., 2003). AFLP, ERIC-PCR, and 
PFGE have been recently applied to characterize YE bioserotype 4/O:3 isolates from Brazilian 
slaughterhouses, showing more than 80% identity among the 61 tested isolates (Paixao et al., 
2013a). AFLP presented higher discriminatory power than ERIC-PCR, and PFGE was the best 
technique for genetic differentiation of bioserotype 4/O:3 strains, even though all the isolates 
presented identity higher than 91%. In all, the isolates tended to be grouped according to the 
slaughterhouse of origin. In Chinese abattoirs, YE pathogenic isolates from pigs mainly 
belonged to bioserotype 3/O:3 and could be differentiated into 49 PFGE patterns (Liang et al., 
2012). Human and pig isolates from the same geographic area gave indistinguishable patterns, 
suggesting that swine are the source of YE human infections. The same conclusion has been 
recently drawn by a study from Italy, where 22 YE bioserotype 4/O:3 pig isolates showed a 
moderate degree of genetic diversity by PFGE and clustered together with 4 human isolates 
(Bonardi et al., 2014). More comprehensive studies on the genetics of human and porcine YE 
bioserotype 4/O:3 strains are therefore necessary to confirm these preliminary evidences that 
swine are the main reservoir of human pathogenic bioserotype 4/O:3 strains. 
1.5. Yersinia enterocolitica genomes 
During the last decade, several Y. enterocolitica genomes have been sequenced and published. 
To date, three complete genome sequences from human isolates are available: YE strain 8081, 
belonging to bioserotype 1B/O:8 (Thomson et al., 2006); YE strain Y11, of bioserotype 4/O:3 
(Batzilla et al., 2011c); and YE strain 105.5R(r), of bioserotype 3/O:9 (Wang et al., 2011). 
Moreover, numerous whole genome shotgun sequences have been obtained from clinical, 
environmental and animal strains of different bioserotypes, including weakly-virulent serotypes 
O:5,27, O:3 and O:9 and non-virulent serotypes O:5 and O:36 (Batzilla et al., 2011a; Batzilla et 
al., 2011b; Fuchs et al., 2011; Klinzing et al., 2012; Reuter et al., 2012; Savin et al., 2013). 
Comparative genome analyses have mainly been performed in order to identify intra-species 
regions of difference among YE strains, using the highly-virulent strain 8081 as reference. 
Introduction  23 
The single circular chromosome of YE has a size of about 4.5-4.8 Mb, with a G+C content of 47-
48% and 7 rRNA operons. Besides harboring dissimilar virulence determinants (as described in 
section 1.2.3 and in Table 3), other metabolism-associated genetic clusters are differentially 
present in the sequenced genomes. An ATP binding cassette transporter system, encoded by 
the Aat cluster, has been identified in the weakly-virulent YE serotypes O:3 and O:9 strains, 
while it is absent from the highly-virulent strain 8081 (Batzilla et al., 2011a; Wang et al., 2011). 
Even though the functionality of this cluster has not been characterized in YE, a possible role in 
pathogenesis cannot be excluded, since in enteroaggregative E. coli this system transports 
dispersin protein out of the bacterial cells, therefore participating in virulence (Nishi et al., 2003). 
The agaVWEF operon, which encodes the enzymes necessary for utilization of the intestinal 
mucin component N-acetyl-galactosamine, is absent from YEE (Batzilla et al., 2011a). Since the 
mucus of the pig’s small intestine is mainly composed of N-acetyl-galactosamine (Mantle et al., 
1980), the aga cluster may serve as fitness factor in YEP, especially for the pig-adapted 
bioserotype 4/O:3 strains. Multiple serotype- or strain-specific bacteriocins and toxin-antitoxin 
systems have been also detected in YE genomes, conferring the bacteria further advantages for 
efficient colonization of their ecological niches. 
The most relevant differences in YE genomes are mobile elements, specifically genomic islands 
and prophages. The Yersinia genomic island YGI-1 is restricted to the virulent biotypes 1B and 
2-5; YGI-2, highly conserved in various members of Enterobacteriaceae, has been only detected 
in biotypes 1A and 1B; YGI-3, a putative integrated plasmid, is unique to strain 8081; lastly, the 
integrated plasmid YGI-4 is variably present in biotype 1B only (Thomson et al., 2006). On the 
other side, YE bioserotype 4/O:3 strains harbor the novel GIYep-01 island, which has been 
proved to be actively mobile through its functional integrase in strain Y11 (Batzilla et al., 2011a). 
Most of the YE novel genomic regions are composed of prophages and prophage-like elements. 
None of the four prophages identified in strain 8081 are conserved among YEP genomes. In 
particular, ΦYE250 is strain-specific, while ΦYE98, ΦYE185 and ΦYE200 are partially detected 
in various 1B isolates (Thomson et al., 2006). Prophage regions have been also specifically 
acquired by YE strain Y11. PhiYep-1 has been found to be highly similar to prophages CUS-1 of 
E. coli and Ypf of Y. pestis, but it is not complete in other bioserotype 4/O:3 strains (Batzilla et 
al., 2011a). Two P2-like prophages, PhiYep-2 and PhiYep-3, are similar to a prophage region in 
Y. pseudotuberculosis. Interestingly, it has been demonstrated that PhiYep-3 is able to precisely 
excise from its attachment site in strain Y11; however, it is not conserved among bioserotype 
4/O:3 isolates, suggesting a recent acquisition and possible use as epidemiological marker 
(Batzilla et al., 2011a). Similarly, five specific prophages have been identified in YE strain 
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105.5R(r) and suspected to be partly responsible for the structural rearrangements and low 
synteny with strain 8081 (Wang et al., 2011). 
The pYV virulence plasmid, carried by virulent YE strains of biotypes 1B and 2-5, is 67.7-72.5 kb 
in size and has a G+C content of 43-44%. The sequences of pYV8081 (bioserotype 1B/O:8) and 
pYVY11 (4/O:3) demonstrated higher divergence than the corresponding chromosomes, while 
pYVY11 and pYVW22703 (2/O:9) showed closely-related sequences (Batzilla et al., 2011a). An 
arsenic resistance arsABRH gene cluster has been identified in pYVY11 and pYVW22703, with 
important differences in the sequences of arsB and arsR genes, but not in pYV8081; moreover, 
mutations have been discovered in the yadA gene of pYVY11 and pYVW22703, causing structural 
changes in YadA of YE strain Y11 (Batzilla et al., 2011a). Comparative analyses among three 
pYV sequences of YE bioserotype 1B/O:8 strains (8081, WA-314 and A127/90) have shown 
general similarity with evident differences in the amino acid sequences of YadA and some T3SS 
proteins, such as SycH, YopM, LcrV and YscP (Foultier and Cornelis, 2003; Oberhettinger et al., 
2011; Snellings et al., 2001). 
Overall, the sequenced genomes of Y. enterocolitica reinforce the current differentiation into two 
subspecies and demonstrate both similarities and specificities, reflecting the evolutionary history 
of the different groups.  
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2. Aims of the study 
The foodborne pathogen Y. enterocolitica represents a noticeably versatile group of organisms 
which cause intestinal and extraintestinal diseases, differ in prevalence around the world, and 
survive in a wide range of natural and host environments. Genomics and molecular 
pathogenesis of yersiniosis have been thoroughly studied and the strategies used by Yersinia to 
overcome host defenses are well understood, especially for highly-virulent strains of bioserotype 
1B/O:8. However, the majority of YE isolates from patients belong to the weakly-virulent 
serotypes O:3, O:9 and O:5,27, which are frequently detected also in animals and food, and lead 
to diseases with divergent severity among the hosts. In particular, serotype O:3 strains are 
responsible for 80-90% of yersiniosis cases worldwide, and are repeatedly isolated from pigs, 
considered as the asymptomatic reservoir of these strains. Evidences of a direct connection 
between animal and human strains are not satisfactory, even if consumption of contaminated 
pork has been suspected to be the main source of clinical cases caused by YE serotype O:3. 
Molecular epidemiology methods have proven to be inadequate in terms of discriminatory power 
for studying the transmission of this group of organisms, preventing efficient control strategies 
and identification of sources of infection. Moreover, colonization and virulence-associated factors 
of serotype O:3 have not been exhaustively characterized, mainly because of its low virulence 
and the inadequacy of the mouse model. 
Whole-genome sequencing has recently demonstrated high impact on all life sciences, providing 
thorough insights into the complete genetic capacity of an organism, its physiology, virulence 
behavior, adaptation to a preferred niche, and evolution. Moreover, genomics is prerequisite for 
the application of further omics technologies. This study, in fact, aims at investigating the 
pathogenesis and evolutionary aspects of YE with a genome-based approach. To appreciate the 
virulence mechanisms of the heterogeneous YE species it is necessary to concentrate on more 
than a single serotype or strain. The findings obtained by comparing highly-virulent strains 
should be used to identify the specific disease-associated abilities and genomic features of the 
weakly-virulent and non-virulent groups, thanks to the availability of multiple sequences. This 
should then allow analysis of the evolution of the whole YE species, and identification of genetic 
markers for a molecular diagnostic test. Focusing on the intra-species microevolution of serotype 
O:3 should provide a better understanding about the population structure, and thus 
epidemiology, of these homogeneous strains. The mechanisms putatively regulating the in vivo 
infection in humans of serotype O:3 strains should also be studied, bringing new insight into the 
low-virulence and adaptation properties of this group.  
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3. Materials and Methods 
3.1. Instruments and consumables 
Standard laboratory devices were used in this study (Table 6). If special instruments, software or 
methods were necessary, they will be explained in the further sections when appropriate. 
Table 6 List of instruments used. 
Instrument Model Supplier 
Agarose gel documentation GelDoc EQ Bio-Rad, Munich 
Centrifuge 3-30KS Sigma GmbH, Osterode 
Centrifuge 1K15 Sigma GmbH, Osterode 
Centrifuge 1-15 Sigma GmbH, Osterode 
DNA workstation L020-GC Kisker Biotech GmbH, Steinfurt 
Electrophoresis chambers 
DNA MGU-402T-FL C.B.S. Scientific, Del Mar, CA, US 
Electrophoresis chambers 
SDS-PAGE Mini PROTEAN-3 Bio-Rad, Munich 
Electrophoresis power supply PowerPac 300 Bio-Rad, Munich 
Electroporation device MicroPulserTM Bio-Rad, Munich 
Film development device Fujifilm FPM-100A Fuji, Düsseldorf 
Hybridization oven PersonalHyb Stratagene, La Jolla, CA, US 
Incubator IPP400 Memmert, Schwabach 
Incubator INP-500 Memmert, Schwabach 
Incubator Type B20 Heraeus, Hanau 
Incubator shaker Excella E24 New Brunswick GmbH, Nürtingen 
Laminar flow hood Herasafe HS12  Heraeus, Hanau 
Mixer Thermomixer compact Eppendorf, Hamburg 
Mixer Thermomixer 5436 Eppendorf, Hamburg 
PCR cycler Veriti 96-w Life Technologies GmbH, Darmstadt 
PCR cycler 2720 Life Technologies GmbH, Darmstadt 
pH meter MP220 Mettler Toledo, Giessen 
Pipettes Labmate Abimed, Langenfeld 
Pipettes 2.5, 10, 100 µl Eppendorf, Hamburg 
Semi-dry blot device Trans-Blot SD Bio-Rad, Munich 
Spectrophotometer Ultrospec 3100 pro Amersham Biosciences, Freiburg 
Tissue homogenizer MM2000 Retsch GmbH, Haan 
Ultrasonic processor UP 50H Hilscher Ultrasonic GmbH, Teltow 
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For consumables, standard products from Becton Dickinson (Heidelberg), Biozym Scientific 
GmbH (Hessisch Oldendorf), Brand GmbH (Wertheim), Braun (Melsungen), Corning 
(Wiesbaden), Eppendorf (Hamburg), Kisker Biotech GmbH (Steinfurt), Merck Millipore (Cork, 
IE), Nunc (Roskilde, DK), and PEQLAB Biotech GmbH (Erlangen) were used. 
3.2. Chemicals, kits and reagents 
Routine tasks were performed with commercially available kits, chemicals and reagents 
purchased from Amersham Biosciences (Freiburg), AppliChem GmbH (Darmstadt), Bio-Rad 
(Munich), Life Technologies GmbH (Darmstadt), Macherey-Nagel (Düren), Merck (Darmstadt), 
Oxoid (Wesel), Roche Diagnostics (Mannheim), Roth (Karlsruhe), Sigma-Aldrich (Taufkirchen) 
and VWR (Darmstadt). Restriction enzymes, T4 DNA ligase and alkaline phosphatase were 
purchased from ThermoScientific (St.Leon-Rot) and used according to the protocols provided by 
the manufacturer. Relevant materials are listed in Table 7.  
Table 7 Commercial chemicals, kits and reagents used in this study. 
Chemical, reagent and kit Supplier 
Anti Human-HRP polyclonal antibody Roth, Karlsruhe 
DIG Nucleic Acid Detection kit Roche Diagnostics, Mannheim 
ECL Western blotting detection reagents GE Healthcare, Freiburg 
dNTP Mix, 10 mM each ThermoScientific, St.Leon-Rot 
GeneRuler 1 kb DNA Ladder ThermoScientific, St.Leon-Rot 
Nitrocellulose membrane Roth, Karlsruhe 
NucleoBond PC 100 kit Macherey-Nagel, Düren 
NucleoSpin Plasmid kit Macherey-Nagel, Düren 
NucleoSpin Tissue kit Macherey-Nagel, Düren 
Nylon membranes Roche Diagnostics, Mannheim 
PCR DIG Probe Synthesis kit Roche Diagnostics, Mannheim 
peqGOLD Gel Extraction kit PEQLAB Biotech GmbH, Erlangen 
Phusion High-Fidelity DNA Polymerase ThermoScientific, St.Leon-Rot 
Protease Inhibitor Cocktail Sigma-Aldrich, Taufkirchen 
recomLine Yersinia IgG 2.0 Mikrogen Diagnostik, Neuried 
Spectra™ Multicolor Broad Range Protein Ladder ThermoScientific, St.Leon-Rot 
Taq DNA Polymerase Master Mix 2.0 VWR, Darmstadt 
 
  
Materials and Methods  28 
3.3. Microbiological methods 
3.3.1. Bacterial strains and plasmids 
In Table 8 and Table 9 bacterial strains and plasmids used in this study are listed. The additional 
Y. enterocolitica strains tested for validation of the patho-serotyping PCR are listed in Table 10. 
Table 8 Bacterial strains used in this study. 
(FBI-Zoo: Food-Borne Zoonotic Infections of Humans, BMBF project; FLI: Friedrich-Löffler Institute; MvPI: 
Max-von-Pettenkofer Institute) 
Y. enterocolitica strains  
Bacterial strain ID Features Reference 
8081 Bioserotype 1B/O:8, American human isolate  (Portnoy et al., 1981) 
WA-314 (ATCC 51871) Bioserotype 1B/O:8, clinical isolate (Heesemann and Laufs, 1983) 
Y11 (DSMZ 13030) Bioserotype 4/O:3, human isolate (Neubauer et al., 2000a) 
W22703 Bioserotype 2/O:9, mutant from strain W227 (Cornelis and Colson, 1975) 
Y5.27P Bioserotype 3/O:5,27 MvPI collection 
NF-O Bioserotype 1A/O:5, clinical isolate (Ratnam et al., 1982) 
IP2222 Bioserotype 1A/O:36, Japanese isolate from 
water (Grant et al., 1999) 
Y8265/556 Bioserotype 4/O:3, French human isolate MvPI collection 
Y5307/647 Bioserotype 4/O:3, Finnish human isolate MvPI collection 
P1 (BR6319) Bioserotype O:3, German isolate from pig Prof. Neubauer, FLI Jena 
P4 (BR0055) Bioserotype O:3, German isolate from pig Prof. Neubauer, FLI Jena 
149 (CN-Y641) Bioserotype 4/O:3, Belgian isolate from puppy MvPI collection 
150 (CN-Y486) Bioserotype 4/O:3, Belgian isolate form calf MvPI collection 
D1 (M1-S3405) Bioserotype 4/O:3, German human isolate MvPI collection 
D2 (M2-S3547) Bioserotype 4/O:3, German human isolate, 
obtained 45 days after D1 from same patient MvPI collection 
D3 (CN-35) Bioserotype 4/O:3, German human isolate MvPI collection 
D4 (CN-142) Bioserotype 4/O:3, Belgian isolate from pig MvPI collection 
D5 (CN-146) Bioserotype 4/O:3, Danish isolate from pig MvPI collection 
D6 (CN-243/Y745) Bioserotype 3/O:3, Japanese isolate MvPI collection 
D7 (P8/FBI-00033) Bioserotype 4/O:3, German isolate from pig FBI-Zoo collection 
D8 (P14/FBI-03871) Bioserotype 4/O:3, German isolate from pig FBI-Zoo collection 
D9 (P15/04247) Bioserotype 4/O:3, German isolate from pig FBI-Zoo collection 
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Other strains   
Species Features Reference 
E. coli T7 express 
(BL21 derivative, no λ-
prophage) 
fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 [dcm] R(zgb-
210::Tn10--TetS) endA1 
D(mcrCmrr)114::IS10 
New England Biolabs, 
Frankfurt 
Y. frederiksenii CN-113 Strain H56-36/81, serotype O:60 MvPI collection 
Y. intermedia CN-114 Strain H9-36/83, serotype O:17 MvPI collection 
Y. kristensenii CN-115 Strain H17-36/83, serotype O:12.25 MvPI collection 
Y. rohdei CN-116 Strain H274-36/85, serotype O:76 MvPI collection 
Y. bercovieri CN-117 Strain H632-36/85, serotype O:16 MvPI collection 
Y. mollaretii CN-118 Strain H279-36/86, serotype O:59 MvPI collection 
Y. pseudotuberculosis Strain IP32953, serotype O:1 (Chain et al., 2004) 
Y. pestis CN-691 Strain KIM, biotype Medievalis (Fetherston and Perry, 1994) 
E. coli Strain UTI89, serotype O18:K1:H7 Prof. Stecher, MvPI 
E. coli Strain CFT073, serotype O6:H1 Prof. Stecher, MvPI 
S. enterica subsp.I Strain C5, serovar Typhimurium Prof. Stecher, MvPI 
S. enterica subsp.I Strain ATCC 14028, serovar Typhimurium Prof. Stecher, MvPI 
C. jejuni Strain L11, serotype Lior 11 MvPI collection 
C. jejuni Strain G23 MvPI collection 
L. pneumophila Strain 2020 Prof. Hilbi, MvPI 
 
Table 9 List of plasmids. 
Plasmid Features Reference 
pET-30a Expression vector, T7 promoter, N-ter and C-ter His·Tag, KanR Novagen, Darmstadt 
pET-30b Expression vector, T7 promoter, N-ter and C-ter His·Tag, KanR Novagen, Darmstadt 
pET-30c Expression vector, T7 promoter, N-ter and C-ter His·Tag, KanR Novagen, Darmstadt 
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Table 10 Y. enterocolitica strains used for validation of the patho-serotyping PCR-based method. 
When necessary, re-serotyping of these strains was performed by Dr. Bader (MvPI, Munich). 
(CVUA: Chemisches und Veterinäruntersuchungsamt Stuttgart; FBI-Zoo: Food-Borne Zoonotic Infections 
of Humans, BMBF project; FLI: Friedrich-Löffler-Institute; MvPI: Max-von-Pettenkofer Institute; RKI: 
Robert Koch Institute, Wernigerode) 
Strain ID Features Source 
CN-32 Serotype 0:3, strain 108P  MvPI collection 
CN-36 Bioserotype 1A/O:5, human isolate  MvPI collection 
CN-38 Bioserotype 1A/O:4,33, isolate from milk  MvPI collection 
CN-39 Bioserotype 1A/O:7,8, isolate from milk  MvPI collection 
CN-40 Bioserotype 1A/O:6.30, isolate from milk  MvPI collection 
CN-41 Bioserotype 1A/O:10,K1, isolate from milk  MvPI collection 
CN-42 Bioserotype 2/O:5,27  MvPI collection 
CN-44 Bioserotype 4/O:9, human isolate  MvPI collection 
CN-45 Bioserotype 4/O:5,27, human isolate  MvPI collection 
CN-47 Bioserotype 3/O:5,27, human isolate  MvPI collection 
CN-49 Bioserotype 2/O:5,27, human isolate  MvPI collection 
CN-52 Bioserotype 1A/O:48  MvPI collection 
CN-53 Bioserotype 1A/O:41,43  MvPI collection 
CN-54 Bioserotype 1A/O:5  MvPI collection 
CN-55 Bioserotype 1B/O:8, strain CDC 544  MvPI collection 
CN-56 Bioserotype 1B/O:8, strain CDC 540/84  MvPI collection 
CN-57 Bioserotype 1B/O:8, strain E 661 Montana  MvPI collection 
CN-58 Bioserotype 1B/O:13, strain USA 329/82  MvPI collection 
CN-59 Bioserotype 1B/O:20, strain CDC 3039/85  MvPI collection 
CN-60 Bioserotype 1B/O:21, strain CDC 209/84  MvPI collection 
CN-101 Bioserotype 1A/O:36  MvPI collection 
CN-170 Serotype O:3, strain 59/03  MvPI collection 
CN-233 Bioserotype 1B/O:8, strain IP636  MvPI collection 
CN-235 Bioserotype 2/O:9, strain IP22393  MvPI collection 
CN-237 Bioserotype 2-3/O:5,27, strain IP199  MvPI collection 
CN-238 Bioserotype 2-3/O:5,27, strain IP885  MvPI collection 
CN-239 Bioserotype 2-3/O:5,27, strain IP1607  MvPI collection 
CN-240 Bioserotype 2-3/O:5,27, strain IP22460  MvPI collection 
CN-242 Bioserotype 4/O:3, strain IP24231  MvPI collection 
CN-244 Bioserotype 4/O:3, strain IP24231  MvPI collection 
CN-245 Bioserotype 4/O:3, strain IP21981  MvPI collection 
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CN-249 Bioserotype 4/O:3, strain IP23357  MvPI collection 
CN-252 Bioserotype 4/O:3, strain IP7032  MvPI collection 
CN-254 Bioserotype 4/O:3, strain IP3692  MvPI collection 
CN-256 Bioserotype 4/O:3, strain IP4115  MvPI collection 
CN-262 Bioserotype 4/O:3, strain IP22274  MvPI collection 
CN-266 Bioserotype 4/O:3, strain IP23227  MvPI collection 
CN-272 Bioserotype 1A/O:5, strain IP124  MvPI collection 
CN-584 Bioserotype 1A/O:5, strain NF-O  MvPI collection 
260 Not typeable, strain FBI-4465 Klinikum der Universität München 
267 Serotype O:3, strain FBI-4848 Klinikum der Universität München 
282 Not typeable, strain FBI-5620 Klinikum der Universität München 
292 Serotype O:27, strain FBI-6584 Klinikum der Universität München 
343 Serotype O:9, strain FBI-5634 Klinikum der Universität München 
377 Serotype O:3, strain FBI-6821 Klinikum der Universität München 
H-82 Strain Ty 4726/85 MvPI collection 
H-89 Strain Ty 448/87 MvPI collection 
H-93 Strain Ty 822/88 MvPI collection 
H-395 Serotype O:5,27 MvPI collection 
H-522 Serotype O:1,2a,3, strain H 523/88 MvPI collection 
H-523 Serotype O:2a,2b,3, strain H 518/88 MvPI collection 
H-534 Bioserotype 2/O:5,27, strain D113 MvPI collection 
H-556 Bioserotype 4/O:3, strain 8265 MvPI collection 
H-568 Bioserotype 2/O:5,27, strain YE873 MvPI collection 
H-647 Bioserotype 4/O:3, strain 5307 MvPI collection 
H-678 Bioserotype 2/O:5,27, strain SZ 3801/03 MvPI collection 
H-679 Bioserotype 2/O:5,27, strain SZ 81/04 MvPI collection 
H-744 Strain S11136 MvPI collection 
H-745 Strain S11149 MvPI collection 
H-746 Serotype O:3, strain S11925 MvPI collection 
H-747 Serotype O:3, strain S12723 MvPI collection 
H-748 Serotype O:3, strain S12891 MvPI collection 
H-749 Serotype O:3, strain S12982 MvPI collection 
H-750 Serotype O:3, strain S13559 MvPI collection 
P2 Bioserotype 4/O:3, strain 0350, from pig Dr. Rau, CVUA, Stuttgart 
P3 Bioserotype 4/O:3, strain 5819, from pig Dr. Rau, CVUA, Stuttgart 
P5 Serotype O:3, strain BR0056, from pig Prof. Neubauer, FLI, Jena 
P6 Serotype O:3, strain BR0057, from pig Prof. Neubauer, FLI, Jena 
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P7 Serotype O:3, strain BR0058, from pig Prof. Neubauer, FLI, Jena 
P9 Bioserotype 4/O:3, strain FBI-03524, from pig FBI-Zoo collection 
P10 Bioserotype 4/O:3, strain FBI-03540, from pig FBI-Zoo collection 
P11 Bioserotype 4/O:3, strain FBI-03585, from pig FBI-Zoo collection 
P12 Bioserotype 4/O:3, strain FBI-03855, from pig FBI-Zoo collection 
P13 Bioserotype 4/O:3, strain FBI-03870, from pig FBI-Zoo collection 
P16 Bioserotype 4/O:3, strain FBI-05198, from pig FBI-Zoo collection 
P17 Bioserotype 4/O:3, strain FBI-05680, from pig FBI-Zoo collection 
06-03972 Bioserotype 3/rough Dr. Tietze, RKI 
06-04957 Bioserotype 3/rough Dr. Tietze, RKI 
07-05684 Bioserotype 3/rough Dr. Tietze, RKI 
08-00920 Bioserotype 1A/rough Dr. Tietze, RKI 
08-02627 Bioserotype 1A/O:5 Dr. Tietze, RKI 
09-05064 Bioserotype 4/O:3 Dr. Tietze, RKI 
09-05074 Bioserotype 4/O:3 Dr. Tietze, RKI 
09-05075 Bioserotype 4/O:3 Dr. Tietze, RKI 
09-05076 Bioserotype 4/O:3 Dr. Tietze, RKI 
09-05259 Bioserotype 3/rough Dr. Tietze, RKI 
09-08364 Bioserotype 3/rough Dr. Tietze, RKI 
10-00826 Bioserotype 1B/O:8 Dr. Tietze, RKI 
10-00827 Bioserotype 1A/O:8 Dr. Tietze, RKI 
11-01204 Bioserotype 3/O:5,27 Dr. Tietze, RKI 
11-06758 Bioserotype 3/O:5,27 Dr. Tietze, RKI 
11-07058 Bioserotype 1A/rough Dr. Tietze, RKI 
11-08263 Bioserotype 3/O:5,27 Dr. Tietze, RKI 
11-08388 Bioserotype 3/O:5,27 Dr. Tietze, RKI 
11-08389 Bioserotype 3/O:5,27 Dr. Tietze, RKI 
12-00565 Bioserotype 3/O:9 Dr. Tietze, RKI 
12-00586 Bioserotype 3/O:9 Dr. Tietze, RKI 
12-00587 Bioserotype 3/O:9 Dr. Tietze, RKI 
12-00821 Bioserotype 1A/rough Dr. Tietze, RKI 
12-01019 Bioserotype 3/O:9 Dr. Tietze, RKI 
12-01336 Bioserotype 1A/O:8 Dr. Tietze, RKI 
12-01511 Bioserotype 1A/O:5 Dr. Tietze, RKI 
12-01512 Bioserotype 1A/O:8 Dr. Tietze, RKI 
12-01527 Bioserotype 3/O:9 Dr. Tietze, RKI 
12-01557 Bioserotype 1A/O:8 (re-serotyped as rough) Dr. Tietze, RKI 
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12-01616 Bioserotype 1A/O:8 Dr. Tietze, RKI 
12-01779 Bioserotype 1A/O:5 Dr. Tietze, RKI 
12-01805 Bioserotype 3/O:9 Dr. Tietze, RKI 
12-01910 Bioserotype 3/O:9 Dr. Tietze, RKI 
12-02272 Bioserotype 1A/O:5 Dr. Tietze, RKI 
12-02439 Bioserotype 1A/O:5 Dr. Tietze, RKI 
12-02966 Bioserotype 1A/O:8 Dr. Tietze, RKI 
12-03062 Bioserotype 1A/O:5 Dr. Tietze, RKI 
12-03266 Bioserotype 1A/rough Dr. Tietze, RKI 
12-03276 Bioserotype 4/O:3 Dr. Tietze, RKI 
12-03288 Bioserotype 1A/rough Dr. Tietze, RKI 
12-03324 Bioserotype 1A/rough Dr. Tietze, RKI 
12-03401 Bioserotype 1A/rough Dr. Tietze, RKI 
12-03475 Bioserotype 4/O:3 Dr. Tietze, RKI 
12-03489 Bioserotype 4/O:3 Dr. Tietze, RKI 
12-03561 Bioserotype 4/O:3 Dr. Tietze, RKI 
12-03562 Bioserotype 4/O:3 Dr. Tietze, RKI 
12-03803 Bioserotype 3/rough Dr. Tietze, RKI 
12-04470 Bioserotype 1A/rough Dr. Tietze, RKI 
12-05220 Bioserotype 1B/O:8 Dr. Tietze, RKI 
13-00330 Bioserotype 4/O:5,27 Dr. Tietze, RKI 
 
3.3.2. Culture media 
Liquid media were prepared by standard formulation (Table 11) in batches and sterilized by 
autoclaving at 121 °C, 1 bar, 20 min. Similarly, solid media were made with the addition of 16 g/l 
agar to the respective media, unless otherwise stated. 
Table 11 Liquid media for microbiological cultures. 
Media Composition 
Lysogeny Broth (LB) 1% tryptone, 0.5% yeast extract, 0.5% NaCl, pH 7.4 
Brain Heart Infusion medium (BHI) 37 g/l BHI powder 
Müller Hinton medium (MH) 21 g/l MH powder 
SOC medium 2% tryptone, 0.5% yeast extract, 0.05% NaCl, 250 
mM KCl, 20 mM Glucose 
Cryopreservation medium LB medium with 20% glycerol 
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3.3.3. Bacterial growth and conservation 
Bacteria were routinely cultured under aerobic conditions in LB medium at 27 °C or 37 °C with 
180-200 rpm shaking. Cultivation of Y. enterocolitica at 37 °C in BHI medium was carried out to 
induce Yop secretion. MH liquid or solid medium was used for antimicrobial susceptibility test 
and growth curve determination, at either 27 °C or 37 °C, as explained below. The optical 
density at 600 nm (OD600) of 900 µl bacterial suspension was determined by spectrophotometry. 
Bacterial pellets from overnight (o/n) culture were stored at -80 °C in cryopreservation medium 
(Table 11) and subsequently recovered streaking out frozen bacteria onto Columbia Blood agar, 
Yersinia selective agar (CIN) or LB agar plates. 
3.3.4. Determining bacterial growth curves 
Bacteria were recovered from frozen stocks, inoculated in MH or LB broth and allowed to grow 
o/n at 27 °C. A fresh sub-culture was then prepared with OD600=0.02 and bacteria were grown at 
27 °C for 6 hours. Every 30 min, OD600 was measured, and serial dilutions in sterile 0.9% NaCl 
solution were prepared from 10-4 to 10-8 and plated on MH or LB agar plates. After o/n growth 
(16-20 h), the colonies on the plates were manually counted and only plates with a colony 
number included between 50 and 400 were taken into account for calculating the colony forming 
unit (CFU)/ml: n° of colonies per plate×10
10-n° of dilution
. 
3.3.5. Antibiotics and antimicrobial susceptibility test 
When appropriate, selection of transformants was obtained by adding kanamycin to liquid media 
or solid agar at the concentration of 30 µg/ml. 
To test antimicrobial susceptibility of Y. enterocolitica, the broth macro-dilution (a) and the disk 
diffusion (b) methods were used, with experiments performed in duplicate. In both techniques, 
o/n cultures from single colonies were freshly inoculated in MH medium at 1:50 dilution and 
grown at 27 °C until the logarithmic phase (OD600=0.5-0.6) had been attained. (a) Serial two-fold 
antibiotic dilutions (from 256 µg/ml to 0.25 µg/ml) were prepared in sterile MH broth in 12-well 
plates. According to previously acquired data (section 3.3.4), bacterial suspension were 
inoculated at a final inoculum of 104 CFU/ml. Plates were incubated at 27 °C for 16-20 h with 
shaking and results determined as absorbance at OD600. (b) Inocula of 104 CFU were prepared 
and spread onto MHA plates, and two antibiotic disks (Oxoid, Wesel) were then placed onto 
each plate. After incubation o/n at 27 °C and 37 °C, results were recorded as diameter of 
inhibition zone. 
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3.3.6. Electrocompetent cells and transformation 
Preparation of electrocompetent cells. In order to make bacterial cells able to receive 
exogenous DNA, bacteria were grown o/n under standard culture conditions and inoculated at a 
1:50 dilution in fresh LB media the following day. The culture was then allowed to grow until 
bacteria reached the logarithmic phase (OD600=0.5-0.6) and placed immediately on ice for 15 
min. Cells were then harvested at 5,000 x g for 15 min at 4 °C, washed twice in cold sterile water 
and once in cold 10% glycerol solution, and finally resuspended in the residual supernatant. 
Aliquots of 55 µl were used for electroporation or stored at -80 °C until further use. 
Transformation by electroporation. For transformation of plasmid DNA into bacteria, 
electrocompetent cells from frozen stocks were thawed on ice, gently mixed with 1 µl of ligation 
mixture (10-30 ng) and transferred into 2 mm cuvettes. Electroporation was performed with a 
MicroPulser, with time=4 ms, potential=2.5 kV, resistance=200 Ω and capacitance=25 µF. 
Immediately after exposure to electrical field, bacteria were re-suspended in 1 ml SOC medium 
at room temperature (RT), incubated for 1 h at 37 °C, and subsequently plated on the 
appropriate selective LB agar plates for o/n growth. 
3.3.7. Isolation of released proteins from Y. enterocolitica 
To isolate secreted Yop proteins, Y. enterocolitica cells were grown o/n in BHI broth at 27 °C. 
The bacteria were then inoculated 1:20 in fresh BHI broth and incubated 2 h at 37 °C. Secretion 
of Yops was stimulated by adding 10 mM MgCl2, 5 mM EGTA, and 0.2 % glucose, allowing 
further growth until OD600=0.7-0.9. The culture was centrifuged at 7,500 rpm, 4 °C for 15 min. 
The supernatant was collected and mixed with TCA (trichloroacetic acid, final concentration 10% 
v/v) for protein precipitation. After 1 h on ice, proteins were pelleted at 14,000 x g, 4 °C, for 20 
min, and washed three times with ice-cold acetone on ice for 20 min, with a centrifugation step 
at 12,000 x g, 4 °C for 10 min. A final wash in distilled water was performed before pelleting the 
proteins (12,000 x g, 4 °C for 10 min) and dissolving them in 30 µl SDS-PAGE sample buffer 
(section 3.5.1). 
3.4. Molecular biology methods 
3.4.1. Isolation of nucleic acids 
Genomic DNA from bacterial suspensions was extracted using the commercial NucleoSpin 
Tissue kit, while plasmid DNA was purified by NucleoSpin Plasmid or NucleoBond PC 100 kits, 
following manufacturer’s instructions. When pure DNA was not necessary, DNA was directly 
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isolated by the boiling methods using two different procedures. As standard method, a single 
colony, or bacterial pellet from 1 ml o/n culture (5 min centrifugation at 6,000 x g), were re-
suspended in 60 µl distilled water and heated at 95-100 °C for 10 min. After centrifugation at 
11,000 x g, 4 °C, 5 min, 50 µl of supernatant were transfer to a new tube and store at 4 °C till 
use. Alternatively, higher quality DNA could be obtained by inoculation of a single colony in 50 µl 
of 25 mM NaOH, heating at 100 °C for 10 min, neutralization of the suspension with 50 µl of 80 
mM Tris/HCl buffer (pH 7.5), and centrifugation at 20,000 x g, 4 °C for 5 min. DNA concentration 
was measured spectrophotometrically at 260 nm absorbance (A260) and the A260/A280 ratio 
determined. An A260/A280 ratio between 1.8 and 2.0 was considered indication of pure DNA. 
3.4.2. Agarose gel electrophoresis 
DNA was separated by electrophoresis in 0.7-2% agarose gels in TAE buffer (40 mM Tris-
Acetate, 1mM EDTA, pH 7.6). Samples were mixed with loading buffer, when necessary, loaded 
onto the gel and electrophoretically separated at varying voltages and times, ranging between 
70-110 V for 60-90 min, depending on the expected DNA size. Gels were stained in an ethidium 
bromide bath for approximately 10 min and the separated DNA was visualized by UV radiation 
using the GelDoc imaging system. 
3.4.3. Oligonucleotides 
All the primers used for PCR amplification in this study were obtained from Eurofins MWG 
Operon (Ebersberg) as salt-free lyophilized oligonucleotides (Table 12). 
Table 12 List of oligonucleotides. 
Primer Sequence (5’-3’) Purpose 
T7 promoter TAATACGACTCACTATAGGG Sequencing of pET-30 insert 
T7 terminator GCTAGTTATTGCTCAGCGG Sequencing of pET-30 insert 
pYVO3_6900_FW TAGGTATGATAGGAGTTACATATCA Specific region for pYV_O:3 
pYVO3_7130_RV CTTATTATTAATATCAATCGACGAT Specific region for pYV_O:3 
yopM_FW TTCAGAAGGGCATTCAATATGTTTA Amplification of yopM 
yopM_RV ACTCAAATACATCATCTTCAAGTTTG Amplification of yopM 
yscP_FW TCTACAGCATCACAGGAACGCCTA Amplification of yscP 
yscP_RV ATGGCTGAGCCGTTGACGTAGC Amplification of yscP 
16S_Yen_FW AATACCGCATAACGTCTTCGGA Identification multiplex 
16S_Yen_RV CTTCTTCTGCGAGTAACGTCAAT Identification multiplex 
inv_FW TGGCATCAATCTCGTGATTTCG Identification multiplex 
inv_RV GTTGCCCCTGAATATCTAAAGTGAC Identification multiplex 
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ail_FW TGTTAATGTGTACGCTGCGAGT Identification multiplex 
ail_RV GTTTGGAGTATTCATATGAAGCGTC Identification multiplex 
ystB_FW AACTTTTTGGACACCGCACAG Identification multiplex 
ystB_RV GTCTGAGTATCGCACGCT Identification multiplex 
wbcA_O8_FW TGATGAACGAGGCGAGTTTGTT O:8 genotyping 
wbcA_O8_RV TACTCCGTCTGTTATGCGGATTTAG O:8 genotyping 
wbbU_O3_FW ACCTCGTATTTTTGAAGATGATCGC O:3 genotyping 
wbbU_O3_RV GTACTCAATAACTTGCTGTTCGGA O:3 genotyping 
per_O9_FW TCCTTCTCCAAATATATAGGTGCCA O:9 genotyping 
per_O9_RV ATGCGGCATTAGATGAGATGGA O:9 genotyping 
wzt_FW GTTAGTTCCTGCATCTGATCGCC O:5/O:5,27 genotyping 
wzt_RV ATCCAGCATCCATGGCTCC O:5/O:5,27 genotyping 
RM_O5,27_FW TTCCAGCACACGTCGAACAAGTTC O:5,27 genotyping 
RM_O5,27_RV AGGAAGATATCCAGTGCCGCT O:5,27 genotyping 
16S_FW_D1 CGATATCTCTAGAAGAGTTTGATCCTGGCTCAG Universal 16S rRNA primer 
16S_FW_D2 CGATATCTCTAGAAGAGTTTGATCATGGCTCAG Universal 16S rRNA primer 
16S_RV_P1 GATATCGGATCCACGGTTACCTTGTTACGACTT Universal 16S rRNA primer 
 
3.4.4. Polymerase chain reaction 
Polymerase chain reaction (PCR) allows amplification of specific nucleic acids by polymerase 
enzymes, nucleoside triphosphates (dNTPs) and specific primers binding the DNA target. The 
three steps involved in one cycle of a PCR reaction are denaturation, annealing and extension. 
In this study, most of the amplification experiments were accomplished with the VWR Red Taq 
DNA polymerase master mix, which is a ready-to-use reaction mix containing the polymerase, 
the dNTPs and a dye with a stabilizer to enable direct loading of PCR products onto agarose 
gels. The master mix contains 150 mM Tris-HCl pH 8.5, 40 mM (NH4)2SO4, 4.0 mM MgCl2, 0.2% 
Tween 20®; 0.4 mM dNTPs; 0.05 units/µl Amplicon Taq polymerase. The final reaction 
composition and the protocol used as standard are described in Table 13. When accurate 
amplification was required, the Phusion Hot Start High-Fidelity DNA polymerase 
(ThermoScientific) was used. This polymerase possesses a 3’->5' exonuclease proofreading 
activity, which is inactivated at RT by a proteic inhibitor. Reaction mix and amplification protocol 
are given in Table 14. 
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Table 13 PCR reaction and cycling conditions used with VWR Red Taq Master Mix. 
Reagent Volume Final concentration 
VWR Master Mix 25 µl 0.2 mM dNTPs, 2.0 mM MgCl2, 1.25 U Taq 
Forward primer 2 µl 0.4 µM 
Reverse primer 2 µl 0.4 µM 
Template DNA 1-5 µl 10-500 ng 
Denatured water up to 50 µl  
Step Temperature and Time Number of Cycles 
Initial denaturation 95 °C, 5 min 1 
Denaturation 95 °C, 30-40 sec 
30-40 Annealing 55-60 °C, 30-60 sec 
Extension 72 °C, 1 min/kb template 
Final extension 72 °C, 8 min 1 
Hold 8 °C, indefinite 1 
Table 14 PCR reaction and cycling conditions used with Phusion High Fidelity DNA polymerase. 
Reagent Volume Final concentration 
5X Phusion HF buffer 10 µl 1X 
2 mM dNTPs 5 µl 200 µM 
Forward primer 2.5 µl 0.5 µM 
Reverse primer 2.5 µl 0.5 µM 
Template DNA 1-5 µl 10-500 ng 
Phusion DNA polymerase 0.5 µl 0.02 U/µl 
Denatured water up to 50 µl  
Step Temperature and Time Number of Cycles 
Initial denaturation 98 °C, 30 sec 1 
Denaturation 98 °C, 10 sec 
25-35 Annealing 65-75 °C, 30 sec 
Extension 72 °C, 30 sec/kb template 
Final extension 72 °C, 8 min 1 
Hold 8 °C, indefinite 1 
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3.4.5. Patho-serotyping PCR 
Primer design. Genome sequences of different Y. enterocolitica serotypes were used as 
references for specific primer design. For both multiplexes 1 and 2 (see below), primer pairs 
were manually designed in order to satisfy the following criteria: (a) primer length is 18–24 bp; 
(b) primers have 40 to 60% G+C content and similar annealing temperature (between 54.5 °C 
and 59.7 °C); (c) primer sequences in one reaction do not form self- or hetero-dimers; (d) primer 
sequences uniquely align to the target region; (e) the produced amplification products have 
unambiguously different sizes. Different annealing temperatures were tested with the designed 
primer pairs in single PCR reactions. Products showing the expected lengths and precise bands 
on agarose gels, without non-specific amplification, were obtained with an annealing 
temperature of 58 °C. 
PCR assays. Two multiplex PCRs were developed for patho-serotyping of Y. enterocolitica. 
Multiplex 1, designed for species identification, was performed with primer pair inv_FW/RV 
(amplicon size: 1,009 bp), ail_FW/RV (431 bp), 16S_Yen_FW/RV (330 bp) and ystB_FW/RV 
(208 bp), while multiplex 2, aimed at molecular serotyping, with primers per_O9_FW/RV (837 
bp), wbbU_O3_FW/RV (463 bp), wbcA_O8_FW/RV (269 bp) and wzt_FW/RV (662 bp). The 50 
µl PCR mixtures were prepared as described in Table 13 with 100 ng of DNA template, and 
amplification was achieved by initial denaturation at 95 °C for 5 min, 30 cycles of denaturation at 
95 °C for 40 sec, primer annealing at 58 °C for 40 sec, extension at 72 °C for 60 sec, and final 
extension at 72 °C for 8 min. The single PCR for discrimination between serotypes O:5 and 
O:5,27 was done as described above with primers RM_O:5,27_FW/RV, resulting in amplification 
of a 627 bp product only in serotype O:5,27 strains. The detection limit of the test was evaluated 
on five YE reference strains, conducting both multiplexes 1 and 2 on diluted DNA samples (1 
ng/µl, 100 pg/µl, 10 pg/µl). 
3.4.6. Synthesis of digoxigenin-labeled probes 
Two digoxigenin (DIG)-dUTP-labeled probes were designed by selecting strain-specific regions 
in the 8081 and WA-314 genomes. The probe specific for detecting strain 8081 is 162 bp long 
and targets part of a putative hemolysin gene encoded by the YAPI island, whereas the 234-bp 
probe specific for strain WA-314 targets a region inside the strain-specific colicin cluster (section 
4.1.1). Both probes were generated using the PCR DIG Probe Synthesis Kit (Roche), which 
produces PCR products with DIG-11-dUTP incorporated as a labeling molecule. Primers and 
amplification protocol are given in Table 15. 
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Table 15 Primer sequences and PCR conditions for synthesis of DIG-labeled probes. 
Primer Sequence (5’-3’) Probe PCR conditions 
Hem_8081_FW 
Hem_8081_RV 
CAATATGACTACCGACCCGGTTAC 
GGATACATCTGCTGGGCGATATAC 
Hem_8081 
162 bp 
- Denaturation 95 °C, 2 min 
- 30 cycles: 
  denaturation 95 °C, 30 sec 
  annealing 60 °C, 30 sec 
  elongation 72 °C, 40 sec 
- Final elongation 72 °C, 7 min Col_WA_FW 
Col_WA_RV 
CGATCGTAGTAGTAAGGCAACTCC 
GACGGTATCATGCCCATAACTG 
Col_WA 
234 bp 
 
3.4.7. Protein expression library generation 
Bacterial inserts. To create an expression library from Y. enterocolitica strain Y11, genomic 
DNA was purified from a saturated o/n liquid culture with the NucleoSpin Tissue kit, partially 
digested with the enzyme FastDigest Sau3AI (4 min at 37 °C) and separated by electrophoresis 
on a 0.7% agarose gel. DNA fragments of 0.5-3.0 kb were collected from the agarose gel and 
purified using a gel extraction kit.  
Expression vectors. The pET-30a, pET-30b and pET-30c expression vectors were extracted 
from E. coli JM109 (stored at –80 °C at the Max von Pettenkofer-Institute strain collection) with a 
Midi kit for plasmid purification, digested with the FastDigest BamHI enzyme and loaded on a 
0.7% agarose gel. The plasmid linear forms were purified by means of a gel extraction kit, 
dephosphorylated by alkaline phosphatase, and pooled together for further applications. 
Ligation and transformation. The bacterial genomic DNA fragments were ligated into pET-30 
expression vectors. Electrocompetent E. coli T7 express cells were used for electroporation of 
the ligation product and the transformants were selected on LB-kanamycin agar plates. After o/n 
incubation at 37 °C, colonies were scraped into LB medium containing 20% glycerol and frozen 
at -80 °C in 0.5 ml aliquots. The library was considered representative (containing at least one 
copy of all sequences) when the number of clones (N) satisfied the following formula: N= ln	(1-P)ln	(1-f) , 
where P is the probability for a gene to be represented (0.99) and f is the fraction of the genome 
in one insert (f= insert lengthbp genome ). 
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3.5. Biochemical and analytical methods 
3.5.1. SDS-PAGE 
For separation of proteins based on their molecular weight, sodium-dodecyl-sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) was performed in acrylamide gel under 
denaturing conditions (Laemmli, 1970). Gels were composed of two layers having different 
buffer contents, namely a 5% stacking gel and a 12% resolving gel. Protein samples were 
dissolved in the sample buffer and loaded into the gel. Electrophoresis was carried out in 
running buffer at 80 V for 20 min and 180 V for approximately 30-50 min, depending on the 
protein size. For protein visualization, gels were stained for 1 h in Coomassie solution and 
subsequently destained in water o/n. Proteins were transferred to nitrocellulose membranes by 
semi-dry electro-transfer at 15 V for 15 min, after equilibrating both SDS-PAGE gels and 
membranes in transfer buffer. All solutions are given in Table 16. 
3.5.2. Western Blot 
Nitrocellulose membranes were incubated o/n (or for 4 h) in blocking buffer (Table 16)  at 4 °C 
and washed 2-3 times in PBST for 10 min, RT (Laemmli, 1970). Proteins were detected by 
immuno-staining with primary antibody diluted in PBST + 0.5% blocking buffer(1:5,000 for 1 h, 
RT), three washing steps for 10 min, incubation with horseradish peroxidase (HRP)-labelled anti-
human secondary antibody (1:10,000, 40-45 min, RT), followed by three final washing steps. 
Chemo-luminescence reaction by the HRP was detected by ECL Western blotting detection 
reagents and visualized on x-ray films. When re-probing was necessary, the membranes were 
incubated 1 h at RT in 5-10 ml stripping buffer, blocked, washed in PBST and then subject to 
first and second antibodies as described above. 
Table 16 Solutions and buffers used for SDS-PAGE and Western Blot experiments. 
Solution Composition 
5X SDS-PAGE sample buffer 225 mM Tris/HCL (pH 6.8), 50% glycerol, 5% SDS, 0.05% 
bromophenol blue, 250 mM DTT 
SDS-PAGE running buffer 25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3 
Coomassie solution 0.15% Coomassie brilliant blue, 50% MeOH, 10% acetic acid 
Transfer buffer (semi-dry) 48 mM Tris, 39 mM glycine, 20% methanol 
Wash buffer (PBST) PBS, 0.2% Tween20 
Blocking buffer 5% milk powder, PBS, 0.2% Tween20 
Stripping buffer 2% SDS, 100 mM NaOH, 50 mM DTT 
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3.5.3. Quantification of proteins 
Proteins were quantified by the Bradford method, which is based on the binding of the 
Coomassie Brilliant Blue dye to protein samples and the comparison to a standard curve 
generated by the reaction of known amounts of a standard protein (Bradford, 1976). BSA 
(bovine serum albumin) was used for the calibration curve, with dilutions (0.2, 0.4, …, 1.8, 2.0 
mg/ml) prepared in the same buffer where the protein samples were dissolved (e.g. lysis buffer). 
For each dilution, 20 µl were mixed with 1 ml of 1:5 diluted Protein Assay dye Reagent (Bio-Rad, 
Munich), OD595 was measured and the standard curve plotted. Dilutions of the protein samples 
were then prepared in duplicate. The protein concentration was finally determined by comparing 
the OD595 with the standard curve, taking into account the dilution factor. 
3.5.4. Colony hybridization 
To specifically detect colonies belonging to either Y. enterocolitica strain WA-314 or 8081, a 
DNA-DNA colony hybridization protocol based on DIG-labeled probes was established 
(Grunstein and Hogness, 1975). All solutions needed are listed in Table 17. 
Preparation of membranes. Nylon membrane disks were placed for 5 min onto the surface of 
LB agar plates from o/n bacterial growth, transferred onto new plates and incubated at 27 °C for 
4 h. Membranes were then placed colony-side up on filter papers soaked with 10% w/v sodium 
dodecyl sulphate (SDS) for 10 min. This procedure was repeatedly done with a denaturation 
solution for 15 min, a neutralization solution for 15 min, and 2X SSC for 10 min. After air-dry, 
membranes were baked at 80 °C for 60 min to cross-link the transferred DNA, and stored at 
4 °C until use. 
Hybridization and detection. Hybridization was carried out under high stringency conditions, 
calculating the temperature of hybridization as Thyb = 49.82 + 0.41 GC%probe - 
600
bpprobe
, and the 
optimal temperature as Topt = Thyb – 20/25 °C. Since Thyb resulted to be 70.16 °C for the probe 
Hem_8081 and 69.12 °C for the probe Col_WA, the Topt for the whole experiment was fixed at 
50 °C. The prepared nylon membranes were placed in glass bottles or 50 ml Falcon tubes and 
pre-hybridized at 50 °C in a hybridization oven for 1 h with 10 ml of hybridization buffer. Labeled 
DIG-probes (section 3.4.6), after denaturation at 97 °C for 5 min, were placed on ice, mixed with 
5 ml of pre-warmed hybridization buffer at a concentration of 2 µl probe/ml, and transferred to 
sterile tubes with the appropriate membrane for the hybridization step at 50 °C for 3 h. Nylon 
membranes were then subject to stringent wash steps in two washing solutions with constant 
agitation: washing solution 1 for 2 x 5 min, RT; washing solution 2 for 2 x 15 min at 67 °C. The 
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DIG Nucleic Acid Detection Kit (Roche) was used to allow colorimetric detection (with 
NBT/BCIP) of the hybridized probes, according to manufacturer’s instructions. To record the 
results, membranes were photographed, scanned and wet stored in plastic bags at 4 °C for any 
further stripping and re-hybridization. Hybridization buffers containing the labeled probes were 
stored at -20 °C and, when needed, re-used after denaturation at 65 °C. 
Table 17 Solutions used in the colony hybridization experiment. 
Solution Composition Use 
Filter saturation 
solution 
10% w/v SDS Saturating the filter paper before 
transferring the colonies 
Denaturation solution 0.5 M NaOH, 1.5 M NaCl, pH 11.5 Soaking the filter paper for 
denaturing the bacterial DNA 
Neutralization solution 1.5 M NaCl, 1.0 M Tris-HCl, pH 7.4 Soaking the filter paper to 
neutralize the nylon membrane 
20X SSC 3 M NaCl, 0.3 M Na3-citrate, pH 7.0 Soaking the filter paper to rinse 
the nylon membrane 
Hybridization buffer 50% v/v formamide, 5X SSC, 1% v/v 
blocking reagent diluted in Buffer 1, 0.1% 
v/v N-lauroylsarcosine, 0.02% v/v SDS 
Hybridization 
N-lauroylsarcosine 
stock solution 
10% w/v N-lauroylsarcosine Stock solution 
SDS stock solution 10% SDS Stock solution 
Washing solution 1 2X SSC, 0.1% SDS w/v Washing the filters before 
blocking 
Washing solution 2 0.5X SSC, 0.1% SDS w/v  Washing the filters before 
blocking 
Maleic acid buffer 0.1 M maleic acid, 0.15 M NaCl, pH 7.5 Dilution of Blocking solution 
Blocking solution 10X 10% Blocking reagent in maleic acid buffer Stock solution 
Blocking solution 1X 1:10 dilution of blocking solution 10X in 
maleic acid buffer (1% final concentration) 
Blocking of unspecific binding 
sites 
Antibody solution Dilute anti-DIG-AP antibody 1:5000 (150 
mU/ml) in Blocking solution 
Binding to the DIG-labeled 
probe 
Washing buffer Buffer 1, 0.3% Tween 20, pH 7.5 Washing of membrane 
Detection buffer 0.1 M Tris-HCl, 0.1 M NaCl, 0.05 M MgCl2, 
pH 9.5 
Alkaline phosphatase buffer; for 
dilution of color substrate 
Color substrate 
solution 
80 µl NBT/BCIP stock solution in 4 ml 
detection buffer 
Color reaction 
TE-buffer 10 mM Tris-HCl, 1mM EDTA, pH 8.0 Stopping the color reaction 
Stripping buffer 0.2 M NaOH, 0.1% SDS Stripping membranes 
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Stripping reaction. To decolorize membranes after hybridization and colorimetric detection for 
further re-probing, a large beaker containing 150 ml of N,N-Dimethylformamide was heated to 
60 °C. Membranes were placed into the hot solution and incubated for 30-60 min until the 
blue/violet color had been removed. They were then rinsed with ample distilled water and 
washed twice at 37 °C in stripping buffer for 20 min. After rinsing with 2X SSC for 5 min, 
membranes were stored wet in 10 ml 2X SSC at 4 °C until hybridization. 
3.5.5. Serum selection and adsorption 
Selection. Sera for the IVIAT (in vivo induced antigen technology) experiment were obtained 
from anonymous clinical human patients with confirmed Y. enterocolitica serotype O:3 infection 
in Poland and Germany (provided by Dr. Waldemar Rastawicki, Warsaw, and by Dr. Konrad 
Trülzsch, Munich, respectively). Immune responsiveness of each individual serum was tested 
with a line immunoassay (Mikrogen, Neuried). Serum samples lacking a significant immune 
response were excluded from further analyses, while the remaining positive samples were 
pooled together to a final volume of 3 ml (Table 18). 
Adsorption. Sera were subject to adsorption with both Y. enterocolitica Y11 and E. coli T7 
express whole cells and cell lysates, in order to remove antibodies which recognize antigens 
expressed in vitro. After growth at 27 °C in LB broth, bacterial cells from 600 ml fresh liquid 
culture (OD600=0.5-0.6) were collected by centrifugation at 10,000 x g, 4 °C, 20 min, and washed 
in cold PBS. Pellets were weighted to add Protease Inhibitor Cocktail accordingly, and used 
directly for adsorption or lysed. For whole cell adsorption, the pellets were dissolved in PBS (1 
ml for 100 ml culture). Bacterial suspension were centrifuged at 15,000 x g, 5 min, 4 °C, pellets 
were re-suspended in an equal volume of sera and incubated at 4 °C for 1 h, with continuous 
shaking. After centrifugation (15,000 x g, 15 min, 4 °C), unadsorbed antibodies were discarded 
from the supernatant, and adsorption was repeated three additional times. For adsorption with 
cell lysates, bacterial pellets from 100 ml culture were dissolved in 1 ml lysis buffer (50 mM Tris-
HCl pH 8, 100 mM NaCl, 10% glycerol, 0.1% NP-40, 1mM PMSF, 0.1 mg/ml lysozyme), 
sonicated on ice three times for 20 sec, and centrifuged at 15,000 x g, 4 °C for 15 min. 
Supernatants (soluble proteins) were transferred to a new tube together with the pellets 
(insoluble proteins), which had been re-suspended in 1 ml lysis buffer. One aliquot was heated 
at 100 °C for 5 min to have heat-denatured cell lysates, and protein concentration of all cell 
lysates was determined (section 3.5.3). According to standard dot-blot protocols, nitrocellulose 
strips were saturated with 25 µg cell lysates, and incubated for 1 h at 4 °C with the sera 
previously adsorbed against whole cells, twice for cell lysates and once for heat-denatured cell 
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lysates. Aliquots of the final adsorbed sera were stored at -20 °C. Efficiency of the adsorption 
process was assessed by SDS-PAGE and Western Blot with unadsorbed, partially adsorbed 
and completely adsorbed sera. 
Table 18 Sera from human patients and relative information (n.a.: not available). 
ID Date of 
collection Serological and clinical info 
Age/Gender of 
patient Source 
Pooled 
for IVIAT 
S1 n.a. Agglutination with O:3 anti-serum n.a. K. Trülzsch Yes 
S2 n.a. Agglutination with O:3 anti-serum n.a. K. Trülzsch Yes 
S3 n.a. Agglutination with O:3 anti-serum n.a. K. Trülzsch No 
S4 20.07.2011 Agglutination with O:3 anti-
serum, 2 weeks after infection n.a. K. Trülzsch No 
S5 2003 Agglutination with O:3 anti-
serum, 1 week after infection n.a. K. Trülzsch Yes 
S6 Feb 2012 Agglutination with O:3 anti-serum 21 years/n.a. K. Trülzsch No 
S7 Feb 2012 Agglutination with O:3 anti-
serum, 10 days after S6 
21 years/n.a. 
(same as S6) K. Trülzsch Yes 
S10 Jun 2009 High level of IgA, IgG, IgM to O:3 LPS and Yops 57 years/female W. Rastawicki No 
S11 Oct 2009 High level of IgA, IgG, IgM to O:3 LPS and Yops 33 years/female W. Rastawicki No 
S12 04.02.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops n.a./female W. Rastawicki Yes 
S13 Feb 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 26 years/female W. Rastawicki No 
S14 02.03.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 30 years/male W. Rastawicki Yes 
S15 26.03.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 37 years/female W. Rastawicki Yes 
S16 May 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 40 years/female W. Rastawicki No 
S17 May 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 41 years/female W. Rastawicki No 
S18 12.05.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 36 years/female W. Rastawicki Yes 
S19 18.05.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 20 years/male W. Rastawicki Yes 
S20 May 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 1 year/female W. Rastawicki No 
S21 24.05.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 41 years/male W. Rastawicki Yes 
S22 Jun 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 29 years/male W. Rastawicki No 
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S23 22.06.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 23 years/female W. Rastawicki Yes 
S24 Jul 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 29 years/female W. Rastawicki No 
S25 Aug 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 49 years/female W. Rastawicki No 
S26 Sep 2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 41 years/male W. Rastawicki No 
S27 25.10.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 51 years/male W. Rastawicki Yes 
S28 04.11.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 51 years/female W. Rastawicki Yes 
S29 16.11.2010 High level of IgA, IgG, IgM to O:3 LPS and Yops 12 years/male W. Rastawicki Yes 
 
3.5.6. Screening of expression library 
Expression library was screened by immunoblotting as follows. Aliquots of the E. coli T7 express 
library glycerol stock were thawed, diluted, and spread onto LB-kanamycin agar to obtain 300-
500 colonies per plate. Master plates were incubated at 30 °C o/n before transfer onto 
nitrocellulose filter disks. Filter disks were placed colony side up on new LB agar containing 1 
mM IPTG and 30 µg/ml kanamycin, and incubated at 37 °C for 4 h. Following induction, 
nitrocellulose filters were removed and washed in water-soaked filter papers. Colony 
immunoblotting was performed as described (section 3.5.2) using the pooled adsorbed sera as 
primary antibody. Clones identified during primary screening were picked from the master plate 
and subject to secondary and tertiary screening, similarly to the first screen. Clones that 
maintained reactivity were considered positive identifications. Antigens were identified by 
isolating the pET-30 plasmids from the positive clones, sequencing the inserts with T7 promoter 
and T7 terminator primers and performing a Blast search against Y. enterocolitica strain Y11. 
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3.6. Mouse experiments 
3.6.1. Preparation of microorganisms 
The mouse-virulent Y. enterocolitica strains 8081 and WA-314 used for animal experiments 
were obtained from Prof. Heesemann (Max-von-Pettenkofer Institute). Both strains had been 
mouse-passaged to select bacteria still maintaining virulence after extended manipulation in 
laboratory conditions, by challenging mice by intra-peritoneal (i.p.) injection and re-isolating the 
bacteria 1 day post-infection. 
3.6.2. Infection of animals 
In order to evaluate the in vivo virulence behavior of Y. enterocolitica strains 8081 and WA-314, 
single-strain and co-infection experiments in a mouse model were carried out. Mouse infection 
was performed with seven-week old C57/BL6 female mice, which were identified with ear tags. 
Groups of 8 mice were used for both single-strain- and co-infection experiments. For this 
purpose, bacteria were o/n grown at 27 °C as described in section 3.3.3, diluted 1:50 in LB 
medium and allowed to further grow at 37 °C for 80 min. Cultures were centrifuged at 4,500 x g 
for 10 min at 4 °C and the harvested bacteria were washed in sterile Dulbecco’s PBS (DPBS). 
Using previously acquired data (section 3.3.4), an infection dose of 1.7 x 104 bacteria was 
prepared for single-strain infection, and 1.2 x 104 bacteria for the co-infection experiment. The 
number of CFU was confirmed by plating dilutions of the infection samples for single-strain 
mixes, counting colonies after 24 h growth at 27 °C, and by colony hybridization for the co-
infection mix (section 3.5.4). Mice were subject to i.p. injection of 600 µl of the appropriate DPBS 
bacterial suspension and weighted every day. 
3.6.3. Recovery of bacteria from mouse organs 
Mice were sacrificed by inhalation of CO2 five days post infection. Livers and spleens were 
immediately removed under sterile conditions and stored in 1 ml DPBS on ice. Organs were 
homogenized by a tissue blender for 4 min. Plating serial dilutions of the homogenized livers 
(10-2, 10-3, 10-4, 10-5) and spleens (10-3, 10-4, 10-5, 10-6) on LB agar plates, followed by incubation 
at 27 °C for 20-24 h, allowed determination of bacterial counts. 
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3.7. Bioinformatics 
3.7.1. Bioinformatics tools 
All the tools used in this study for bioinformatics analysis and their respective references/sources 
are listed in Table 19. 
Table 19 List of used bioinformatics tools. 
Software/ 
Platform Description Reference/Link 
BioEdit Biological sequence alignment editor (Hall, 1999) 
Blast Basic Local Alignment Search Tool (Altschul et al., 1990) 
BRIG Interactive generation of comparative genomic images (Alikhan et al., 2011) 
BWA Mapping of short read using Burrows-Wheeler transform (Li and Durbin, 2009) 
CDD Conserved Domain Database of the NCBI (Marchler-Bauer et al., 2013) 
CLC DNA 
Workbench 
Comprehensive workbench for DNA, RNA, 
and protein analyses CLC bio, Aarhus, Denmark 
CLC Genomic 
Workbench High-throughput sequencing data analysis CLC bio, Aarhus, Denmark 
ClustalW Multiple sequence alignment (Larkin et al., 2007) 
Edgar Comparative analysis of annotated genomes (Blom et al., 2009) 
FastQC Quality control of reads from all sequencing platforms 
http://www.bioinformatics.babraham.
ac.uk/projects/fastqc/ 
FreeBayes Bayesian genetic variant detector http://arxiv.org/abs/1207.3907 
Galaxy Web-based platform for data intensive biomedical research (Goecks et al., 2010) 
GATK Post-processing and SNP calling (DePristo et al., 2011) 
Gene 
Ontology 
Ontology of defined terms representing gene 
product properties (Ashburner et al., 2000) 
KAAS Server for automatic genome annotation and pathway reconstruction (Moriya et al., 2007) 
Maple Metabolic And Physiological potential Evaluator (Takami et al., 2012) 
Mauve Generation of multiple genome alignments for comparative genomics (Darling et al., 2010) 
MLST Web-based method for MLST of bacterial 
species based on WGS data (Larsen et al., 2012) 
MUSCLE Multiple sequence alignment (Edgar, 2004) 
NCBI Biomedical and genomic databases www.ncbi.nlm.nih.gov 
Pfam Large collection of protein families (Finn et al., 2006) 
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PGAAP Prokaryotic Genome Automatic Annotation Pipeline 
http://www.ncbi.nlm.nih.gov/genome/
annotation_prok/ 
PHAST Rapid and accurate identification, annotation 
and graphically displaying of prophages (Zhou et al., 2011) 
Phylip Programs for inferring phylogenies (Felsenstein, 1989) 
Picard Manipulation of SAM files http://picard.sourceforge.net/ 
Prophage 
Finder 
Prediction of prophage loci in prokaryotic 
genomes (Bose and Barber, 2006) 
PsortB Bacterial localization prediction tool (Yu et al., 2010) 
PubMLST Public databases for molecular typing and 
microbial genome diversity (Jolley and Maiden, 2010) 
RAST Automated service for high-quality annotation 
of bacterial genomes (Aziz et al., 2008) 
SAMtools Manipulation of SAM files, SNP calling (Li et al., 2009) 
SEED Comparative genomic environment (Overbeek et al., 2005) 
SignalP Predicts of signal peptide cleavage sites (Petersen et al., 2011) 
tRNAscan-SE Web-server for tRNA gene search in genomic 
sequences (Schattner et al., 2005) 
 
3.7.2. General sequence analysis 
Whole genome, gene and protein sequences were acquired from the online NCBI databases. 
Y. enterocolitica strains and accession numbers of their sequenced genomes are given in Table 
20. Basic sequence manipulation and visualization were performed using BioEdit Sequence 
Alignment Editor, version 7.0.5.3, and CLC DNA Workbench, version 6.0. Homology searches in 
public databases were done using Blast, while identification of conserved protein domains was 
obtained by CDD and Pfam database search. MLST profiles of Y. enterocolitica strains were 
determined in silico using the MLST (MultiLocus Sequence Typing) service (version 1.7); the 
Yersinia MLST allele sequences, in particular, are based on the scheme hosted at the PubMLST 
database. 
3.7.3. Sequencing of bacterial DNA and read quality control 
The genomic sequence of Y. enterocolitica strain WA-314 was acquired by BGI-Hongkong Co. 
(Hong Kong), who performed high-throughput Illumina paired-end sequencing, quality control of 
raw data and assembly of the short reads with SOAPdenovo. The methods described in sections 
3.7.4 and 3.7.5 were therefore not applied to this sample. All the YE serotype O:3 genomes 
generated in this study were obtained by re-sequencing with the Illumina MiSeq technology, with 
a 150-bp paired-end library (IMGM Laboratory, Martinsried) or a 250-bp paired-end library 
Materials and Methods  50 
(collaboration with Prof. Kalinowski, University of Bielefeld). Reads were subject to quality 
control using the program CLC Genomics Workbench versions 6 and 7 and the FastQC tool 
embedded in the Galaxy platform (Table 19). In particular, sequencing accuracy was assessed 
by measuring the base calling accuracy using the Phred quality score (Q score), which indicates 
the probability (P) that a given base is incorrect in a logarithmic scale (Q = -10 log10 P). For 
example, a Phred score of 30 means that the chances that a base is called incorrectly are 1 in 
1,000 with an accuracy of 99.9%, while a Phred score of 40 corresponds to a base call accuracy 
of 99.99%. 
Table 20 Y. enterocolitica genome sequences used in this study. 
Strain Bioserotype Genome Accession N° Reference 
8081 1B/O:8 NC_008800 and NC_008791 (pYV) (Thomson et al., 2006) 
WA-314 1B/O:8 AKKR00000000 This study (Garzetti et al., 2012) 
a127/90 1B/O:8 NC_004564 (pYV) (Foultier and Cornelis, 2003) 
Y11 4/O:3 NC_017564 and NC_017565 (pYV) (Batzilla et al., 2011c) 
Y8265 4/O:3 CACU01000000 (Batzilla et al., 2011a) 
Y5307 4/O:3 CACV01000000 (Batzilla et al., 2011a) 
W22703 2/O:9 FR718488-FR718797 (Fuchs et al., 2011) 
105.5R(r) 3/O:9 CP002246.1 (Wang et al., 2011) 
Y5.27P 3/O:5,27 CACW00000000 (Batzilla et al., 2011a) 
NF-O 1A/O:5 CACY00000000 (Batzilla et al., 2011b) 
IP2222 1A/O:36 CACZ00000000 (Batzilla et al., 2011b) 
IP10393 4/O:3 CAOV01000000 (Savin et al., 2013) 
PhRBD_Ye1 n.a./O:3 AGQO00000000 (Klinzing et al., 2012) 
YE12/03 4/O:3 HF933425 (Reuter et al., 2012) 
O3-gb 4/O:3 n.a. Provided by Dr. A. McNally, Nottingham 
 
3.7.4. Read mapping and alignment post-processing 
Reads from each isolate were mapped against the chromosome of Y. enterocolitica strain Y11 
serotype O:3 reference genome using the BWA (Burrows-Wheeler Aligner) Galaxy wrapper with 
default parameters. Mapping quality reports were generated by CLC Genomics Workbench, 
providing coverage statistics and read distributions. Alignments were filtered using SAMtools 
(Galaxy wrapper for sam_bitwise_flag_filter), in order to remove unmapped and unpaired reads, 
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and Picard (Galaxy wrapper for MarkDuplicates), to reduce the data set by including only one 
copy of the duplicate sequences, which may arise from PCR amplification artifacts during library 
construction. The GATK tools embedded in galaxy were then used to perform a local re-
alignment, to transform regions with mismatches around indels into clean reads. This step is 
recommended, since these misalignments are easily mistaken as SNPs. A base quality score 
recalibration is also performed with GATK tools, in order to make error rates more accurate and 
informative than the ones provided by the sequencers. 
In case a de novo assembly of genomes was required, paired reads were assembled by the 
CLC Genomics Workbench, with the following settings: Minimum contig length = 200; Mismatch 
cost = 2; Insertion cost = 3; Deletion cost = 3; Length fraction = 0.5; Similarity fraction = 0.8. 
3.7.5. Variant calling and filtering 
Variants were identified with different approaches, depending on the type of genome sequence. 
For assembled genomes downloaded from public databases, variants were called using the web 
server snpTree version 1.1, with 10 bp as minimum distance between SNPs and 20 bp as 
minimum distance to end of sequence. For the genomes obtained in this study and mapped 
against a reference, variants were detected combining the results from two tools (FreeBayes 
and SAMtools). The FreeBayes algorithm was run in Galaxy with the following parameters: 
Minimum mapping quality = 30; Minimum base quality = 20; Minimum coverage = 10; Minimum 
variant probability = 0.8. Variants were identified by SAMtools with Minimum mapping quality = 
30 and Minimum base quality = 20. GATK tools allowed merging of the variants called by both 
methods, to obtain a more robust variant detection procedure. Variants called in assembled 
genomes were then combined with the ones obtained from mapped sequences, and filtered to 
exclude the ones within phage regions and repetitive elements. After manual inspection, low-
confidence alleles with a quality score < 130 or heterozygous base call were removed. 
Functional consequences (e.g. non-synonymous mutations and amino acid changes) of the 
detected variants were computed by CLC Genomics Workbench. 
3.7.6. Genome annotation 
For annotating the assembled bacterial genomes, the RAST (Rapid Annotations using 
Subsystems Technology) online server was employed. This automatic annotation service is 
based on a library of manually curated subsystems and on protein families, mainly derived from 
the subsystems, called FIGfams. When genomes were to be submitted to the GenBank 
database, the PGAAP pipeline of the NCBI was used, combining ab initio gene prediction 
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algorithms with homology based methods. Identification of tRNA genes was done by tRNAscan-
SE and prophage regions were determined by PHAST and Prophage Finder. 
3.7.7. Whole genome comparison 
Comparison of multiple whole genome sequences was conducted by means of various 
programs. To align regions conserved in subsets of the genomes, the Mauve genome alignment 
package (version 2.3.1) was used. In particular, alignments were done by the progressiveMauve 
algorithm, which is able to align a large number of genomes with high accuracy, also taking care 
of regions differentially conserved among the analyzed organisms. For the generation of 
comparative genomic circular images, the BRIG (BLAST Ring Image Generator) software was 
chosen. Genome comparison based on the identification of orthologous genes, using 
bidirectional best hits (BBHs) as orthology criterion, was achieved by Edgar (Efficient Database 
framework for comparative Genome Analyses using BLAST score Ratios), allowing, among 
other features, classification of genes as core or pan genes. In particular, core genome 
development plots were calculated in Edgar according to the approach described in (Tettelin et 
al., 2005), while pan-genome statistics, based on a Heaps' law approach (Tettelin et al., 2008), 
were kindly provided by Dr. Jochen Blom (Justus-Liebig-University Giessen). Comparison 
analyses were also performed within the SEED environment, connected to the RAST server. 
3.7.8. Functional annotation and comparative functionome analysis 
Genes were functionally classified using KAAS (KEGG Automatic Annotation Server) by BLAST 
best-hit comparisons against KEGG Genes, a database created from public resources. The 
KAAS results contain KO (KEGG Orthology) assignments, which consist of manually defined 
ortholog groups for all proteins and functional RNAs, allowing automatic generation of KEGG 
Pathways and KEGG Modules (Moriya et al., 2007). Comparison among comprehensive 
functional categories (functionomes) could be obtained by MAPLE (Metabolic And Physiological 
potentiaL Evaluator), which calculates the completion ratio of all KEGG functional modules in 
each organisms based on KEGG Module (Takami et al., 2012). KEGG Module is a collection of 
pathway modules, which are manually defined functional units (such as consecutive reaction 
steps or operons); structural complex modules, which comprise multiple molecules (such as the 
subunits of transporters); functional essential sets; and signature modules. The query 
sequences are assigned to KO identifiers, whose combinations define each module, allowing 
functional annotation.  
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3.7.9. Phylogenetic analyses 
Construction of the phylogenetic tree for analysis of the Y. enterocolitica species was performed 
using the protein sequences of all the core genes (calculated by the Edgar software, section 
3.7.8) of a selection of genomes. Orthologous CDSs found in all genomes were concatenated 
and aligned using the multiple alignment tool MUSCLE. Uninformative characters not matching 
the alignment were removed by Gblocks. A distance matrix was then calculated from this 
alignment and finally a phylogenetic tree was constructed under the Neighbor-Joining method. 
The two latter methods were used in the Phylip implementations. A majority rule-consensus tree 
of 100 bootstrap replicates was also computed to evaluate node support. 
A SNP-based phylogenetic tree was reconstructed using the filtered variants vcf file from section 
3.7.5 as input and the sequence from YE strain Y11 as reference, removing insertions and 
deletions. For each strain, a nucleotide sequence containing the concatenated base calls at 
each SNP location was obtained. After performing a multiple alignment by MUSCLE, a DNA-
based phylogeny was calculated using the Neighbor-Joining method with Phylip. 
3.8. Statistics 
Statistical analyses of results from the mouse experiments were performed with Prism software 
(GraphPAd) using the two-tailed unpaired Student’s t test with Welch’s correction and one way 
ANOVA. A P value < 0.05 was considered statistically significant. 
Statistics on the called variants were also done with Prism software using a non-linear 
regression, with 95% confidence intervals and weighted sum of squares (1/Y).  
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4. Results 
Y. enterocolitica is an important foodborne pathogen strongly associated with consumption of 
food products of porcine origin. Serotypes O:8, O:3, O:9 and O:5,27 are the most prevalent in 
humans, but genomics and pathogenesis studies have been mainly carried out on the mouse-
virulent serotype O:8, especially strain 8081. In order to understand the pathogenicity and 
evolutionary mechanisms of a bacterial species, however, there is a need to analyze more than 
a single genome (section 4.1) and to characterize genomic features of multiple serotypes 
(section 4.2). Moreover, molecular epidemiology has shown low resolution for the microevolution 
of the most frequently isolated strains of serotype O:3, whose virulence and colonization factors 
are unknown. The precise intra-species relationships of this serotype, therefore, need further 
analysis (section 4.3), as well as the mechanisms underlying the pathogenicity in humans 
(section 4.4). 
4.1. Highly-virulent Y. enterocolitica subsp. enterocolitica 
Two Y. enterocolitica subsp. enterocolitica bioserotype 1B/O:8 strains, namely 8081 and 
WA-314, are commonly used in Yersinia research laboratories for their high-virulence properties 
in mouse infection models. The genome of strain 8081, the first YE to be sequenced (Thomson 
et al., 2006), was compared to the genome sequence of strain WA-314, obtained in this study, to 
disclose the virulence and fitness determinants shared by the high-virulence group, together with 
in vitro and in vivo experimental analyses. 
4.1.1. Whole genome comparison of Y. enterocolitica bioserotype 1B/O:8 
General features. The sequencing and assembly of the high-quality Y. enterocolitica strain 
WA-314 whole-genome, obtained in cooperation with BGI-Hongkong Co., produced 129 contigs, 
which could be further assembled in 4 large scaffolds and 8 contigs, with an additional scaffold 
constituting the pYV virulence plasmid. After head-to-tail concatenation of contigs with no 
definite order, the chromosome size resulted to have ~4,459,631 bp, with a G+C content of 
47.24%, while the pYV is ~65,033 bp long, having 43.6% of G+C content (Table 21). These 
sizes are underestimated due to the inter-scaffold gaps, which represent repetitive regions not 
resolved by the used sequencing approach. RAST automatic annotation identified 4,086 coding 
sequences (CDSs) in the genome, and 87 CDSs in the pYV plasmid. Overall, 87.1% of the 
proteins have length < 500 aa, the bigger protein is 3,054 aa long and the smallest is formed by 
38 aa (Figure 4). The chromosome also harbors 65 tRNA genes of 70-91 bp, and 7 prophage-
like regions, which are 10-42 kb large. The contig sequences have been deposited in public 
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databases (DDBJ/EMBL/GenBank) as Whole Genome Shotgun project under Accession 
Numbers AKKR01000001-AKKR01000129. 
The main features of the chromosomal and plasmidic sequences of YE strains 8081 and 
WA-314 are summarized in Table 21. The smaller size of strain WA-314 may be explained by 
the incompleteness of the genome and the presence of gaps between contigs, while the higher 
number of CDSs is probably due to the different annotation procedures adopted. Comparison 
with SEED considering only bidirectional best hit proteins with a minimum similarity score of 40% 
showed that 3,702 orthologous CDSs are shared between strain WA-314 and 8081 
chromosomes, including the main known virulence factors. Genes specifically found in either of 
the two genomes mainly belong to hypothetical proteins or proteins encoded by mobile 
elements, such as prophages, but include also protein-encoding genes with specific assigned 
functions (Table 22).  
Table 21 Properties of the chromosomes and pYV plasmids of Y. enterocolitica strains WA-314 and 8081. 
Property Chromosome 
strain WA-314 
Chromosome 
strain 8081 pYVWA-314 pYV8081 
Size ~ 4,459,631 bp 4,615,899 bp ~ 65,033 bp 67,721 bp 
G+C content 47.24% 47.27% 43.6% 43% 
Number of CDS 4,086 4,037 87 72 
Average gene size 909 bp 968 bp 550 bp 675 bp 
tRNA ~ 65 81 0 0 
Prophage regions 7 4 0 0 
 
 
Figure 4 Histograms and statistics of Y. enterocolitica strain WA-314 protein length. 
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Mobile elements. Apart from the conserved YGI-1 and YGI-2, genomic islands and prophage-
like regions represent the largest source of genetic variation between genomes of YE strains 
8081 and WA-314 (Figure 5). Strain WA-314 is devoid of the YAPI (Yersinia Adhesion 
Pathogenicity Island), a 66-kb virulence-associated region located within the Plasticity Zone (PZ) 
of strain 8081 and integrated between an intact and a partial tRNA-Phe copy, which remains 
complete in strain WA-314. This island carries a type IV secretion system, a putative hemolysin, 
a toxin-antitoxin system (CcdAB family) and an arsenic resistance operon. The YGI-4, which is 
variably present in YE 1B, is absent from strain WA-314, while in strain 8081 it is substituted by 
a putative integrated plasmid. In contrast to the 4 prophages of strain 8081, 7 prophage-like 
regions were identified in strain WA-314 (Figure 5). Analysis with PHAST classified prophages 
YWA-1 and YWA-5 as intact, YWA-7 and YWA-2 as questionable, and YWA-3, YWA-4 and 
YWA-6 as incomplete. Prophages detected in strain 8081, ΦYE185 and ΦYE200, and ΦYE98, 
are partly similar to YWA-1 and YWA-2, respectively. A strain-independent acquisition of these 
prophages is likely, as these regions are not located in the same chromosomal context. 
Curiously, prophage YWA-1 is 70% identical to the bacteriophage L-413C of Y. pestis 
(Accession Number NC_004745), while YWA-2 shares CDSs with phage HP2 of Haemophilus 
influenzae (Accession Number NC_003315). The P4-like prophage YWA-4, located in a 
chromosomal region corresponding to the putative integrated plasmid YGI-3 in strain 8081 (see 
also Figure 20), harbors a PilV-like protein (locus tag: YWA314_12491) containing a Shufflon N-
terminal region, similarly to adhesins in Y. enterocolitica subsp. palearctica and in Y. intermedia. 
As part of a probable operon encoding ancient type IV pili, this protein may be involved in 
adhesion to and invasion of the human intestinal cells. 
Table 22 Significant regions and genes of difference in highly-virulent Y. enterocolitica. 
Region or gene 
cluster Strain 8081 Strain WA-314 Description 
YAPI (PZ) Present Absent Pathogenicity island 
YGI-3 Present (plasmid) Present (prophage) Putative hot-spot region for HGT 
YGI-4 Present Absent Integrated plasmid 
YE0694 
YWA314_00878 83% protein sequence identity Putative adhesion 
YE3700 
YWA314_14949 32% protein sequence identity Autotransporter 
YE1111-1114 
YWA314_11901-11886 85% DNA sequence identity Fimbrial operon 
YWA314_17584-17599 Absent Present Restriction modification system 
YWA314_20244-20259 Absent Present Colicin operon 
YWA314_07469 Absent Present XAT acetyltransferase 
 
Results  57 
Strain WA-314 specific genes. A restriction-modification (RM) system, a putative colicin cluster 
and a xenobiotic-acyltransferase (XAT)-encoding gene are specific acquisitions of YE strain 
WA-314. RM systems are defense mechanisms developed by bacteria to defend themselves 
against external DNA, which is cleaved by an endonuclease, after recognizing non-methylated 
cytosines. The host DNA is protected by methylated cytosines, and C to T mutations are 
repaired by very-short-patch repair proteins. The RM cluster of strain WA-314 is composed of 4 
CDSs (locus tags: YWA314_17584-17599), which encode an EcoRII-like type II restriction 
endonuclease, a Vsr endonuclease, a cytosine methylase and a DNA-binding protein. This 
cluster is 95% identical to a RM system in YE serotype O:5,27 (section 4.2.8) and 86% identical 
to RM clusters carried by genomes of Y. bercovieri and Y. frederiksenii, indicating a probable 
parallel acquisition of this cluster from the environment. 
Colicins are a type of bacteriocins produced by some bacteria to compete with closely related 
strains, with the producing bacteria being protected against the colicin activity by antagonist 
immunity proteins. They can act as pore-forming toxins or as endonucleases and may need a 
lysis protein to be released (Cascales et al., 2007). The colicin cluster detected in strain WA-314 
consists of four CDSs (locus tags: YWA314_20244-20259), encoding three putative immunity 
proteins and one putative colicin. In particular, the bacteriocin sequence contains a cloacin-like 
tRNAse C-ter domain and an S-pyocin-like N-ter domain, suggesting an enzymatic 
endonuclease activity. The operon is located between a phage anti-termination protein- and a 
pilus chaperone-encoding gene, similarly to colicin clusters of YEP isolates, which share the 
same chromosomal background (section 4.2.2 and Figure 16). Moreover, according to Blast 
analysis, putative colicin-encoding genes are carried by other Yersinia species, indicating an 
ancient evolutionary origin of bacteriocin-like clusters in Yersinia and subsequent genetic loss in 
strain 8081. 
The 221-aa XAT protein of strain WA-314 (locus tag: YWA314_07469), also annotated as 
chloramphenicol acetyltransferase and similar to streptogramin-A/virginiamycin/antibiotic 
acetyltransferases from various proteobacteria, is curiously present in YEP strains, but not in 
other bioserotype 1B/O:8 strains, as revealed by Blast search. In the same genomic location, 
strain 8081 harbors a 119-aa hypothetical protein (locus tag: YE2013), which seems to be strain-
specific. Regarding the XAT protein of strain WA-314, the detected LbH (Left-handed parallel 
beta-Helix) domain, containing complete active sites and hexapeptide repeats, is typically 
present in the XAT class of hexapeptide acyltransferases, which inactivate antibiotics via 
enzymatic CoA-dependent acetylation. This gene might be responsible for the different 
resistance to streptogramins observed (see below).  
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Figure 5 Comparative circular representation of the genomes of Y. enterocolitica strains 8081 vs WA-314 
(top) and WA-314 vs 8081 (bottom). Significant regions and genes are shown in the outer ring. Modified 
from (Garzetti et al., 2012). 
Identification of new putative virulence determinants. Genomic comparison of the two 
highly-virulent YE strains 8081 and WA-314 revealed presence of genes with low-sequence 
similarity, which might be associated with virulence. A 635-aa outer membrane protein (locus 
tag: YE3700) in strain 8081 is only 32% identical to its orthologous protein in strain WA-314, a 
902-aa putative autotransporter (locus tag: YWA314_14949). The two genes share the same 
genomic region and have both low G+C content (43.1% in strain 8081 and 39.2% in strain 
WA-314). While YWA314_14949 has homologous genes in Y. pestis, Y. similis and 
Y. pseudotuberculosis, YE3700 can be found only in YE. Autotransporters in Gram-negative 
bacteria are highly diverse and perform a variety of functions that promote virulence by 
catalyzing proteolysis, serving as adhesins or cytotoxins, and mediating actin-promoted motility. 
These proteins are commonly organized in a signal peptide, followed by an N-terminal 
passenger domain, which is transported through the outer membrane by a pore formed by the 
C-terminal translocator domain (Benz and Schmidt, 2011). Both proteins of strains 8081 and 
WA-314 contain at the C-terminus an autotransporter beta-domain, traditionally involved in type 
V secretion of the protein itself. Additionally, a pertactin-like passenger domain of T5SS 
autotransporters could be recognized at the central region of YWA314_14949, similarly to the 
homologous AidA-I protein in E. coli, whereas no significant hits were found for the N-ter of 
YE3700. SignalP (version 4.1) could not predict any signal peptide in either of the two proteins, 
probably due to the low sequence identity among autotransporter sequences (Dautin and 
Bernstein, 2007). 
A long adhesin shares 83% sequence identity between YE strains 8081 (locus tag: YE0694, 
2,484 aa) and WA-314 (locus tag: YWA314_00878, 2,490 aa), but is missing in YEP, as 
previously described (Thomson et al., 2006), in Y. pestis and Y. pseudotuberculosis. Differences 
mainly lie in the C-terminal part of the proteins, where no known domains were detected. Both 
proteins contain, from the N-terminal to the C-terminal, a lysine motif (a small globular domain 
involved in peptidoglycan-binding), a domain of unknown function DUF3442 (intimin/invasin), 
and multiple bacterial Ig-like domains (typically found in bacterial surface proteins associated 
with cell-adhesion and pathogenicity). Interestingly, these adhesins are classified into the KEGG 
pathway “Bacterial invasion of epithelial cells”, together with the Ysa-T3SS proteins YspD and 
YspB. 
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A type-1 fimbrial operon has been identified as chromosomal region of difference among 
Yersinia species, since it is specifically carried by YE bioserotype 1B/O:8 (Thomson et al., 
2006). In strains 8081 (locus tags: YE1111-1114) and WA-314 (locus tags: YWA314_11901-
11886) the DNA sequence of the whole operon is 84.7% identical, with the most differences 
located in the first and last genes of the operon, encoding two fimbrial subunits. In particular, 
homologous proteins YE1111 (343 aa) and YWA314_11901 (274 aa) show an amino acid 
sequence similarity score of 36.7%, and proteins YE1114 (175 aa) and YWA314_11886 (177 
aa) are 42.3% identical. While a signal peptide was recognized only in one WA-314 protein, 
YWA314_11886, both fimbrial proteins of strain 8081 contain a signal peptide at the N-terminal, 
suggesting a role in motility and secretion of these three proteins and unclear function of protein 
YWA314_11901. 
Plasmid-encoded features. The DNA sequence of the pYVWA-314 was found to be identical to 
that previously published (Oberhettinger et al., 2011), as expected. Whole-sequence comparison 
between pYV8081 and pYVWA-314 (Figure 6) shows significant differences in repeat regions and in 
three Ysc-T3SS protein-encoding genes (yopM, yscP and lcrV), minor mutations in yadA and the 
presence of the ylpA gene in pYVWA-314. 
The LRR (leucine-rich repeat) effector protein YopM has shown interesting heterogeneity among 
YE bioserotype 1B/O:8 isolates (Boland et al., 1998; Heesemann et al., 1986b). Consistently, 
the yopM8081 gene (locus tag: YEP0010) is 1,104 bp long and encodes a 367-aa protein with 13 
LRRs, while yopMWA-314 (locus tag: YWA314_20912) is 1,518 bp long and the encoded protein is 
composed of 505 residues. Being 100% identical to that of YopMa127/90, YopMWA-314 possesses 3 
additional copies of LRR12-LRR13-LRR14 compared to YopM8081 (Figure 7). 
The lcrVWA-314 (locus tag: YWA314_20937, 1,002 bp) and lcrV8081 (locus tag: YEP0015, 975 bp) 
genes demonstrated an overall similarity of 95.9%. As previously observed (Roggenkamp et al., 
1997), the V-antigen LcrVWA-314 protein contains a 9-aa insertion (LHEVGVIAG) between 
residues 229 and 237, similarly to LcrVa127/90 (Foultier and Cornelis, 2003). This insertion is 
missing in LcrV8081, in weakly-virulent YE, in Y. pestis and Y. pseudotuberculosis, but is carried 
by LcrV proteins of serotype O:13 and O:20 strains (also biotype 1B) (Roggenkamp et al., 1997). 
The YscP protein sequence of YE isolates contains a variable number of three repeated motifs 
of 14 aa, 25 aa and 46 aa (Wagner et al., 2009). Conforming to these data, the yscPWA-314 is a 
1,617-bp gene, encoding a 538-aa protein (locus tag: YWA314_20992), while yscP8081 is 1,359 
bp long and encodes a protein of 452 residues (locus tag: YEP0026). The longer YcsPWA-314 
protein possesses 3 additional repeats, absent from YE strain 8081 and from strains belonging 
to the weakly-virulent group, which in turn have 2 extra specific repeats (Figure 8). 
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The 422-aa virulence adhesin YadA of YE strains 8081 and WA-314 showed 96.9% of protein 
sequence similarity. In particular, between residues 53 and 67 there are six differing amino 
acids: AAEaLggtnalakSI in strains 8081 and EVRaPggtnalakGT in strain WA-314. This region is 
located in the head domain of the protein and is surface-exposed (Roggenkamp et al., 2003). 
A notable difference found by comparison of the pYV sequences is the presence of the ylpA 
gene in pYVWA-314 (locus tag: YWA314_20862), which is missing from pYV8081 but present in 
pYVa127/90, in pYV plasmids of YEP, of Y. pestis and Y. pseudotuberculosis. The encoded YlpA 
protein is an outer membrane lipoprotein homologous to the enterobacterial TraT protein, which 
inhibits phagocytosis in E. coli (Aguero et al., 1984). 
 
Figure 6 Mauve comparison between pYV8081 and pYVWA-314. 
Each sequence is arranged in a horizontal track filled with a colored similarity plot, the height of which is 
proportional to the level of sequence identity in that region (white shades therefore indicate regions with 
low or no sequence homology). Below the tracks, annotated CDSs are shown as white boxes on two 
different levels according to the coding strand, while repeated regions are designed as colored boxes. 
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Figure 7 Alignment of YopM proteins and LRR structure. 
Sequences from Y. enterocolitica bioserotype 1B/O:8 strains are aligned against Y. pestis CO92 as 
reference strain. LRR numbers as in (Vieux and Barrick, 2011). Modified from (Garzetti et al., 2012). 
 
 
Figure 8 Alignment of YscP proteins. 
Sequences from Y. enterocolitica highly-virulent strains (8081, WA-314 and a127/90) and weakly-virulent 
strains (Y11 and W22703) are displayed. Below the alignment, green, red and blue lines highlight the 
repeats of 14 aa, 25 aa, and 46 aa, respectively (Garzetti et al., 2012). 
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4.1.2. Functional characterization of strains 8081 and WA-314 
Bacterial growth curve. The correlation between CFU/ml and OD600 during growth at 27 °C 
was determined for both Y. enterocolitica strains 8081 and WA-314, as described in section 
3.3.4, revealing small reproducible differences (Figure 9). In LB and MH liquid media, both 
strains exhibited similar growth properties, reaching an OD600 of 0.5 (8081) and 0.56 (WA-314) 
after 6 h. However, when considering the CFU/ml ratio, strain WA-314 showed a slightly faster 
growth behavior, achieving a CFU/ml of 4.76x108, compared to a ratio of 2.1x108 for strain 8081. 
To note, no clear differences in metabolic and regulatory factors, which would explain the fastest 
growth rate of strain WA-314, were identified by genome analysis (section 4.1.1). 
 
Figure 9 Growth curves of Y. enterocolitica strains 8081 and WA-314. 
 
Resistance to chloramphenicol and streptogramins. Streptogramins are cyclic peptide 
antibiotics inhibiting protein synthesis. Being poorly hydrophilic molecules, they cannot enter the 
permeability barrier of Gram-negative bacteria, which are therefore intrinsically resistant. 
Chloramphenicol, on the other side, is a broad-spectrum antibiotic, also used in the treatment of 
yersiniosis. Due to the presence of a specific chloramphenicol/streptogramin acetyltransferase 
XAT gene in strain WA-314 (section 4.1.1), antimicrobial susceptibility tests to these classes of 
antibiotics were performed by broth dilution and disk diffusion methods, comparing the behavior 
of YE strains WA-314 and 8081. Chloramphenicol and virginiamycin, a streptogramin antibiotic, 
were added to the liquid media at serial two-fold dilutions. The two strains grew slightly 
differently in the presence of chloramphenicol, showing an MIC (minimal inhibitory 
concentration) of 4 µg/ml for strain 8081 and of 8 µg/ml for strain WA-314 (Figure 10).  
Virginiamycin, on the other hand, seemed to have low antimicrobial effect on strain 8081 and no 
effect on strain WA-314, whose growth was drastically reduced only at the antibiotic 
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concentration of 256 µg/ml. The disk diffusion method was also utilized to check the antibacterial 
activity of chloramphenicol and quinupristin/dalfopristin, two streptogramin antibiotics which 
show bactericidal activity only when used in combination with each other. Commercially 
available chloramphenicol (30 µg) and quinupristin/dalfopristin (15 µg) disks were applied to the 
surface of dried agar plates, previously inoculated with YE strains 8081 and WA-314. After o/n 
growth at 27 and 37 °C, the diameter of inhibition zones showed that both strains were clearly 
susceptible to chloramphenicol. The resistance to streptogramins is evident for strain WA-314 at 
both tested temperatures, while strain 8081 showed a lower resistance level (Table 23). The 
observed differences may be related to the XAT gene present in strain WA-314 but absent from 
strain 8081 (see above). Interestingly, this gene is 99% similar to a streptogramin A 
acetyltransferase (sat) gene from YE, which has been characterized, proving its functionality and 
acetylating activity (Seoane and Garcia Lobo, 2000). Curiously, virginiamycin has been used in 
farm animal feed as a growth promoter, but is now banned in Europe because of the selection 
for streptogramin resistance, which may be transferred to humans (Simjee et al., 2006). The 
close contact of YE with pigs might have selected for a streptogramin acetyltransferase gene 
with high affinity for this class of antibiotics. 
 
Figure 10 Antimicrobial susceptibility test by broth dilutions. 
Growth of Y. enterocolitica strains 8081 and WA-314 with chloramphenicol and virginiamycin was tested. 
Data are represented as mean of OD600 absorbance values between two independent experiments after 
o/n growth at 27 °C in MH broth. CTRL: negative control (no antibiotics added). 
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Table 23 Disk diffusion test results. 
Y. enterocolitica strains 8081 and WA-314 were tested for susceptibility to chloramphenicol and 
quinupristin/dalfopristin. Results are expressed as diameters of inhibition zone (cm). 
Antibiotic Temperature Strain 8081 Strain WA-314 
Chloramphenicol 
27 °C 2.4 2.3 2 2 
37 °C 2.5 2.6 2.1 2.2 
Quinupristin/Dalfopristin 
27 °C 0.9 1 0 0 
37 °C 1.1 1 0 0 
 
4.1.3. Different virulence properties of highly-virulent Y. enterocolitica  
Experiment optimization. The in vivo virulence properties of Y. enterocolitica strains 8081 and 
WA-314 were tested in a mouse model and compared by means of a co-infection experiment. 
Discrimination between YE strains 8081 and WA-314 was successfully obtained by a colony 
hybridization method using DIG-labeled probes (sections 3.4.6 and 3.5.4). Genomic comparison 
results allowed designing of strain-specific probes, Hem_8081 and Col_WA, targeting the 
putative hemolysin gene (locus tag: YE3454) in the YAPI region of strain 8081 and the colicin 
gene (YWA314_20259) of strain WA-314, respectively. Preliminary experiments to test the 
performance of the developed protocol were carried out analyzing plates with spotted known 
bacterial suspensions of either strain 8081 or WA-314. Once the colony hybridization protocol 
proved to be optimally working, cultures of the two strains were mixed, plated on the surface of 
agar plates and subject to the hybridization method. As demonstrated in Figure 11 A and B, 
probe Hem_8081 recognized colonies which were not targeted by Col_WA, and vice versa. 
Superimposing the membranes and examining the image in comparison with the original plate 
(Figure 11 C and D) revealed that all the bacterial colonies were recognized by either of the 
probes, and that no colonies were detected by both probes. This demonstrated the specificity of 
the developed method and its capability to differentiate between the two YE strains. 
Infection in a mouse model. Three groups of 8 mice were infected with YE strain 8081, strain 
WA-314, or a 1:1 mix of both microorganisms, via i.p. injection of bacterial suspensions (section 
3.6.2). Mice were weighted everyday, before they were sacrificed five days post infection (Figure 
12). Except for mice n° 9 and 21, all the animals lost from 13.5% (mouse n° 11, co-infected) to 
32% (mouse n° 5, infected with strain 8081) of their body weight, with no significant differences 
among the three groups. 
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Figure 11 Example of colony hybridization experiment. 
One nylon membrane from an LB-plate containing both Y. enterocolitica strains 8081 and WA-314 (C) was 
probed with Hem_8081 (A), stripped and re-probed with Col_WA (B). Superimposing images from A, in 
violet, and B, in pink, confirmed specificity of the probes (D). Modified from (Garzetti et al., 2012). 
 
To prove that the two strains were equally present in the co-infection mixture, the colony 
hybridization protocol was conducted on agar plates incubated with dilutions of the mix. After 
colorimetric detection, colonies were manually counted and the results confirmed the 1:1 
proportion between YE strain 8081 and strain WA-314 (out of 217 colonies, 100 were 
recognized by probe Col-WA and 117 by Hem_8081). 
Counting of bacteria recovered from spleens and livers of the three groups of mice allowed 
comparison of bacterial loads and, consequently, of the virulence efficiency of the tested YE 
strains (Figure 13). Overall, bacterial counts were higher in spleen samples than in livers, as 
expected from previous experiments with YE done in our Institute. No bacteria were extracted 
from both organs of mice n° 9 and 21, indicating an unsuccessful i.p. injection, as confirmed by 
the lack of weight body loss in these two mice (Figure 12). Moreover, the bacterial count in the 
spleen of mouse n° 17 was zero, while few bacteria (3x106) were still present in the liver. 
Statistically significant differences were found between bacterial loads from spleens of mice 
independently infected with strain 8081 and strain WA-314 (P=0.011), and from livers of mice 
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infected with strain 8081 and co-infected mice (P=0.006). Bacterial colonization of mice infected 
with strain WA-314 alone and with combined strains was not significantly different in either 
organs (Pspleen=0.86 and Pliver=0.27). Livers from mice infected with strain 8081 contained fewer 
bacteria than WA-314 single infection, but the difference was not statistically significant 
(P=0.16). 
 
Figure 12 Mouse weight loss. 
A total of 24 mice were divided into 3 groups and infected with Y. enterocolitica strain 8081, mice number 
1, 2, 3, 4, 5, 16, 17, 18 (A); strain WA-314, mice number 6, 7, 8, 9, 10, 19, 20, 21 (B); and a mixture of 
both strains, mice number 11, 12, 13, 14, 15, 22, 23, 24 (C). The weight loss average of the mice 
belonging to each group is shown in (D). 
 
To investigate whether the colonization of YE strains 8081 and WA-314 was equally efficient 
during co-infection, the optimized colony hybridization experiment (sections 3.5.4 and 4.1.2) was 
applied to bacteria recovered from spleens and livers of co-infected mice (Figure 14). Overall, 
YE strain WA-314 outperformed strain 8081. Strain 8081 exceeded strain WA-314 only in mouse 
n° 13, whose spleen contained the lowest bacterial count of the whole study (5.81x106), 
suggesting an incorrect inoculation of the bacterial mix in this mouse or a pre-induction of 
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inflammatory response because of mesenterial irritation. Without taking this mouse into 
consideration, on average strain WA-314 accounted for the 80.5% of the total bacterial loads in 
the organs of co-infected mice, indicating that strain WA-314 overcame strain 8081 in 
colonization of host tissues due to increased mouse virulence. 
 
Figure 13 Mouse infection experiments. 
Graphs show log-transformed bacterial counts (CFU/ml) recovered from spleens and livers of mice 
infected with Y. enterocolitica strain 8081, strain WA-314 and co-infected with both strains. The horizontal 
bars represent the mean number of bacteria for each group. Overall ANOVA analyses gave P=0.06 for 
spleen data, and P=0.016 for liver data. Individual groups were compared using two-tailed unpaired t test 
with Welch’s correction: ns, not significant; *, P<0.05; **, P<0.01. Modified from (Garzetti et al., 2012). 
 
 
Figure 14 Differentiation of Y. enterocolitica strains 8081 and WA-314 in co-infected mice. 
Data were obtained applying the colony hybridization method on bacteria recovered form spleens and 
livers of the 8 co-infected mice. Strain WA-314 overcame strain 8081 in 7 out of 8 mice. (Garzetti et al., 
2012).  
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4.2. Genome diversity of the Y. enterocolitica species 
Whole genome sequences of different strains belonging to Y. enterocolitica subsp. palearctica 
are available in public databases, and have been analyzed in previous studies to identify novel 
virulence genes and fitness factors of the weakly-virulent group, emphasizing the dissimilarities 
with the highly-virulent strain 8081 (section 1.5). However, one genome is not sufficient to gather 
the completeness of the variable population structure of Y. enterocolitica subsp. enterocolitica, 
as shown in this study (section 4.1). In addition, undisclosed differences within YEP genomes 
may explain the adaptation of these bacteria to a variety of ecological niches and their wide 
dissemination in humans, despite the low virulence (section 1.4). In this section, genome 
sequences of weakly-virulent and non-virulent strains are analyzed between each other and in 
relation to the mouse-virulent YEE genomic traits (section 4.1.1), allowing also a thorough 
investigation of the species YE in its entirety. 
The 10 genomes used in this study and their main characteristics are summarized in Table 21 
(YEE) and Table 24 (YEP): 2 highly-virulent strains of bioserotype 1B/O:8 (8081 and WA-314); 6 
weakly-virulent strains of serotype O:9 (W22703 and 105.5R(r)), bioserotype 4/O:3 (Y11, Y8265, 
Y5307) and serotype O:5,27 (Y5.27P); 2 non-virulent strains of bioserotype 1A/O:5 (NF-O) and 
1A/O:36 (IP2222). These strains cover the main serotypes isolated from diseased humans and 
include also an environmental isolate and a non-virulent strain isolated from a patient, 
representing the diversity of the species YE and the isolates with clinical and non-clinical 
significance. 
4.2.1. Y. enterocolitica subsp. palearctica whole-genome comparison 
To gain a general understanding of the main genomic differences in Y. enterocolitica subsp. 
palearctica, BRIG comparisons were computed using the two complete genomes of strains Y11 
and 105.5R(r) as references (Figure 15). As expected, prophages represent the main source of 
genomic variation, even if some of them (e.g. PhiYep-2 and PhiYep-3) are partly conserved 
among different serotypes. The LPS/O-ag cluster is clearly serotype-specific (see section 4.2.7), 
while the Aat, Flag-2 and Tc clusters are exclusively carried by weakly-virulent strains of 
serotypes O:3, O:9 and O:5,27, as previously determined (section 1.5). Interestingly, apart from 
prophage regions, hypothetical proteins and O-ag-encoding genes, the three YE serotype O:3 
strains carry other serotype-specific regions, such as the genomic island named GIYep-01 
(Batzilla et al., 2011a), a colicin type 7 Cja (locus tag: Y11_38121), a putative N-
acetylglucosamine-binding protein (Y11_42051) and a HipBA system (Y11_28521-28531) 
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located within prophage Phi-b. On the other hand, regions specifically acquired by serotype O:9 
strains only include prophages, hypothetical proteins and the O-ag gene clusters. 
Table 24 Main features of the Y. enterocolitica subsp. palearctica genomes analyzed in this study. 
Data correspond to information published in the GenBank database or calculated by the RAST server. 
Feature Y. enterocolitica strain 
 Y11 105.5R(r) Y5.27P NF-O 
Bioserotype 4/O:3 3/O:9 3/O:5,27 1A/O:5 
Origin human, Germany human, China human, Germany human, Canada 
GenBank Acc. No. FR729477 CP002246, CP002247 
CACW01000001-
CACW01000020 
CACY01000001-
CACY01000097 
No. of contigs 1 1 20 97 
Genome Size 
(Mbp) 4.55 4.55 ≥ 4.66 ≥ 4.66 
G+C content (%) 47.0 47.0 46.9 47.1 
Predicted CDSs 4,349 4,016 ≥ 4,351 ≥ 4,160 
tRNA 70 71 ≥ 98 ≥ 76 
 IP2222 W22703 Y8265 Y5307 
Bioserotype 1A/O:36 2/O:9 4/O:3 4/O:3 
Origin water, Japan human, Belgium human, France human, Finland 
GenBank Acc. No. CACZ01000001-CACZ01000074 
FR718488-
FR718797 
CACU01000001-
CACU01000014 
CACV01000001-
CACV01000018 
No. of contigs 74 305 14 18 
Genome Size 
(Mbp) ≥ 4.75 ≥ 4.75 ≥ 4.52 ≥ 4.55 
G+C content (%) 47.1 46.9 47 46.9 
Predicted CDSs ≥ 4,234 ≥ 5,006 4,296 4,393 
tRNA ≥ 82 ≥ 68 ≥ 61 ≥ 94 
 
Concentrating the investigation into serotype- and subspecies-specific features allowed 
discovering of highly variable regions in YEP and YEE genomes located within or near mobile 
elements. An interesting region, from now on called VR1 (variable region 1) for more clearness, 
is located in the same chromosomal location between transposase-encoding genes (locus tags: 
Y11_22211-22491), and carries functional units differentially present in the analyzed strains 
(Table 25). In particular, a four-CDS cluster (Y11_22231-22261), which encodes anaerobic 
DMSO reductases in YE serotypes O:3, O:9 and O:5,27, is replaced by nine genes encoding 
carbohydrate ABC transporters and transketolases in biotype 1B (YE0818-0826). Strains of 
biotype 1A carry both gene clusters and an additional 1A-specific cluster involved in fucose 
metabolism and carbohydrate transport. A cluster (Y11_22281-22341) with homologous 
functions to the LIV (leucine, isoleucine, and valine) branched-chain amino acid transport system 
(encoded by the livKHMGF operon) is then only present in YEP strains. It is flanked by a 
sorbose uptake system (Y11_22371-22421), which is universal for YE, by an enterotoxin-
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encoding gene, unique for 1A strains, and by an ABC transporter cluster, specific for 1A and 1B 
strains (YE0801-0806). Curiously, another ABC transport system, the phosphate transporter 
PstBAC (Y11_43361-43381), is inserted in YEP genomes in a region corresponding to 
transposase-genes of the IS1400 in YEE (YE1122-1123). To note, all YE carry a LIV transport 
system (YE0230-0234 and Y11_34321-34361); therefore, strains of the YEP possess two LIV 
system-encoding gene clusters, denoting nutritional versatility and ability to catabolize a diverse 
array of organic compounds. 
Flanked by a tRNA-Ser-encoding gene (locus tag: Y11_t25250), genomes of YEP strains harbor 
nine CDSs that are absent from strain 8081 and WA-314. These genes (Y11_04791-04871) 
belong to the nrfABCDEFG operon, which encodes enzymes involved in the anaerobic reduction 
of nitrite to ammonium in the so-called dissimilatory nitrate reduction process. The nitrite 
reductase gene remnant YE1598 of strain 8081 is a pseudogene of nrfG. Overall, YEP have two 
systems for nitrite reduction, NrfAH and NirBD, while YEE can use only the NirBD pathway, as 
supported by KEGG and SEED metabolic analyses. 
A known species-specific region of hyper-variability in YE is the 200-kb locus named plasticity 
zone (PZ) in strain 8081 (Table 3 and Table 25). The second large flagellar operon Flag-2 is 
found within the PZ of genomes of weakly-virulent strains but it is absent from biotypes 1A and 
1B. The Flag-2 cluster is complete in serotypes O:9 (locus tags: YE105_C3260-C3302) and 
O:5,27, and is divided into two parts by a transposase-gene insertion. The second part of the 
Flag-2 (YE105_C3289-C3302) is missing in serotype O:3 strains, which are therefore devoid of 
the components for flagellum transport and assembly. Serotype O:3 strains also lack the 
adjacent genes (YE105_C3304-C3311), encoding the fep-fes gene cluster required for uptake 
and utilization of the siderophore enterochelin, which are present in all other analyzed serotypes, 
as previously discovered (Schubert et al., 1999). YE biotypes 1B and 1A carry also the fepA 
gene (YE3624), containing a frameshift mutation in highly-virulent strains, and five genes 
encoding exported and outer membrane proteins (YE3626-3630). In the region corresponding to 
these genes, strains of biotypes 2-5 uniquely harbor the Aat (aggregative adherence transporter) 
system (YE105_C3315-C3324), followed by a Gifsy-2 prophage protein (YE105_C3326). 
In YE serotype O:3 genomes, two transposase-encoding genes are inserted where the other 
strains possess a genetic cluster (locus tags: YE3357-3361) involved in sucrose transfer and 
metabolism. Interestingly, analyzing the KEGG “Starch and sucrose metabolism” pathway, it 
appears that strain Y11 has only one maltodextrin glucosidase (Y11_20981) for regulating 
intracellular levels of maltose, in contrast to strains 8081 and 105.5R(r), which can count on two 
enzymes (YE3359 and YE3177-MalZ). 
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In addition to the previously-discovered and above-mentioned gene clusters, YEP-specific 
acquisitions include: sucrose permease and hydrolase (locus tags: Y11_05791-05801); 
multidrug resistance proteins (Y11_09551-09561), flanked by three biotype 1A-specific nitric 
oxide reductases; chloramphenicol-acetyltransferase (locus tag: Y11_12731); 10-CDS cluster 
encoding amino acid transporters (Y11_21641-21741, with Y11_21711 being only present in 
serotype O:3 and biotype 1A strains); metyltransferases and transporters (Y11_23741-23771); 
Na+/bile acid symporter, hemolysin activator and hemolysin protein (Y11_27781-22801); 
regulator of cell morphogenesis and NO signaling (Y11_36341). The presence of gene clusters 
shared between the weakly-virulent and non-virulent groups, however, is not correlated with the 
YE phylogenetic relationships (section 4.2.5), and may suggest an independent parallel 
acquisition of these features. 
Table 25 Functional units encoded by the variable regions VR1 and PZ in Y. enterocolitica. 
Gene clusters Highly-virulent biotype 1B 
Weakly-virulent 
biotypes 2-5 
Non-virulent 
biotype 1A 
VR1 
   
Y11_22231-22261 
DMSO reductases - + + 
YE0818-0826 
Carbohydrate ABC transporters + - + 
Fucose metabolism and 
carbohydrate transport system - - + 
Y11_22281-22341 
LIV transport system - + + 
Y11_22371-22421 sorbose 
Uptake system + + + 
Outer membrane autotransporter - - + 
Enterotoxin gene - - + 
YE0801-0806 
ABC transporters + - + 
PZ 
   
YE105_C3260-C3302 
Flag-2 - 
+ 
(partly absent in O:3) - 
YE105_C3304-C3311 
fep-fes cluster + 
+ 
(absent in O:3) + 
YE3624 
fepA gene + - + 
YE3626-3630 
Outer membrane proteins + - + 
YE105_C3315-C3324 
Aat transporters - + - 
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4.2.2. Putative virulence determinants in Y. enterocolitica subsp. palearctica 
Comparison of multiple genomes belonging to each subspecies permitted identification of yet 
undiscovered putative disease-associated factors in Y. enterocolitica subsp. palearctica. 
An RTX-toxin cluster (locus tags: Y11_18761-18781) has been proposed as YEP specific 
virulence factor (section 1.2.3, page 12); this cluster is absent from strain IP2222 (1A/O:36), 
while genes in strain NF-O (1A/O:5) show low sequence similarity. Notably, all YE genomes 
contain a variety of other genes annotated as “putative-RTX family protein”. One cluster (locus 
tags: YE1998-2000) is conserved among all strains and encodes three transporters probably 
implicated in RTX toxin/hemolysin secretion. A large RTX-family protein-encoding region (locus 
tag: YE1322) is present in all pathogenic strains and in the environmental strain IP2222, while it 
is absent from the genome of strain NF-O. Another protein (locus tag: YE2966, Y11_18861), 
encoding a putative hemolysin, has a high sequence similarity score (99%) among YEE and 
among YEP genomes, but between the two subspecies the sequence identity of the protein is 
lower (59-67%). 
A five-CDS beta-fimbriae cluster (locus tags: Y11_14931-14971) has been specifically detected 
in YEP genomes and is located near a transposase for IS1667, in a region where YEE strains 
harbor a gene fragment encoding a putative fimbriae chaperone (locus tag: YE2602). The genes 
of this cluster encode a PapD-like chaperone protein, a large PapC-like usher protein and three 
beta-fimbriae major subunits. The biogenesis of fimbriae requires the two-component assembly 
and transport system consisting of the chaperone/usher pathway, suggesting that the three beta-
fimbriae subunits of the YE cluster might be correctly assembled and used by the bacteria to 
attach to host surfaces. Similarly, another 4-genes fimbrial cluster (locus tags: Y11_26051-
26081) is specific for the weakly-virulent strains of serotypes O:3, O:5,27 and O:9, while it is 
absent from biotypes 1A and 1B. It encodes two fimbrial subunits, a fimbrial usher porin and a 
chaperone protein. As the other cluster, these usher and chaperone proteins share sequence 
similarity with the PapC and PapD super-families, respectively. Notably, this cluster is partly 
carried by the genomes of Y. intermedia, Y. mollaretii, Y. massiliensis and Y. frederiksenii, which 
are typically considered as non-pathogenic but whose clinical significance remains controversial. 
A putative Ig-like invasin (locus tag: Y11_38661) is specific for YEP. The 1,024-aa protein 
contains a DUF3442 domain of uncharacterized bacterial proteins and three bacterial Ig-like 
domains, indicating a probable location on the cell surface and a role in pathogenicity. In fact, Ig-
like domains in enterobacteria are known to play important functions during host cell adhesion 
and invasion, and to be structural components of fimbrial systems and of the intimin/invasin 
family of outer membrane adhesins (Bodelon et al., 2013). 
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Figure 15 Genomic comparison of Y. enterocolitica subsp. palearctica based on the sequence of strains 
Y11, bioserotype 4/O:3 (top), and 105.5R(r), bioserotype 3/O:9 (bottom). 
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An intriguing protein family which might play a role in virulence of YEP includes autotransporters. 
In fact, these secreted and cell-surface-exposed proteins are produced by a large variety of 
pathogenic Gram-negative bacteria and have virulence-related functions, including adhesion, 
biofilm formation and apoptosis (Grijpstra et al., 2013). One gene (locus tag: Y11_42801, 
YE105_C3026), whose sequence is weakly conserved among the analyzed strains, is absent 
from YEE genomes. This protein contains a C-ter autotransporter beta-domain which enables 
the N-ter pertactin-like passenger domain to be exported across the membrane. Curiously, the 
YEP genes have homologous in Y. pestis, Y. pseudotuberculosis and Y. similis. A protein with 
similar structure has been previously discussed in biotype 1B strains (locus tag: YE3700 and 
YWA314_14949) as putative virulence factor (section 4.1.1). Orthologous to this gene are found 
in all YE genomes. The short genes (1,274 bp) from weakly-virulent strains (locus tag: 
Y11_25751, YE105_C3400) show high sequence similarity among each other (99.9%), but are 
47% identical to YE3700 and 27% to YWA314_14949, being mainly similar to the C-ter regions 
and having homologous genes only in YE genomes. In contrast, the long biotype 1A genes 
(2,825 bp) are found in Y. pestis, Y. pseudotuberculosis and Y. similis, and exhibit 37.7% of 
sequence similarity with YE3700 and 72.6% with YWA314_14949. Interestingly, weakly-virulent 
YE carry a second adjacent gene encoding a long putative pertactin-family protein (locus tag: 
Y11_25741), containing both passenger and beta-barrel autotransporter domains. A third gene 
encoding an outer membrane autotransporter is specific for the two analyzed non-virulent strains 
NF-O and IP2222. It is located between genes YE0798 and YE0799 in the highly variable region 
VR1 discussed above. The gene shares 76% identity with genes in Y. pestis, 
Y. pseudotuberculosis and Y. similis, while the protein sequence is 80% identical to 
autotransporters in Y. rohdei and Y. frederiksenii. Pertactin-like passenger and autotransporter 
domains of the adhesin AidA are recognized. Finally, it is worth mention that all analyzed YE 
genomes carry the highly conserved YapE autotransporter protein (locus tag: YE4059), which 
has a demonstrated important role in efficiently colonizing mammalian host tissues by Y. pestis 
(Lawrenz et al., 2009). 
A colicin-like locus absent from YEE strain 8081 has been detected in strains Y11 (4/O:3) and 
105.5R(r) (3/O:9) (Batzilla et al., 2011a; Wang et al., 2011). The cluster in serotypes O:3 and 
O:9 strains is located between the ilvC gene (locus tag: Y11_33501) and a pilus assembly 
chaperone PapD (locus tag: Y11_33551), flanked by a phage antitermination protein-encoding 
gene; it is composed of four/five CDSs, depending on the bacterial strain (Figure 16). The 
homologous colicin locus in biotype 1A strains is inserted downstream the phage antitermination 
protein, near the PapD-encoding CDS. Surprisingly, a similar cluster has been detected in the 
YEE strain WA-314 (section 4.1.1), and is 95% and 74% identical to the cluster carried by the 
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non-virulent and weakly-virulent strains, respectively. Interestingly, the Y11_33511 colicin 
protein of strain Y11 contains not only a cloacin-like tRNAse C-ter domain and an S-pyocin-like 
domain, as in protein YWA314_20244 of strain WA-314, but also a conserved domain belonging 
to the apolipophorin-III family, which plays a critical role in the transport of lipids during insect 
flight. Overall, the colicin cluster in YE resembles a locus in Y. similis and Y. pestis, explaining 
the presence of an insect-related protein domain and supporting the hypothesis of a common 
origin of the bacteriocin cluster in Yersinia species. To note, all the analyzed YE strains carry the 
Tol and TonB transit machineries required for translocation of colicin-like proteins, and a colicin 
V production membrane protein CvpA, indicating a putative successful functionality of the 
detected bacteriocin gene clusters. 
 
Figure 16 Colicin clusters in Y. enterocolitica. 
The colicin operon structure is similar in all serotypes, with small differences in the insertion locus and in 
protein length.  
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4.2.3. Core and pan-genomes of Y. enterocolitica 
The core and pan-genomes of the whole species Y. enterocolitica were obtained by iterative 
pairwise comparison of the 10 selected genomes, using the orthology-based software Edgar 
(section 3.7.7). The core genes are defined as the genes common to all the analyzed genomes, 
while the pan-genome comprises the core genes, the dispensable genes (present in two or more 
genomes) and the unique genes specific to single strains. The core genome is relevant for a 
bacterial species as it is linked to the fundamental biological processes and derived traits from a 
common ancestor, while the dispensable and unique genomes more often govern the genetic 
features related to variation in virulence and adaptation (Tettelin et al., 2008). 
Considering that some YE strains do not carry the pYV virulence plasmid, this analysis was 
accomplished using only the chromosomal sequences. The core genome of YE, identified using 
strain 8081 as reference, consists of 3,090 orthologous genes, accounting on average for 73.7% 
of the whole coding genome. Overall, there is a descending trend of the core genome size with 
increasing sequence number, as predicted by the Edgar software using a non-linear least 
squares model fit (Figure 17). The core genome quickly reaches a plateau at value 3,061 with 20 
genomes, indicating that even a small genome size of 10 is sufficient to satisfactorily describe 
the core genome of the species YE. Intriguingly, calculating the core genome without one strain 
of bioserotypes 4/O:3 or 1A/O:5 does not considerably increase the number of genes shared by 
all isolates (Table 26), suggesting a stable genetic backbone in these strains. In contrast, 
removing the bioserotype 2/O:9 strain W22703 causes the biggest increment of the core gene 
number, in accordance with the outlying position of this strain in the YE phylogeny (section 
4.2.5). Since the core genome is based on the orthologous genes and is, therefore, dependent 
on the annotations, the anomalous high number of CDSs in strain W22703 (Table 24) may 
account for the important increment in the core genome observed when this strain is missing. 
Annotating the core genes by means of the KEGG Automatic Annotation Server (KAAS) server 
(section 3.7.8), 2,346 genes out of 3,090 (75.9%) can be functionally assigned to a KEGG 
orthology. The majority of these genes are predicted to be involved in various housekeeping 
functions, especially those related to carbohydrate and amino acid metabolism, and associated 
transport activities (ABC transporters and two-component systems). 
The pan-genome calculated on the 10 YE genomes and with strain 8081 as reference consists 
of 8,102 genes, of which 5,012 are dispensable/unique genes. Thus, the wide pool of non-core 
genes mainly contributes to the large pan-genome of YE. As expected, reducing the number of 
genomes, the number of pan genes also decreases (Table 26). In contrast to the core genome, 
the pan-genome does not display an asymptotic trend and increases with the incorporation of 
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additional genomes (Figure 18). Moreover, the plot of singletons/new genes is well fit by a 
decaying function and the extrapolated curve reaches an asymptotic value of 122.6. This means 
that every newly sequenced genome could bring on average 122 new genes. These data 
reveals that YE possesses an open pan-genome, indicating strong genetic plasticity, which is 
typical of bacterial species able to colonize multiple environments and having multiple ways of 
exchanging genetic material. 
Table 26 Core and pan-genome sizes of Y. enterocolitica. 
Core and pan genes were calculated using strain 8081 as reference on 10 or 9 genomes, removing one 
sequence at a time. When strain 8081 itself was excluded, strain Y11 was utilized as reference. 
Y. enterocolitica 
strain excluded 
Number of 
core genes 
Number of 
pan genes 
none 3,090 8,102 
8081 (1B/O:8) 3,110 7,844 
Y11 (4/O:3) 3,095 7,937 
105.5R(r) (3/O:9) 3,121 8,058 
Y5.27P (3/O:5,27) 3,102 7,902 
W22703 (2/O:9) 3,168 7,095 
Y8265 (4/O:3) 3,099 8,032 
Y5307 (4/O:3) 3,096 7,949 
WA-314 (1B/O:8) 3,112 7,893 
IP2222 (1A/O:36) 3,105 7,676 
NF-O (1A/O:5) 3,097 7,781 
 
 
Figure 17 Trend of the core genome size of Y. enterocolitica. 
The number of genes is plotted as mean function of the number of genomic sequences (x) added. 
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4.2.4. Strain-specific genes and clusters 
An indicative parameter about the genetic variability of a species is the set of singletons unique 
per genome (genes without any hit against any other genome). As shown in Figure 19, 
Y. enterocolitica bioserotypes 4/O:3 and 3/O:9 strains do not greatly participate in the species 
variability, while the majority of new discovered genes come from strains of biotypes 1A and 1B. 
The exception of strain W22703 may be explained by the high number of CDSs predicted in this 
genome (Table 24). Interestingly, the number of singletons corresponds to the phylogenetic 
relationships between the analyzed strains (section 4.2.5), in that closely-related strains, such as 
the ones belonging to serotype O:3, have a low number of singletons and, therefore, lower 
genetic diversity. 
 
Figure 18 Y. enterocolitica pan-genome and singleton development plots. 
Graphs show the accumulated number (mean) of pan and new genes against the number of genomes (x). 
 
The unique genes detected in the analyzed 10 genomes mainly encode hypothetical proteins or 
are carried by mobile regions. In particular, 100% of the singletons detected in the three YEP 
strains Y8265, Y5307 and 105.5R(r) encode hypothetical proteins. Only one gene exclusive for 
strain Y11, found within the PhiYep3 phage, is assigned to a specific feature (locus tag: 
Y11_13111, NAD-dependent DNA ligase), while the other 24 genes are annotated as 
hypothetical proteins. In strain W22703, 86.5% of unique genes encode hypothetical/unknown 
proteins. The remaining 13.5% include transposase-encoding genes and, mostly, genes 
truncated or annotated differently than in the other strains. 
As expected by the previous comparison between YE bioserotype 1B/O:8 (section 4.1.1), the 
genes exclusively found in strains 8081 and WA-314 belong to strain-specific prophages and 
genomic islands (e.g. YAPI in strain 8081). The non-virulent human isolate NF-O possesses 
87.3% of unique genes carried by phages or insertion sequences or encoding hypothetical 
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proteins. Interestingly, 7 adjacent genes specific for strain NF-O, inserted between the YE2671 
and YE2672 genes in strain 8081, encode ABC transporter proteins and an 
alkylhydroperoxidase-like protein, AhdP family. Performing a Blast search across public DNA 
sequences, it appears that this gene cluster is not present in genomes of other Yersinia strains, 
but resembles regions in a plasmid from the γ-proteobacterium Pantoea sp., in the 
α-proteobacterium Mesorhizobium australicum, and from the β-proteobacterium 
Verminephrobacter eiseniae. This is evidence of a strain-independent acquisition of these genes 
by lateral gene transfer, probably during co-existence with other microorganisms in the same 
environment/host. Similarly, the singletons of the environmental YE strain IP2222 encode mainly 
hypothetical proteins or are found in mobile elements (90%). A 12-CDS region, inserted near a 
prophage and in the same chromosomal location as the YGI-3 in strain 8081, carries proteins 
homologous to the srfABC virulence cluster in Salmonella sp. and to ABC-type antimicrobial 
peptide transporters. Similar clusters have been detected by SEED in other γ-proteobacteria like 
Azotobacter vinelandii, Pseudomonas sp. and Pasteurella sp., suggesting that this genomic 
region is an important hot-spot for acquisition of genetic material in YE (section 4.1.1 and Figure 
20), with possible gene flows among proteobacteria. 
 
 
Figure 19 Unique genes in Y. enterocolitica genomes. 
The chart contains the number of singletons per each genome against all the other genomes; numbers in 
brackets refer to the singleton genes against the whole core genome. 
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Figure 20 Mauve comparison of the YGI-3 genomic region across five Y. enterocolitica isolates. 
The YGI-3 is a putative plasmid inserted in strain 8081 between two tRNA genes (between the green and 
yellow similarity blocks), while in strain IP2222 a large prophage and the srfABC cluster replace the island. 
4.2.5. Core genome-based phylogeny of Y. enterocolitica 
To address the phylogeny of the whole species Y. enterocolitica, a phylogenetic tree was 
computed based on the core proteins of the analyzed 10 sequences (section 4.2.1) to maximize 
the sequence support. In fact, despite the differences in gene prediction algorithms, genes that 
are well conserved among a species are easier to annotate; therefore, the conserved core 
genome likely provides sufficient quality to reveal accurate relations among the analyzed strains. 
The concatenated multiple alignment of the core protein sequences consisted of 1,014,040 aa 
residues, which were used to construct a neighbor-joining tree (Figure 21). Examining the 
phylogenetic relationships of the species revealed three main distinct clusters, which reflect the 
classification in non-virulent, weakly-virulent and mouse-virulent strains, and five different 
lineages (biotypes 1A and 1B, and serotypes O:9, O:5,27 and O:3). Therefore, for the weakly-
virulent group, the phylogeny is congruent with the serotype, suggesting that serotyping might be 
an accurate criterion for determining grouping and typing of YE. Notably, the serotype O:3 
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strains are tightly clustered together with short terminal branches compared with the other 
lineages, indicating low genetic diversity and likely efficient restriction barrier. 
 
Figure 21 Phylogeny of Y. enterocolitica. 
Neighbor-joining tree based on the core genome alignment of the 10 analyzed sequences. Strains are 
clustered according to their virulence-based classification and to their biotypes/serotypes. Branch lengths 
are measured in units of the expected fraction of changed amino acids. 
4.2.6. Characterization of the Y. enterocolitica functionome 
To evaluate the metabolic and physiological potential of Y. enterocolitica, the functionomes of 
strain Y11, 8081 and 105.5R(r) complete genomes, already available as KEGG annotated 
genomes, were compared by the Metabolic And Physiological potentiaL Evaluator (MAPLE) 
system. This program is useful to map genes of individual genomes with KEGG-defined 
functional modules and to calculate module completion ratios (MCRs), corresponding to the 
percentage of a module completed by the input genes (section 3.7.8). The gene products of the 
three analyzed strains were assigned to KO identifiers constituting 125 pathway and 87 
structural complex modules. Interestingly, no significant differences were identified in terms of 
pathway modules, while differences in the MCR of some structural complexes appeared (Figure 
22). The highly-virulent strain 8081 contains all the three genes which complete the “Erythritol 
transport system” module, while strains Y11 and 105.5R(r) have a MCR of 0.0% and, therefore, 
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no genes involved in this biological system. Corroborating the genome-comparison results 
(section 4.2.1), this module belongs to the monosaccharide ABC transporters composed of 
genes YE0818, YE0821 and YE0820, which are specifically present in biotypes 1B and 1A 
strains. Moreover, the “Type II general secretion system” module is complete in strain 8081, 
while in the two weakly-virulent strains the MCR is 81.8%. This 11-component module 
corresponds to the yts1 and yts2 loci (Table 3), whose genes may be assigned to the same KO 
identifier, when having the same function; for example, genes YE3349 (in yts2) and YE3565 (in 
yts1) are both membrane-associated secretins and belong to KO2453-GspD (general secretion 
protein D). Strain 8081 harbors both T2SSs, confirming the completeness of the module, while 
strains Y11 and 105.5R(r) possess only the yts2 system,  and therefore lack the yts1-specific 
GspM (YE3573) and GspH (YE3569) proteins, resulting in a lower MCR for this module. On the 
other hand, 2 modules are not represented in strain 8081 but are 100.0% complete in strains 
Y11 and 105.5R(r). Firstly, the “Lipopolysaccharide transport system” complex includes two 
ABC-2-transporter encoding-genes located within the serotype O:3 and O:9 O-ag clusters, which 
show high similarity (see section 4.2.7). Secondly, genomic comparison analyses have identified 
the agaVWEF operon (utilization of N-acetyl-galactosamine) as specific YEP acquisition (section 
1.5). Accordingly, the MCR for the complex module “PTS system, N-acetylgalactosamine-
specific” is 100.0% for the YEP strains Y11 and 105.5R(r) and 0.0% for the YEE strain 8081, 
which is devoid of this cluster.  
To note, the 25% MCR for the module “PTS system, galactosamine-specific” in strains Y11 and 
105.5R(r) is due to the presence of one of the four KO identifiers composing this module, 
KO2744, corresponding to the AgaF transporter, which is also assigned to the N-
acetylgalactosamine structural complex. The other three proteins of this module, which is 
involved in the conversion of galactosamine to galactosamine-6-phosphate, are not encoded by 
strains Y11 and 105.5R(r), and therefore this module is not functional in any YE strain. The 
“Cobalt/Nickel transport system” module consists of 4 KO components, corresponding to the 
cbiOQNM genes belonging to the cob/pdu operon for cobalamin (vitamin B12) biosynthesis in 
YE (Thomson et al., 2006). In strain 8081 the cbiN gene is not annotated, leading to the 
observed MCR ratio of 75.0%; however, in the other bioserotype 1B/O:8 strain, namely WA-314, 
the cbiN gene is present (locus tag: YWA314_04428), suggesting that this module is complete 
also in highly-virulent strains. Curiously, the pathway module “Cobalamin biosynthesis” shows a 
MCR ratio of 87.5% in all three strains, since 2 out of 9 components related to the CobR and 
CobC proteins are missing. Nevertheless, production of vitamin B12 has been demonstrated in 
YE strain 8081, when grown in anaerobic conditions (Prentice et al., 2003). 
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Figure 22 Y. enterocolitica functionome analysis. 
Module completion ratios (MCR %) of structural complexes in Y. enterocolitica strains Y11, 8081 and 
105.5R(r) are compared, showing differences in the metabolic potential of these strains. An MCR of 100% 
means that all the genetic components of the module were detected in the corresponding genome. 
 
4.2.7. Serotype-specific O-antigen clusters 
Serotype is an important characteristic for Y. enterocolitica subtyping which is based on the 
O-antigen entity of the LPS (section 1.1.1 and Figure 1). In this study, availability of whole-
genome sequences from YE belonging to the main pathogenic serotypes (O:8, O:3, O:9 and 
O:5,27) and to two non-virulent ones (O:5 and O:36) allowed identification of so far unknown O-
ag cluster genomic locations and genetic structures. In contrast to YE serotype O:8 and O:36, 
whose O-ag loci are clustered between the hemH and gsk genes, the O-ag cluster of the other 
analyzed serotypes is located elsewhere in the genome, while the hemH-gsk locus is occupied 
by the outer core (OC) genes (Figure 23). Interestingly, the OC clusters of serotypes O:3, O:9, 
O:5,27 and O:5 show a similarity score of 99%. 
The O-ag gene region of YE serotype O:9 (locus tags: YE105_C1500-1511) is situated between 
the gnd and galF genes, as in E. coli and S. enterica. The serotype O:3 O-ag gene cluster (locus 
tags: Y11_16641-16781) lies also in this region, in particular between the galU gene and a 
transposase-encoding gene (Figure 24). The wbbS-wbbX locus, which is involved in the 
synthesis of nucleotide sugar precursors and processing the O-ag, is separated from the 
glycosyltransferase-encoding genes by a second transposase-gene. The corresponding region 
in serotype O:8 also harbors several transposase-genes (locus tags: YE2773-YE2777), 
suggesting probable lateral gene transfer events in this recombinational hot-spot region. This 
hypothesis is reinforced by the atypical G+C content of the O-ag cluster sequences in serotypes 
O:3 and O:9 (38% and 35%, respectively, compared to the average YE genomic G+C content of 
47%). In contrast to serotypes O:8, O:3 and O:9, whose O-ag gene organization has been 
already described, nothing has been studied about the O-ag genetic loci of YE serotypes O:5,27 
and O:5, even if their structures have been determined (Gorshkova et al., 1986). Comparison of 
genome sequences discovered different locations for these two clusters, despite their similarity 
score of 97.3%. The O-ag genes of serotype O:5,27 are situated near a phage-remnant (Figure 
24), in a region where also YE serotypes O:8 and O:3 carry transposase- and phage-related 
genes (locus tags: YE0505-0512 and Y11_37371-37451). Importantly, no gene cluster specific 
for the factor 27 was identified, as well as its chemical structure was not determined during 
chemical elucidation of the lipopolysaccharides (Gorshkova et al., 1986). The O-ag gene cluster 
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of serotype O:5 is inserted between the gor and yapE genes (locus tags: YE4057-4058). The 
specific cluster includes also a transposase-encoding gene and part of the gor gene (Figure 24); 
three additional genes, encoding a permease, a DNA-binding protein and a quinone 
oxidoreductase, are also present in the other non-virulent strain IP2222 but absent from all the 
other virulent strains. Finally, the so far unknown O-ag cluster of YE serotype O:36 was 
identified by genomic analysis of strain IP2222. These genes occupy the hemH-gsk locus, as in 
serotype O:8, and encode enzymes participating in the synthesis of sucrose, paratose and 
tyvelose; additional 4 genes, which are located upstream between the adk and the hemK genes, 
encode enzymes involved in mannose metabolism. Curiously, 40% of this cluster is 70% 
identical to O-ag gene cluster in Y. pseudotuberculosis and Y. pestis strains. 
4.2.8. Patho-serotyping of Y. enterocolitica 
The genome-wide study of the O-ag genetic clusters of the most common Y. enterocolitica 
serotypes facilitated the identification of serotype-specific genes for developing a serotyping 
PCR multiplex. Combined with another multiplex for species identification and discrimination 
between virulent and non-virulent strains, the established PCR-based method could be used for 
patho-serotyping of YE. 
Selection of targets for the identification multiplex 1. To detect YE isolates with an 
unambiguous PCR method, together with the genetically stable 16S rRNA gene the inv gene 
was chosen, since it has been detected by molecular methods in YE strains with 100% 
frequency, regardless of isolation source, serotype or pathogenicity degree. For differentiation 
between virulent (biotypes 1B and 2–5) and non-virulent (biotype 1A) strains, the ail and ystB 
genes were added. The chromosomally-encoded ail gene has been shown to be a stable marker 
for virulent strains, while the ystB gene is specifically carried by strains of biotype 1A and, 
therefore, is a distinguishing marker for non-virulent strains (section 1.2.3 and Table 3). Notably, 
ystB is 76.5% identical to the ystA gene present in genomes of virulent strains. 
Selection of targets for the serotyping multiplex 2. Serotype-specific regions were selected 
based on the results obtained from the genome comparison of different YE (section 4.2.7). The 
rfbC/wbbU gene (locus tag: Y11-16731), previously used for detection of serotype O:3 by a PCR 
method (Weynants et al., 1996), was confirmed as appropriate serotype O:3-specific target. In 
fact, no significant hits with genes in publicly available Yersinia and no-Yersinia genomes were 
found by BLAST analysis. Similarly, the per gene (locus tag: YE105_C1505) was selected as 
distinctive target for serotype O:9, as described in (Jacobsen et al., 2005). To note, the DNA 
sequences of per genes of YE serotype O:9 and Brucella sp. show a similarity score of 64%. In 
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order to avoid cross-reaction, the designed per_O9_FW/RV primers were subject to BLAST 
search against Brucella, revealing no significant matches. To unambiguously detect strains 
belonging to serotype O:8, the rfbC/wbcA gene (locus tag: YE3085) was selected, because of its 
similar role but low sequence similarity (51.7%) with the orthologous rfbC/wbbU gene in YE 
serotype O:3. As preannounced by the results on the genome analyses, target regions carried 
within the YE serotype O:5,27 O-ag gene cluster but absent from that of serotype O:5 could not 
be identified. A gene (rfbE/wzt) was therefore selected as specific amplification target for both 
serotypes O:5,27 and O:5. The two gene sequences showed 97.2% sequence identity, and no 
polymorphisms could be used to design primers specific for either serotype according to the 
chosen criteria (see below). A suitable target for unique detection of serotype O:5,27 was found 
thanks to the whole-genome comparison, which revealed a restriction modification (RM) system 
(inserted between locus tags YE4166 and YE4167) absent from serotype O:5, as well as from 
serotype O:3 and O:9 genomes and from strain 8081. Curiously, it demonstrated 95.2% identity 
to the RM system detected in strain WA-314 as strain-specific region (section 4.1.1). Hence, this 
locus could not be applied to the serotyping multiplex, since amplification would occur in strains 
of serotype O:5,27 and in some strains of serotype O:8. Primers targeting the RM in serotype 
O:5,27 genomes, however, could be used in a single PCR reaction to differentiate between YE 
serotypes O:5,27 and O:5 strains giving a positive signal for the wzt gene. 
Specificity of the PCR assays. Genomic DNAs extracted from six YE reference strains 
(WA-314, Y11, W22703, Y5.27P, NF-O and IP2222, Table 8) were subject to both multiplexes 1 
and 2, using 100 ng of template for all reactions. As shown in Figure 25, the sizes of the 
amplification products sufficiently differed from each other and allowed a clear discrimination of 
the bands on an electrophoresis gel, without non-specific amplicons. According to the designed 
method, multiplex 1 produced different patterns depending on the virulence of the tested strains, 
in that all YE strains showed a product for the 16S rRNA and the inv targets; also, the ail 
amplicon was positive in the virulent strains (WA-314, Y11, W22703 and Y5.27P) but negative in 
the non-virulent ones (NF-O and IP2222), with opposite results from the ystB amplification. In 
general, testing virulent strains with the developed assay would give pattern inv(+), 16S 
rRNA(+), ail(+), ystB(-), while pattern inv(+), 16S rRNA(+), ail(-), ystB(+) would result from non-
virulent strains. To check that the identification multiplex is species-specific, non-YE and non-
Yersinia strains were tested (Table 8 and Figure 26). Y. intermedia showed a weak band 
corresponding to the 16S rRNA amplicon, while feeble non-specific bands were present in the 
reactions from C. jejuni, S. enterica and L. pneumophila; a miss-identification is anyway avoided 
by the inv gene product, which is not amplified in any of the tested species. Lastly, sensitivity 
tests showed that amplification of all products was obtained with at least 1 ng/µl of DNA 
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template, while the 16S rRNA amplicon could be detected also at a dilution of 0.01 ng/µl (Figure 
27 A). 
The serotyping multiplex PCR has been successfully designed for identification of the main YE 
serotypes (O:3, O:9, O:8, O:5,27) based on the amplification of a single PCR product in each 
reaction (Figure 25). Y. enterocolitica strain IP2222 of serotype O:36, which is not recognized by 
the assay, gave no amplification. Similarly, negative results would be produced by isolates 
belonging to serotypes distinct from the targeted ones. Amplification of the wzt_O:5,27 target 
occurred not only in serotype O:5,27 but, as anticipated, also in serotype O:5. Discrimination 
between these two strains was achieved by combining the results of the multiplexes 1 and 2. In 
fact, the non-virulent strain of serotype O:5 had pattern inv(+), 16S rRNA(+), ail(-), ystB(+), 
wzt(+), while pattern inv(+),16S rRNA(+), ail(+), ystB(-), wzt(+) resulted from the virulent 
serotype O:5,27 strain. An evident distinction derived by the application of the single PCR 
targeting the RM system in YE serotype O:5,27, which resulted in amplification of the 627 bp 
product only in strain Y5.27P. This reaction was also tested on the other reference strains, 
resulting in a positive amplification only in strain WA-314, as expected. 
Validation of the patho-serotyping assay. To test the validity of the developed PCR assays, 
133 YE isolates (Table 10), belonging to known or unknown serotypes and originating from 
different hosts and countries, were analyzed. Phenotypic information about the strains were 
obtained from the respective supplier institutions upon receipt of the microbiological materials or, 
in case of the 50 strains from Dr. Tietze, RKI, after completion of the genotypic experiments, in 
order to perform a blind validation study. PCR mixtures were always prepared using 100 ng of 
the gDNA templates, as done with the reference strains, so that results were equivalent. Data 
resulting from the patho-serotyping PCR-based method were therefore compared to the 
phenotypic data (Table 27). 
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Figure 23 hemH-gsk locus in Y. enterocolitica. 
This locus is occupied by the O-ag cluster in serotype O:8 strains and by the OC cluster in serotypes O:3, O:9, O:5,27 and O:5. Drawn to scale. 
 
 
Figure 24 O-ag genetic regions of Y. enterocolitica subsp. palearctica. 
The organization of the O-ag clusters and flanking regions of serotype O:3, O:9, O:5,27 and O:5 are displayed. Drawn to scale. (Garzetti et al., 2014). 
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Figure 25 Identification and serotyping of Y. enterocolitica reference strains. 
Results from the identification and serotyping multiplexes are displayed (A). A negative control (NC, no 
genomic DNA) was added to confirm absence of non-specific amplification. The amplification of the 
RM_O:5,27 system in strain Y5.27P was compared to that of strain NF-O (B). MW: molecular weight. 
Modified from (Garzetti et al., 2014). 
 
 
Figure 26 Specificity test of the identification multiplex. 
Non-Y. enterocolitica and non-Yersinia strains were subject to multiplex 1 amplification starting from 100 
ng of purified gDNA. Y. enterocolitica strains WA-314 and NF-O were used as positive controls. 
 
The identification multiplex produced concordant results in 130 out of 133 YE strains. From 
strains P10 and P11, two pig-isolates classified as bioserotype 4/O:3 by conventional methods, 
no amplification was detected, while the 16S rRNA fragment was weakly amplified from strain 
12-03803, typed as rough biotype 3. The absence of the inv amplicon suggested that these 3 
strains do not belong to the species YE; therefore, the 16S rRNA gene was sequenced with the 
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universal primers 16S_FW_D1,D2 and 16S_RV_P1 for bacterial identification. Blast analysis of 
the sequences from strains P10 and P11 gave significant hits with Y. frederiksenii 16S rRNA, 
while strain 12-03803 sequence was identical to the one from Y. kristensenii. Accordingly, 
Y. frederiksenii isolates belonging to serotype O:3 have been reported (Aleksic et al., 1986). 
Since the discordant strains were found to be non-YE, the identification multiplex could be 
considered 100% specific. 
Results from molecular and conventional serotyping methods were concordant in 126 out of 133 
examined strains. Since a completely negative amplification was again obtained from strains 
P10 and P11, they were re-serotyped by phenotypic methods, which confirmed their positive 
agglutination to serotype O:3 antiserum. Together with the results from the 16S rRNA 
sequencing, this suggests that a dissimilar sequence of the wbbU gene is present in the O-ag 
gene cluster of these YE-like O:3 strains. No amplification was also observed in strain 12-01557, 
of bioserotype 1A/O:8. Having pattern inv(+), 16S rRNA(+), ail(−), ystB(+), this strain was 
genotyped as YE biotype 1A, probably belonging to serotype O:7,8, which is rarely found 
because of the difficult access to the corresponding antiserum. Accordingly, re-serotyping could 
not confirm the previously determined serotype O:8 and classified this strain as rough. Strain 
292, conventionally designated as serotype O:27, gave negative results from both multiplex 2 
and the O:5,27-specific PCR. Seeing that the identification multiplex for this strain resulted in 
pattern inv(+), 16S rRNA(+), ail(−), ystB(+), it was classified as non-virulent (biotype 1A), 
consistently with re-serotyping, that produced no reaction with known anti-sera (O:3, O:9, O:8, 
O:5, O:27). Bioserotype 1A/O:7,8 strain 39 gave a 1A/O:8-like pattern, namely inv(+), 16S 
rRNA(+), ail(-), ystB(+), wbcA-O:8 (+). Moreover, amplification of the wbbU-O:3 product resulted 
from strains of serotypes O:1,2a,3 and O:2a,2b,3 (522 and 523), leading to an inaccurate 
genotyping of these rare strains as virulent YE serotype O:3. YE strains of serotypes O:13 (58), 
O:20 (59) and O:21 (60), which were found positive for the ail target but negative for any product 
in the serotyping multiplex, were genotyped as virulent YE. 
The third O:5,27-specific PCR was tested on 29 YE strains belonging to either serotypes O:5 or 
O:5,27 (Table 25). Considering that strain 292 turned out to be not-typeable, the selected RM 
cluster was detected with 100% prevalence in all serotype O:5.27 strains, while no reaction was 
produced from serotype O:5 strains, confirming its specificity. 
A total number of 19 rough (14) and unknown (5) YE strains were tested during the validation 
process. Except for strain 12-03803, which turned out to belong to the species Y. kristensenii, 
the patho-serotyping assay confirmed the identification as YE of the other 18 strains. In 
particular, 8 strains (08-00920, 11-07058, 12-00821, 12-03266, 12-03288, 12-03324, 12-03401, 
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12 04470), producing negative results from the serotyping multiplex, were genotyped as biotype 
1A; 5 rough strains (06-03972, 06-04957, 07-05684, 09-05259, 09-08364) were serotyped by 
our molecular assay as YE serotype O:9; 3 (82, 89, 93) and 2 (260, 282) unknown strains were 
typed as YE serotype O:3 and biotype 1A, respectively. 
Colony PCR experiment. To check the feasibility of a faster patho-serotyping assay, colony 
PCR protocols were applied, eliminating the gDNA extraction step (section 3.4.1). Satisfactory 
results were obtained with both standard and NaOH-based methods for the identification 
multiplex, while non-specific products were occasionally amplified in the serotyping multiplex. 
The expected bands were anyway brighter than the non-specific ones and allowed identification 
of the serotype (Figure 27 B and C). 
 
Figure 27 Sensitivity of the patho-serotyping assay and colony PCR experiments. 
Genomic DNA samples extracted from five Y. enterocolitica strains (1: WA-314; 2: Y11, 3: Y5.27P; 4: 
W22703; 5: NF-O) were diluted to 1, 0.1 and 0.01 ng/µl and used as template for both identification and 
serotyping multiplexes. The detection limit of the test resulted to be 1 ng/µl (A). Random samples were 
processed according to colony PCR standard (B) or NaOH-based (C) methods. 
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Table 27 Validation of the Y. enterocolitica patho-serotyping method. 
Results from the 133 tested strains are summarized as positive (+) or negative (-) amplification for each product and classified according to their 
phenotype. Discordant results between phenotypic and genotypic methods are marked by *. Modified from (Garzetti et al., 2014). 
Strain 
count 
Multiplex PCR assays Identification and serotyping 
inv ail 16S 
rRNA ystB 
wbcA 
O:8 
wbbU 
O:3 
wzt 
O:5,27 
per 
O:9 
RM 
O:5,27 Phenotypic methods Genotypic methods 
31 + + +  -  - +   -  - 
 
Y. enterocolitica 4/O:3 Y. enterocolitica O:3 
1 + + +  -  - +   -  - 
 
Y. enterocolitica 3/O:3 Y. enterocolitica O:3 
16 + + +  -  - +   -  - 
 
Y. enterocolitica O:3 Y. enterocolitica O:3 
3 + + +  -  - +   -  - 
 
Y. enterocolitica unknown Y. enterocolitica O:3 
1* + + +  -  - +   -  - 
 
Y. enterocolitica O:1,2a,3 Y. enterocolitica O:3 
1* + + +  -  - +   -  - 
 
Y. enterocolitica O:2a,2b,3 Y. enterocolitica O:3 
8 + + +  -  -  -  - + 
 
Y. enterocolitica 3/O:9 Y. enterocolitica O:9 
1 + + +  -  -  -  - + 
 
Y. enterocolitica 2/O:9 Y. enterocolitica O:9 
1 + + +  -  -  -  - + 
 
Y. enterocolitica 4/O:9 Y. enterocolitica O:9 
1 + + +  -  -  -  - + 
 
Y. enterocolitica O:9 Y. enterocolitica O:9 
5 + + +  -  -  -  - + 
 
Y. enterocolitica 3/rough Y. enterocolitica O:9 
3 + + +  - +  -  -  - 
 
Y. enterocolitica 1B/O:8 Y. enterocolitica 1B/O:8 
3 + + +  - +  -  -  - 
 
Y. enterocolitica O:8 Y. enterocolitica 1B/O:8 
5 +  - + + +  -  -  - 
 
Y. enterocolitica 1A/O:8 Y. enterocolitica 1A/O:8 
1* +  - + + +  -  -  - 
 
Y. enterocolitica 1A/O:7,8 Y. enterocolitica 1A/O:8 
6 + + +  -  -  - +  - + Y. enterocolitica 3/O:5,27 Y. enterocolitica O:5,27 
10 + + +  -  -  - +  - + Y. enterocolitica 2-3/O:5,27 Y. enterocolitica O:5,27 
2 + + +  -  -  - +  - + Y. enterocolitica 4/O:5,27 Y. enterocolitica O:5,27 
10 +  - + +  -  - +  -  - Y. enterocolitica 1A/O:5 Y. enterocolitica 1A/O:5 
1* +  - + +  -  -  -  -  - Y. enterocolitica O:27 Y. enterocolitica 1A 
8 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/rough Y. enterocolitica 1A 
2 +  - + +  -  -  -  -  Y. enterocolitica unknown Y. enterocolitica 1A 
1 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/O:8  Y. enterocolitica 1A 
1 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/O:36 Y. enterocolitica 1A 
1 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/O:6,30 Y. enterocolitica 1A 
1 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/O:4,33 Y. enterocolitica 1A 
1 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/O:10 Y. enterocolitica 1A 
1 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/O:48 Y. enterocolitica 1A 
1 +  - + +  -  -  -  - 
 
Y. enterocolitica 1A/O:41,43 Y. enterocolitica 1A 
2*  -  -  -  -  -  -  -  - 
 
Y. enterocolitica 4/O:3 Y. frederiksenii 
1*  -  - +  -  -  -  -  - 
 
Y. enterocolitica 3/rough Y. kristensenii 
1 + + +  -  -  -  -  - 
 
Y. enterocolitica 1B/O:13 Y. enterocolitica virulent 
1 + + +  -  -  -  -  - 
 
Y. enterocolitica 1B/O:20 Y. enterocolitica virulent 
1 + + +  -  -  -  -  - 
 
Y. enterocolitica 1B/O:21 Y. enterocolitica virulent 
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4.3. Microevolution of Y. enterocolitica serotype O:3 
The most predominant serotype among Y. enterocolitica isolates recovered from humans and 
animals, especially wild and slaughter pigs in Europe, is serotype O:3 (section 1.4.2). A 
thoroughly comparison of YE serotype O:3 genome sequences might bring new insights into the 
epidemiology and evolution of these closely related strains, but such analysis is currently 
missing. Therefore, to create a representative serotype O:3 population framework, a total 
number of 20 whole-genome sequences were analyzed in this study, including 7 genomes 
retrieved from the GenBank public database (Y11, Y8265, Y5307, YE12/03, O3-gb, IP10393, 
PhRBD_Ye1) and 13 newly-sequenced samples (P1, P4, 149, 150, D1, D2, D3, D4, D5, D6, D7, 
D8, D9),  which were isolated between 1982 and 2011 from all over the world and from different 
sources (Table 8, Table 20 and Table 29). 
4.3.1. Re-sequencing of Y. enterocolitica serotype O:3 genomes 
Whole-genome sequencing of the new 13 Y. enterocolitica strains produced 2.02 to 5.41 million 
reads, with an average Phred score of 32.4 to 34.9 and an average coverage ranging between 
62.5X and 200.3X (Table 28). The differences in the average read length between the first 4 
strains and the remaining 9 is due to the Illumina technology adopted from the two sequencing 
centers (section 3.7.3). Mapping was performed against the chromosome of YE strain Y11, used 
as reference in all the following analyses. The unmapped reads were aligned to the pYV 
sequence of strain Y11, confirming presence or absence of the pYV plasmid in the samples, 
previously detected by PCR with primers pYVO3_6900_FW and pYVO3_7130_RV. 
4.3.2. Y. enterocolitica serotype O:3 genome features 
Genome features of the 20 Y. enterocolitica strains included in the study, representing the 
ecological and geographical diversity of serotype O:3, are summarized in Table 29. The 
genomes have an average sequence length of 4,523,761 bp, with the highly fragmented 
sequence of strain PhRBD_Ye1 representing the smallest chromosome and the complete 
genome of strain Y11 the largest one. Interestingly, despite the genome size close to the 
average, strain YE12/03 possesses the lowest number of CDSs (3,893), and the highest G+C 
content (48.22%). Strains PhRBD_Ye1 and O3-gb also have a low number of CDSs (3,926 and 
4,098, respectively), in contrast to the others, which have approximately 4,200-4,400 genes. The 
newly-sequenced genomes have the same number of tRNAs as the reference strain Y11, as 
consequence of the mapping assembly process. Among them, the Japanese strain D6 shows 
the smallest chromosome, suggesting high diversity or genome loss in relation to the German 
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reference strain. Performing a de novo assembly of strain D6 reads (section 3.7.4) resulted in 
220 contigs with a total genome length of 4,513,546 bp. Subtracting the 72,389 bp of the pYV 
plasmid, the genome size is similar to the one obtained by read mapping, excluding the high 
diversity supposition. Together with the small size of the Philippines strain PhRBD_Ye1, this 
may indicate a geographical-dependent genomic decay/gain of serotype O:3 isolates. 
Table 28 Sequencing statistics of the 13 Y. enterocolitica genomes obtained in this study. 
Data refers to the mapping against the chromosome of strain Y11. 
Strain pYV plasmid 
Total n° of 
reads 
Average 
read length 
Average 
Phred score 
Mapped 
reads 
Mapped 
reads % 
Average 
coverage 
P1 yes 2,024,398 147.4 32.4 1,946,897 96.2 62.5 
P4 no 5,410,706 142.5 33.3 5,293,958 97.8 164.02 
149 yes 4,030,740 146.4 33.2 3,860,211 95.8 123.05 
150 no 3,326,812 147 32.4 3,239,522 97.4 103.45 
D1 yes 2,701,604 250 34.8 2,587,891 95.8 140.08 
D2 yes 3,045,848 250 34.7 2,906,181 95.4 156.92 
D3 no 3,904,574 250 34.8 3,733,035 95.6 200.3 
D4 no 3,224,206 250 34.6 3,108,133 96.4 167.85 
D5 no 3,464,498 250 34.9 3,364,572 97.1 181.9 
D6 yes 2,617,798 250 34.7 2,466,742 94.2 133.2 
D7 yes 2,656,406 250 34.7 2,550,860 96.0 138.17 
D8 yes 3,692,876 250 34.5 3,542,267 95.9 191.14 
D9 yes 2,608,096 250 34.8 2,511,661 96.3 136.16 
 
4.3.3. Y. enterocolitica serotype O:3 core and pan-genomes 
Determination of the core and pan-genomes of serotype O:3 strains was done as described in 
section 4.2.1 for the whole species, using Y. enterocolitica strain Y11 as reference genome and 
excluding the pYV plasmid sequences. The core genome of the 20 serotype O:3 strains is 
formed by 3,313 CDSs, while calculating it separately on the 10 human and 10 animal isolates 
produced 3,411 and 3,652 genes, respectively. According to the KAAS metabolic annotation, 
2,401 out of 3,313 core genes (72.5%) are associated with a KO term, mainly belonging to 
metabolism- and transport-related KEGG pathways. Analyzing the core development plot and 
the corresponding decay function (Figure 28 A) results in continue reduction of the core genes 
with an increasing number of genomes. An asymptote is reached at 3,209 genes with 110 
genomes, in contrast to the core plot of the whole YE species, which achieves a plateau with 
only 20 genomes (section 4.2.1). The pan-genome of YE serotype O:3, composed of 5,613 
CDSs, is remarkably small if compared to the whole species pan-genome of 8,102 genes, 
calculated on 10 instead of 20 genomes (section 4.2.1). The pan-genome curve increases with 
the sequential addition of genomes (Figure 28 B), but with a small and decreasing average rate 
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(96 added genes per genome at the first 5 iterations, 54 at 10, 30 genes at 20, and 13 genes at 
50). This suggests that, after the inclusion of ten genomes, incorporating additional samples 
leads to a minor increase in the pan-genome size. This is supported by the expected number of 
singletons for each newly sequenced strain, which is predicted to be highly variable when adding 
1 to 4 genomes, while it is asymptotic after 17 iterations at a value of 25.85 (Figure 28 C). In 
fact, singletons mostly encode mobile element-related and hypothetical proteins. YE serotype 
O:3, therefore, displays a rather close pan-genome, confirming the low genetic diversity of this 
group. 
Table 29 Genome features of the Y. enterocolitica serotype O:3 used in this analysis. 
Strain Source Country Year N° 
contigs Total bp G+C % CDSs tRNAs 
Y11 human Germany n.a. 1 4,553,420 47.01 4,349 70 
Y8265 human France 1987 14 4,521,393 47.0 4,296 61 
Y5307 human Finland 1995 18 4,553,105 46.9 4,393 94 
IP10393 human France 1982 12 4,463,212 47.0 4,181 64 
YE12/03 human UK 2003 4 4,527,945 48.22 3,893 72 
O3-gb human UK 2003 2 4,526,243 46.99 4,098 70 
PhRBD_Ye1 swine Philippines n.a. 112 4,377,740 46.75 3,926 59 
P1 swine Germany 2003 44 4,536,730 47.0 4,333 70 
P4 swine Germany 2011 57 4,522,265 47.0 4,290 70 
149 puppy Belgium 2003 27 4,545,697 47.0 4,335 70 
150 calf Belgium n.a. 28 4,544,272 47.0 4,333 70 
D1 human Germany 1998 31 4,547,778 47.02 4,342 70 
D2 human Germany 1998 30 4,547,263 47.02 4,338 70 
D3 human Germany 1994 44 4,521,714 47.02 4,307 70 
D4 swine Belgium 1992 20 4,552,170 47.01 4,338 70 
D5 swine Denmark 1992 50 4,508,397 47.02 4,290 70 
D6 human Japan n.a. 51 4,471,866 46.97 4,227 70 
D7 swine Germany 2008 22 4,549,711 47.01 4,330 70 
D8 swine Germany 2008 15 4,552,293 47.02 4,344 70 
D9 swine Germany 2009 22 4,552,015 47.01 4,334 70 
 
4.3.4. Whole-genome comparison 
Genome sequences of the 20 Y. enterocolitica serotype O:3 strains were analyzed by Mauve 
and BRIG comparisons (section 3.7.7). Confirming the results from the previous analyses 
(section 4.2), serotype O:3 strains appear genetically closely related, with the main detected 
genomic differences being situated within or near prophage regions (Figure 29). The Japanese 
strain D6 suffered the most significant prophage loss, especially in the PhiYep3 and PhiYep2 
regions. In particular, PhiYep3 is only partly present, while PhiYep2 is completely not inserted at 
the corresponding tRNA-Met (locus tag: Y11_t04610), in contrast to the other strains. 
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Interestingly, strain D5 seems to have lost a 12.2 kb region carrying 17 CDSs (locus tags: 
Y11_09381-09541), near a transposase-gene (Y11_09361) and the PhiYep1 prophage. The 
encoded proteins have functions in purine metabolism, transcription regulation, enzymatic 
hydrolysis and histidine transport. Similarly, strain 150 is devoid of a 8-gene locus (Y11_13551-
13621) inserted downstream the prophage PhiYep3, between the tRNAs Y11_t16450-t16440-
t16430 and the transposase Y11_13631. The missing encoded proteins are mainly hypothetical, 
but include also a response regulator UvrY, an alpha-amylase and a biotin synthesis protein. 
Notably, the serotype O:3-specific GIYep-01 genomic island, which is inserted in the same 
chromosomal background of the HPI in serotype O:8 strains, is conserved in all the 20 analyzed 
strains, despite its ability to excise from the chromosome (Batzilla et al., 2011a). This may 
suggest that a strong selection pressure has occurred during the evolution of serotype O:3 
strains to maintain the GIYep-01 island and spread it through the whole population. In fact, 
genes encoded by this island include a metallo-beta-lactamase (locus tag: Y11_15111), a two-
component response system (Y11_15131-15141), and a putative fimbrial cluster (Y11_15151-
15191), which may confer advantages in patho-adaptation. 
 
Figure 28 Core, pan-genome and singleton development plots of Y. enterocolitica serotype O:3. 
Mean values for each genome count are shown. 
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Figure 29 Whole genome comparison of Y. enterocolitica serotype O:3. 
From the inside out, circles represent G+C content of the reference strain Y11 and comparison of strains 
YE12/03, O3-gb, PhRBD_Ye1, IP10393, Y8265, Y5307, P1, P4, 149, 150, D1 to D9. The outermost ring 
shows the main features of serotype O:3 genomes. Strains isolated from humans are drawn in shades of 
red, while animal-isolates in shades of green. 
The low genomic variability in YE serotype O:3 is coupled with a conserved functionome, as 
calculated by MAPLE (section 3.7.8). Functional comparison among the 13 newly-sequenced 
strains and the reference strain Y11 showed no differences in the MCR of the 121 pathway, 92 
complex and 3 signature modules. A small variation in 1 out of 28 functional sets was detected 
in strain 150, which has a MCR of 50.0% instead of 100.0% for the module “BarA-UvrY two-
component regulatory system”, since the UvrY protein is missing (see above). 
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Two YE strains, which were isolated from the same human patient with 40 days of difference, 
namely D1 and D2 (Table 8), were included in the sequencing project to study whether 
prolonged contact with the host could influence mutations in the stable serotype O:3 genome. 
Confirming the strong stability of serotype O:3 genomes, no significant variations were found by 
whole-genome comparison between strains D1 and D2, except for small errors in the 
annotations, due to the automatic process adopted (section 3.7.6). 
4.3.5. In silico MLST typing 
In order to relate the WGS data with conventional typing scheme, the MLST profile was defined 
for all 20 Y. enterocolitica strains analyzed, using a public online service (section 3.7.2). The 
Yersinia sp. MLST scheme is based on the genetic variability of seven house-keeping genes 
(aarF, dfp, galR, glnS, hemA, rfaE and speA) (Jolley and Maiden, 2010); unique combinations of 
alleles at each locus specify the 158 Yersinia sequence types (ST). Strains P1 and 149 belong 
to ST23, while all the other eighteen strains are of ST18, with 1 SNP in the galR locus for strain 
Y8265 and 2 SNPs in the loci rfaE and speA for strain D6. Interestingly, searching the PubMLST 
database for YE isolates revealed that the majority of serotype O:3 strains belong to ST18, and 
that ST23 is found only in German isolates. The MLST method, therefore, does not have enough 
discriminatory power to distinguish among serotype O:3 strains. 
4.3.6. Whole genome phylogeny of Y. enterocolitica serotype O:3 
The core genome calculated on the 20 Y. enterocolitica serotype O:3 strains was used to infer 
the phylogenetic relationship of this group, as previously described (section 3.7.9 and section 
4.2.5). The Japanese strain D6 was chosen as outgroup to root the tree, due to its higher 
divergence to the reference strain Y11, compared to the other strains. The resulting phylogeny 
(Figure 30) revealed three main lineages (A, B and C) with a total of 14 clusters, corresponding 
to the terminal nodes. Except for strains D1 and D2, which belong to the same discrete cluster 
as they were isolated from the same patient, there is no evident clustering according to the 
isolation source, while the tree seems to be partly congruent with the geographical origin. In fact, 
the two North-European isolates (D5 and Y5307) are clustered in lineage B together with the two 
French (Y8265 and IP10393) ones, whereas the three Belgian strains (149, 150 and D4) are all 
in lineage A. On the contrary, isolates from Germany and Great Britain are found in both 
lineages. A third group is formed by the Japanese strain D6, which is clearly distant from the 
other analyzed samples, Notably, the two strains belonging to ST23 (P1 and 149) form a 
discrete cluster at terminal branches. 
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Figure 30 Whole-genome phylogeny of Y. enterocolitica serotype O:3. 
Neighbor-joining phylogram based on core genes, rooted with the Japanese strain D6 as outgroup. 
Information about host origin, country and MLST is given in colored blocks for each strain. Inset shows the 
same tree as slanted cladogram, to clearer demonstrate the relationships between tree leaves and nodes. 
4.3.7. Variant-based evolution of Y. enterocolitica serotype O:3 
Variants in Y. enterocolitica serotype O:3 were detected from a total of 19 strains using the 
complete genome sequence of strain Y11 as reference (section 3.7.5). Initially, 3,256 variants 
were called; after filtering, e.g. excluding variants within repetitive components of the genome 
(phages, insertion sequences and rRNAs) and with low quality, the final total number of high-
quality variants in the non-repetitive genome resulted to be 2,758 (Table 30 and Table 31). 
Considering the whole genome (4.55 Mb) and the core genome (3.23 Mb) sizes of strain Y11, 
the variant ratio is 1 per 1.65 kb (61.3 per 100 kb) and 1 per 1.2 kb (85.4 per 100 kb), 
respectively. Importantly, these values well correlate with the level of genomic sequence 
diversity of bacterial pathogens considered as “genetically monomorphic”, which have between 
226 and 7 SNPs per 100 kb (Achtman, 2008, 2012). 
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Table 30 General information of called variants in Y. enterocolitica serotype O:3. 
 Number Frequency 
Total Variants 2,758 100 
SNPs 2,607 94.53 
Deletions 41 1.49 
Insertions 110 3.99 
   
Intergenic 621 22.51 
Synonymous 759 27.52 
Nonsynonymous 1,262 45.76 
Nonsense 53 1.92 
Frameshift 62 2.25 
In tRNAs 1 0.04 
   
In CDSs 2,136 77.45 
In core CDSs 1,795 65.08 
 
Adaptive selection. Approximately 77.5% of variants occur within protein-coding sequences, 
and almost 50% cause modifications (nonsynonymous, nonsense, frameshift) within the affected 
protein sequences. Overall, 1,457 genes (32.8%) contain at least one variant, including 1 tRNA-
Leu gene and 1,456 CDSs, while the remaining 67.2% of genes are not affected. The 
distribution of variants per gene is shown in Figure 31 and follows a Poisson distribution in the 
range of 0-6 variants per gene. Curiously, there is one gene which deviates from the model, as it 
contains 22 SNPs, namely Y11_15631, encoding a hypothetical protein. Y11_15631 is a large 
gene (2,744 bp), which may explain the high variability, and only 3 of the 22 SNPs are 
nonsynonymous, occurring singularly in strain Y5307. To note, analysis with CDD identified 
phage-baseplate assembly domains within the amino acid sequence, even though it is not 
located within a prophage region nor adjacent genes encode phage-related proteins. Therefore, 
the high number of SNPs cannot be considered a signal of diversifying selection in this gene. 
Homoplasic variants which occurred multiple times independently in different lineages may also 
be evidence of selection. To identify potential evidences of adaptive selection in localized 
genetic regions, clusters of nonsynonymous variants located within five amino acids of the 
encoded proteins were investigated. Nine genes satisfied these criteria, containing a total 
number of 30 nonsynonymous variants (1 insertion and 29 SNPs) (Table 32). In particular, two 
SNPs occur in the same codon of the Y11_26741 protein in two different strains, D8 (A335G) 
and D6 (T334C), causing the amino acid changes Tyr112Cys and Tyr112His, respectively. 
Codon Glu39 of Y11_15081 contains two SNPs, which cause change Glu39Val in strain D6 and 
a nonsense mutation in strain PhRBD_Ye1. Moreover, gene Y11_38851 is subject to two nearby 
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mutations, Ser41Arg and Asp44Asn in the same isolate D6. Except for gene Y11_15081, 
encoding a hypothetical protein, the other eight CDSs belong to the core genome of serotype 
O:3 isolates and encode proteins involved in metabolic and transport functions.  
Table 31 Included and excluded regions from variant detection analysis. 
Data refers to the reference genome of Y. enterocolitica strain Y11. 
Genes Excluded Included Total Included (%) 
rRNA 22 0 22 0.0 
tRNA 4 66 70 94.3 
CDS 391 3,958 4,349 91.0 
   IS elements 107 0 107 0.0 
   Phages 284 0 284 0.0 
Total genes 417 4,024 4,441 90.6 
Genomic bp Excluded bp Included bp Total bp Included bp (%) 
rRNA 32,370 0 32,370 0.0 
tRNA 315 5,121 5,435 94.2 
CDS 268,637 3,569,249 3,837,886 93.0 
   IS elements 86,457 0 86,457 0.0 
   Phages 228,841 0 228,841 0.0 
Intergenic 46,662 631,067 677,729 93.1 
Total genome 347,983 4,205,437 4,553,420 92.4 
 
Functional gene loss. A total number of 132 variants causing gene-inactivating mutations, like 
nonsense, frameshifts and truncations, were identified. They consist of 69 SNPs, 41 insertions 
and 22 deletions, and are found in 1 genome (78 variants), 2-4 (15), 8-13 (33) and more than 14 
sequences (6). The 127 affected genes, including 69 core genes, can then be considered as 
pseudogenes, and constitute approximately 2.9% of YE serotype O:3 CDSs, which is a high 
percentage, if compared to S. typhimurium (0.9%) and E. coli strain K12 (0.7%) (McClelland et 
al., 2001). Importantly, high pseudogene frequencies have been associated with bacterial 
organisms with a restricted range of hosts, including Yersinia sp. (Parkhill et al., 2003; Thomson 
et al., 2006). 
4.3.8. SNP-based phylogeny 
Using SNPs called in the nonrepetitive component of the genome against the reference strain 
Y11, a phylogenetic tree was reconstructed to study the microevolution of Y. enterocolitica 
serotype O:3 (section 3.7.9). Insertions and deletions were excluded from the analysis, since the 
concordance of indels called from different pipelines is low (O'Rawe et al., 2013), and the 
analyzed genomes were not all obtained from the same sequencing technology. Overall, SNPs 
traced a similar phylogeny (Figure 32) to the one defined by the core-genome-based tree (Figure 
30), recognizing the three main lineages A, B and C and 15 clusters, with the two ST23 strains 
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forming one cluster and the other ST18 strains the remaining ones. SNP-based phylogeny, 
therefore, shows a discriminatory power to the strain level higher than the MLST scheme, being 
useful for typing of YE serotype O:3. The Japanese strain D6 looks even more distantly related 
than the other samples; in fact, 1,116 SNPs out of 2,607 (42.8%) are singularly carried by this 
strain. A sub-grouping according to new or downloaded sequences appears, probably due to the 
different methods applied for variant calling on already assembled and re-sequenced genomes 
(section 3.7.6). Interestingly, the English strain O3-gb contains only 2 SNPs and is, therefore, 
strictly clustered with the German reference strain Y11 furthest from the root, indicating recent 
genetic diversification. In contrast, isolate 150 forms a discrete cluster on a branch closest to the 
root, compared to the previous whole-genome phylogeny. The two strains D1 and D2, which 
have been isolated from the same patient, are clustered together, as expected. Considering the 
10 isolates from animals and the 10 isolates from humans, no detected SNPs are able to 
distinguish between the two groups, as well as no SNPs are shared by all 8 isolates from pigs. 
Moreover, the human isolates are mostly located on distal branches, indicating recent mutations, 
while the animal samples, especially from swine, mainly lie on branches closest to the root with 
older mutations, in both core-genome- and SNP-based trees. If pig carriers constitute the 
reservoir for YE serotype O:3, this may account for the different SNP-based phylogenetic ages 
observed in strains of human and animal origin. 
 
Figure 31 Distribution of serotype O:3 variants per gene. 
Inset graph shows gene number on a log scale. Lines indicate the Poisson distribution fitted to the data. 
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Table 32 Genes with potential signal of adaptive selection. 
(ns: nonsynonymous variants) 
Gene Locus Number of ns Gene product Core gene 
Y11_05871 4 O-acetylhomoserine sulfhydrylase; O-succinylhomoserine sulfhydrylase Yes 
Y11_09291 3 N-acetylmuramoyl-L-alanine amidase Yes 
Y11_15081 3 Hypothetical protein No 
Y11_15171 4 Putative outer membrane usher protein Yes 
Y11_17061 3 Hydrogenase-4 component F Yes 
Y11_20111 3 Potassium efflux system KefA protein Yes 
Y11_26741 4 L-seryl-tRNA(Sec) selenium transferase-related protein Yes 
Y11_38851 3 3-isopropylmalate dehydrogenase Yes 
Y11_43381 3 Phosphate transport system permease protein PstC Yes 
 
 
Figure 32 Phylogeny of Y. enterocolitica serotype O:3 based on SNPs. 
The neighbor-joining tree was constructed from concatenated SNPs for each strain, producing 2,607-bp 
long sequences. Branch lengths are measured in units of the expected fraction of changed nucleotides, 
scale as indicated. A slanted cladogram is shown as inset to better reveal the associations among 
samples. See Figure 30 for comparison. 
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4.4. Screening of genes expressed during Y. enterocolitica O:3 infection 
In this study the IVIAT (in vivo induced antigen technology) immuno-screening method was 
applied to strain Y11 to identify bacterial antigens which are expressed during Y. enterocolitica 
serotype O:3 infection and cause a humoral immune response in human patients. Briefly (Figure 
33), IVIAT utilizes sera from patients with infection caused by the pathogen of interest. Sera are 
pooled from several individuals and adsorbed against bacteria grown under standard laboratory 
culture conditions, in order to remove antibodies that bind bacterial antigens expressed in vitro, 
while retaining antibodies that recognize bacterial antigens specifically produced in vivo. 
Adsorbed serum is then used to probe an inducible protein expression library of the pathogen. 
 
Figure 33 Schematic representation of IVIAT experiment. Modified from (Rollins et al., 2005). 
Results  106 
4.4.1. Selection and adsorption of human sera 
Sera from 27 human patients with positive Y. enterocolitica serotype O:3 infection were collected 
and tested for positive immune response to antigens YopM, V-Ag, YopD, MyfA, YopE (section 
3.5.5). Only 14 sera gave clear and unambiguous results, with significant immune response, and 
were retained for the following adsorption step (Table 18). Pooled sera were adsorbed against 
whole cells, native and denatured cell lysates of YE strain Y11 and of the host expression strain 
E. coli T7 express, in order to expose the sera to both surface-exposed and non-exposed 
proteins synthesized during in vitro growth. Multiple rounds of adsorption were conducted and 
reactivity of the treated sera was compared against the unabsorbed sera by western blot to 
ascertain the efficiency of the adsorption. As shown in Figure 34, the adsorption steps were 
successful and antibodies specific to in vitro antigens had been completely eliminated. In fact, 
loss of immuno-reactivity of whole cell and lysate antigens was evident, while immuno-reactivity 
of known in vivo expressed antigens, like the Yop effector proteins (extracted as in section 
3.3.7), was nearly preserved after complete adsorption. 
 
Figure 34 Evaluation of the serum adsorption process efficiency. 
Immune reaction against Yops, whole cells (WC) and cell lysates (CL) of unadsorbed (A), adsorbed (B) 
and partially adsorbed (C) sera is shown. 
4.4.2. Screening of a Y. enterocolitica strain Y11 expression library 
An IPTG-inducible expression library in E. coli T7 express was created from ~ 70,000 clones 
transformed with genomic fragments of Y. enterocolitica strain Y11 (sections 3.4.7 and 3.3.6). 
Considering the minimum insert size of 0.5 kb, a representative library should be obtained from 
41,860 clones, while inserts of 3 kb require 6,975 clones. The expression library could therefore 
be considered as representative and containing at least one copy of all possible sequences. 
Screening of a significant number of clones (~ 50,000) identified 219 reactive clones, but only 34 
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of them preserved immune-reactivity after second and third screening and were therefore 
processed for plasmid isolation and sequencing of the inserts. 
4.4.3. In vivo induced antigens identified by IVIAT 
Insert sequences expressed by the 34 reactive clones were subject to Blast search to determine 
the encoded genes. Sub-cellular localization was then determined by the PsortB version 3.0 
software, together with analysis of the Gene Ontology cellular component term (Table 19). A 
total number of 45 Y. enterocolitica serotype O:3 genes or gene fragments were represented by 
the immuno-reactive clones (Table 33). These in vivo induced (IVI) genes are predicted to be 
especially associated with different metabolic and biosynthetic functions, but also in motility, host 
adhesion and invasion, regulation, transport and cell wall synthesis/remodeling. 
Table 33 Y. enterocolitica serotype O:3 gene products identified by IVIAT. 
Functional 
category 
ORF Gene product, function Predicted cellular 
localization 
Host 
adaptation  
Y11_p0711 type III secretion inner membrane protein 
YscU, T3SS 
Cytoplasmic membrane 
and invasion Y11_41911 Acid stress chaperone, acid resistance Periplasmic 
Metabolism Y11_05151 N-methyl-L-tryptophan oxidase, 
oxidoreductase activity 
Cytoplasmic 
 Y11_06801 hydroxypyruvate isomerase, hydroxypyruvate 
isomerase activity 
Cytoplasmic 
 Y11_20631 cytochrome O ubiquinol oxidase subunit III, 
aerobic electron transport chain 
Cytoplasmic membrane 
 Y11_21501 acyl-CoA dehydrogenase short-chain 
specific, beta-oxidation 
Cytoplasmic membrane 
 Y11_22271 class I fumarate hydratase, TCA cycle Cytoplasmic 
 Y11_24891 ADP-ribose pyrophosphatase, purine 
metabolism 
Cytoplasmic 
 Y11_27461 glutathione S-transferase, glutathione 
metabolism 
Cytoplasmic 
 Y11_29751 ATPase subunit beta, ATP synthesis Cytoplasmic membrane 
 Y11_32421 nitrite reductase [NAD(P)H] small subunit 
NirD, nitrate assimilation 
Cytoplasmic 
 Y11_32431 nitrite reductase [NAD(P)H] large subunit 
NirB, nitrate assimilation 
Cytoplasmic 
Regulation Y11_00711 putative two-component system sensor 
kinase, two-component regulatory system 
Cytoplasmic membrane 
 Y11_20391 nitrogen regulatory protein P-II, transcription 
regulation 
Cytoplasmic membrane 
 Y11_29371 nitrogen regulation protein GlnG, 
transcription regulation 
Cytoplasmic 
 Y11_15401 transcriptional regulatory protein UhpA, 
transcription regulation 
Cytoplasmic 
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 Y11_15411 sensor histidine protein kinase UhpB G6P 
specific, regulatory system 
Cytoplasmic membrane 
 Y11_38441 transcriptional activator NhaR, transcription 
regulation 
Cytoplasmic 
Transport Y11_00941 oxalate/formate antiporter, transmembrane 
transport 
Cytoplasmic membrane 
 Y11_22281 BCAA/urea binding protein, ABC transporter Periplasmic/ 
Cytoplasmic membrane 
 Y11_32661 taurine transport system permease TauC, 
transporter activity 
Cytoplasmic membrane 
 Y11_40611 lysophospholipid transporter LplT, lipid 
transport 
Cytoplasmic membrane 
 Y11_41901 hoxn/HupN/NixA family nickel/cobalt 
transporter, metal ion transport 
Cytoplasmic membrane 
Motility and 
cell adhesion 
Y11_14281 flagellar motor switch protein FliN, motor 
activity 
Unknown 
 Y11_14291 flagellar biosynthesis protein FliO, flagellum 
organization 
Cytoplasmic membrane 
 Y11_14301 flagellar biosynthesis protein FliP, protein 
secretion 
Cytoplasmic membrane 
 Y11_14311 flagellar biosynthesis protein FliQ, flagellum 
assembly 
Cytoplasmic membrane 
 Y11_22651 fimbriae usher protein MrfC, fimbrium 
biogenesis 
Outer Membrane 
 Y11_22661 MrfB fimbrial protein, pilus Extracellular 
Molecular  Y11_03341 endonuclease IV Nfo, DNA binding/repair Cytoplasmic 
biosynthesis 
and 
Y11_08121 Phospho-2-dehydro-3-deoxyheptonate 
aldolase, amino acid biosynthesis 
Cytoplasmic 
degradation Y11_16351 uroporphyrinogen-III methyltransferase 
CobA, porphyrin-containing compound 
biosynthesis 
Cytoplasmic 
 Y11_16361 L-threonine 3-O-phosphate decarboxylase 
CobD, porphyrin-containing compound 
biosynthesis 
Cytoplasmic 
 Y11_23401 radical SAM family enzyme, porphyrin-
containing compound biosynthesis 
Cytoplasmic 
 Y11_26251 glutamate synthase [NADPH] large chain, 
glutamate biosynthesis 
Cytoplasmic 
 Y11_29191 ATP-dependent DNA helicase RecG, DNA 
recombination and repair 
Cytoplasmic 
 Y11_29621 aspartate--ammonia ligase AsnA, amino acid 
biosynthesis 
Cytoplasmic 
 Y11_38531 carbamoyl-phosphate synthase large chain 
CarB, amino acid biosynthesis 
Periplasmic/ 
Cytoplasmic membrane 
Cell wall 
synthesis 
Y11_39031 UDP-N-acetylmuramoylalanine--D-glutamate 
ligase MurD, cell wall biosynthesis  
Periplasmic/ 
Cytoplasmic membrane 
 Y11_42431 N-acetylmuramic acid 6-phosphate etherase, 
cell wall biogenesis and recycling 
Cytoplasmic 
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 Y11_42851 penicillin-insensitive transglycosylase & 
transpeptidase PBP-1C, peptidoglycan 
biosynthesis 
Cytoplasmic membrane 
Putative  Y11_24881 putative cytoplasmic protein Unknown 
Function Y11_27471 uncharacterized protein, DNA binding Unknown 
 Y11_27481 HipA protein Unknown 
 Y11_33161 uncharacterized protein Unknown 
  
Virulence-related IVI genes. The only virulence plasmid-encoded IVI antigen observed by 
IVIAT is the yscU gene. YscU is an integral inner-membrane protein, which belongs to the export 
apparatus of the T3SS injectisome and, therefore, is involved in host invasion. It contains a 
transmembrane domain and a soluble cytosolic domain (Allaoui et al., 1994); interestingly, the 
gene insert sequenced from the reactive clone corresponds to the C-terminal cytoplasmic 
domain of this protein. 
A periplasmic acid stress chaperone (locus tag: Y11_41911) was identified and assigned to a 
host adaptation function, since it represents a strategy developed by food-borne enteric 
pathogens to survive the gastric acidic environment, when travelling through the stomach to the 
intestine (Hong et al., 2012). This protein contains domains belonging to the acid-resistance 
protein HdeB and to the HdeA/HdeB family, and has been annotated as HdeB. In E. coli and 
Shigella sp. the hdeAB genes constitute an operon and are located in the acid fitness island 
(Carter et al., 2012). The hdeA gene could not be found in any Yersinia species, nor was the 
acid fitness island. The IVI hdeB gene, on the other hand, is 48% identical to hdeB in E. coli and 
is conserved among YE strains. It is located downstream the urease cluster (Y11_41821-
41901), which is also involved in acid tolerance, neutralizing H+ by converting urea to ammonia. 
Two IVI antigens (Y11_22651 and Y11_22661), belonging to a large fimbrial cluster composed 
of 8 CDSs (Y11_22601-22691), are conserved among YE strains and resemble the Mrf/Stf/Ste 
fimbrial systems in other Enterobacteriaceae. The IVI usher protein MrfC contains the PapC N-
ter and C-ter domains and has homologous proteins in Serratia sp. and YE-like genomes, but 
not in Y. pestis or in Y. pseudotuberculosis. Remarkably, a StbC fimbrial usher protein has been 
identified by IVIAT performed with the poultry-adapted S. enterica serovar pullorum (Li et al., 
2013). This protein has a similarity score of 42.5% with the IVI MrfC protein identified in YE 
strain Y11; however, both proteins contain the same conserved PapC N-ter usher and PapC C-
ter domains. 
IVIAT identified another virulence-related gene, Y11_00711, which encodes a membrane-bound 
sensor kinase. This protein putatively belongs to a two-component transduction system, together 
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with the adjacent response regulator Y11_00701. Two-component systems are used by bacteria 
to respond to environmental stimuli, by transferring a phosphate from the sensor histidine kinase 
to an aspartate residue within the conserved regulatory domain of the response regulator. 
Phosphorylation then activates a variable effector domain, triggering the cellular response and, 
thus, regulating processes such as chemotaxis, osmoregulation and metabolism, as well as 
expression of toxins and other pathogenic proteins (West and Stock, 2001). Interestingly, two IVI 
gene products (Y11_15401 and Y11_15411) correspond to the C-ter and N-ter part of the UhpA 
and UhpB proteins, respectively. These proteins form another two-component regulatory 
system, which is stimulated by the presence of glucose-6-phosphate and enables the bacteria to 
adsorb organophosphate compounds from the environment and use them as energy source. 
Flagella are considered virulence factors for various pathogens and, indeed, four immunogenic 
products involved in flagellar assembly were detected by IVIAT. FliN is a component of the 
motor switch and consists of a SpoA (surface presentation of antigens) domain, while FliO, FliP 
and FliQ are integral membrane proteins essential for the flagellar export machinery. The genes 
are located within the Flag-1 cluster, common to all YE. 
Macromolecular biosynthesis and metabolism. Proteins associated with biosynthesis and 
metabolism are essential for bacterial survival and growth in vivo and, consequently, for bacterial 
infection. IVIAT detected several enzymes involved in the synthesis of cell molecules, including 
amino acids, glutathione and cofactors. In particular, three IVI proteins (CobA, CobD and 
Y11_23401) are components of the porphyrin/cobalamin metabolic pathway, with genes cobA 
and cobD belonging to the cob/pdu operon uniquely acquired by YE (Thomson et al., 2006). 
Cobalamin, an essential cofactor in animals and plants, is produced by YE only in anaerobic 
conditions and is used to ferment propanediol as important source of energy (Prentice et al., 
2003). 
Other three IVI proteins involved in energy metabolism were classified as part of the nitrogen 
metabolism pathway of YE strain Y11. The NirBD nitrite reductases allow the bacteria to reduce 
nitrite to ammonium, while the glutamate synthase (NADPH) Y11_26251 assimilates ammonia 
by converting L-glutamine into L-glutamate. In addition, two nitrogen regulatory proteins were 
identified by IVIAT. The GlnG protein is a two-component response regulator of the NtrC family. 
This system responds to nitrogen-limited conditions and induces the transcription of the GlnA 
glutamine synthetase, facilitating the assimilation of nitrogen-containing compounds. Overall, YE 
may be assisted by these nitrogen metabolism-related proteins to persist in anaerobic 
conditions. Two other IVI proteins participate in energy metabolism and, specifically, in the 
aerobic oxidative phosphorylation. The cytochrome O ubiquinol oxidase (Y11_20631) is located 
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in the prokaryotic electron transport chain and reduces oxygen into water. The final enzyme in 
this pathway is the ATP synthase (the IVI gene Y11_29751), a multi-subunit enzyme which 
drives the synthesis of ATP from ADP and phosphate. 
Among the three IVI proteins involved in cell wall synthesis, the PBP-1C penicillin-binding 
protein has a bifunctional action of transglycosylase and transpeptidase, containing the 
respective domains at the N- and C-termini. This membrane-associated macromolecule is 
required not only for peptidoglycan and cell wall biosynthesis but also for cell division. 
Interestingly, the YE PBP-1C protein has a similarity score of 64% with the orthologous IVI 
protein in S. pullorum (Li et al., 2013). 
DNA repair and recombination have essential roles in maintaining prokaryotic cell viability and 
survival in response to significant environmental stress. Accordingly, IVIAT identified two 
enzymes implicated in DNA repair. The Nfo protein, an apurinic/apyrimidinic (AP) endonuclease 
IV, is involved in the DNA base excision repair pathway, while the RecG helicase belongs to the 
homologous recombination system.  
Transport proteins. Among the IVI transporters, a protein with predicted short-chain amide and 
urea transport activity was detected. This protein is a periplasmic binding protein-dependent 
ATP-Binding Cassette (ABC) transporter. Interestingly, the corresponding gene locus 
Y11_22281 is located within the second LIV gene cluster specifically carried by YEP genomes 
and absent from the highly-virulent strains (section 4.2.1). KEGG analyses classified this protein, 
together with the products of the loci Y11_22341 and Y11_34321, as LivK high-affinity system 
for branched-chain amino acid (BCAA) transport. Importantly, the change in intracellular BCAA 
concentration is a trophic signal playing a role in bacterial regulatory processes related to 
chromosome structural organization and proteolysis (D'Ari et al., 1993; Guedon et al., 2001). 
The TauC ABC transporter belongs to the sulfur metabolism pathway and allows bacteria to 
assimilate extracellular taurine, which can be then converted into sulfite by the taurine 
dioxygenase TauD, providing sulfur for growth. Taurine is an organic acid which constitutes the 
human bile and can be found in the large intestine and in different animal tissues; it is also used 
as food additive for cats and dogs. 
IVI antigens with putative functions. Four proteins with unknown function were identified by 
IVIAT. One of them is predicted to be a HipA-like toxin, with serine/threonine kinase activity, 
containing both HipA N- and C-ter conserved domains. The HipA activity is usually overcome by 
the antitoxin HipB, a transcription repressor which also regulates hipBA expression. In fact, the 
adjacent gene, Y11_27471, is the hypothetical HipB HTH-type transcriptional regulator, 
belonging to the xenobiotic response element family. HipA has demonstrated multidrug 
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tolerance, characteristic of dormant bacteria or persisters, suggesting that the HipBA system 
acts as a bacterial persistence factor (Schumacher et al., 2009). 
4.4.4. Genomic analysis of IVI genes 
Making use of the genome analysis of YE serotype O:3 (section 4.3), IVI genes could be 
assigned to core genes and genes with variants. Among the 45 identified IVI genes, 40 belong 
to the core genome of serotype O:3; as expected, the pYV-encoded IVI locus Y11_p0711 is not 
included, as the core genes were calculated using only the chromosomal sequences (section 
4.3.3). The other 4 non-core IVI genes are Y11_00941, Y11_15411, Y11_22661 and 
Y11_26251. Curiously, 20 IVI genes contain a total of 31 variants, consisting of 19 
nonsynonymous, 2 frameshift (Table 34) and 10 synonymous mutations. Considering the 
distribution across the serotype O:3 phylogeny (Figure 32), 25 out of 31 variants (80.6%) occur 
in single samples, 2 are specific for the cluster of strains 149, P1 and D7 (in genes Y11_20631, 
synonymous, and Y11_24881, nonsynonymous) and 1 for strain PhRBD_Ye1 and YE12-03 (the 
nonsynonymous SNP in the RecG protein). Interestingly, a synonymous mutation in Y11_42431 
in present only in lineage B, while the two mutations in Y11_15411 and Y11_40611 are shared 
by lineages B and C. 
Table 34 IVI genes containing nonsynonymous SNPs and Indels (fs: frameshift). 
IVI gene Core gene Variant mutation Product 
Y11_00941 No Glu37fs oxalate/formate antiporter 
Y11_05151 Yes Gly144Ser N-methyl-L-tryptophan oxidase 
  Pro120Ser  
Y11_15401 Yes Asp152Glu transcriptional regulatory protein UhpA 
Y11_15411 No Thr409Ala sensor histidine protein kinase UhpB 
Y11_16351 Yes Gly10Ser uroporphyrinogen-III methyltransferase 
Y11_21501 Yes Gln104Leu acyl-CoA dehydrogenase, short-chain specific 
Y11_22651 Yes Ala380Val fimbriae usher protein StfC 
  Thr204Ser  
Y11_24881 Yes Val78Leu putative cytoplasmic protein 
Y11_26251 No Val444Gly glutamate synthase [NADPH] large chain 
Y11_29191 Yes Glu254Lys ATP-dependent DNA helicase RecG 
Y11_29621 Yes Ala206Val aspartate--ammonia ligase 
Y11_32431 Yes Val429Ala nitrite reductase [NAD(P)H] large subunit 
  Ala7Thr 
 Y11_38531 Yes Pro17Leu carbamoyl-phosphate synthase large chain 
Y11_39031 Yes Ala27Val UDP-N-acetylmuramoylalanine--D-glutamate ligase 
Y11_40611 Yes Leu255Pro lysophospholipid transporter LplT 
  Ala374Glu 
 Y11_41901 Yes Asp167Gly hoxn/HupN/NixA family nickel/cobalt transporter 
Y11_42851 Yes Leu29fs penicillin-insensitive PBP-1C 
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5. Discussion 
Comparative genomics investigation into the heterogeneity of different Y. enterocolitica 
serotypes showed a general great diversity as whole species, corresponding to the wide range 
of niches where these bacteria can proliferate. In contrast to the mouse-virulent and non-virulent 
biotypes 1B and 1A, the weakly-virulent serotypes demonstrated lower genetic heterogeneity 
and, especially, serotype O:3 strains proved to be genetically monomorphic, in accordance with 
their host specialization. Despite the known restricted metabolic capacity of the genetic 
nondiverse weakly-virulent group, metabolic gene clusters which might provide anaerobic growth 
advantages in specific ecological niches have been discovered. Moreover, genome-wide 
investigations allowed development of a molecular serotyping scheme, which could be used as 
basis for an efficient epidemiological and typing tool. Finally, genome analyses, together with 
results from the IVIAT technique, also revealed the importance of fimbriae, flagella and 
autotransporters in virulence/fitness and host adaptation properties of YE. 
5.1. High heterogeneity of Y. enterocolitica subsp. enterocolitica 
Highly-virulent Y. enterocolitica strains of bioserotype 1B/O:8 have been largely and 
interchangeably used to elucidate the virulence/fitness mechanisms of this gastrointestinal 
pathogen. According to the results obtained in this study, YE strains 8081 and WA-314 
demonstrated not only high genomic diversity, but also different behaviors during in vitro and in 
vivo growth.  
5.1.1. Genomic diversity of Y. enterocolitica subsp. enterocolitica 
The newly sequenced genome of Y. enterocolitica strain WA-314 was analyzed and compared 
to the reference genome of strain 8081 (Thomson et al., 2006). Overall, the two highly-virulent 
strains have similar genome properties (Table 21), with strain WA-314 having smaller 
chromosome and plasmid sizes because of the incompleteness of the sequences. In fact, 
shotgun sequencing approaches are based on libraries created by the fragmented target 
genome, producing sequence reads which have to be ordered and assembled. When the 
sequence contains repeats, correct assemblies are not easily obtained, since algorithms are not 
able to place the read in the different alternative positions through the genome. The resulting 
assemblies are therefore formed by scaffolds, with gaps usually representing the un-assembled 
repetitive regions (e.g. transposases, insertion sequences and tRNAs). Since these gaps have 
not been closed in the genome of YE strain WA-314, the resulting sequence sizes and the 
number of tRNAs are underestimated and smaller than the related strain 8081. 
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Approximately 91% of genes in strain WA-314 have orthologs in the genome of strain 8081, with 
the remaining 9% mostly encoding hypothetical and mobile element-related proteins. In fact, 
important differences have been detected in prophages and genomic islands. Strain WA-314 is 
devoid of the islands YGI-3, YGI-4 and YAPI, which is involved in Y. pseudotuberculosis 
virulence (Collyn et al., 2004). Additionally, strain WA-314 harbors seven prophages, which 
show low sequence similarity with prophage regions in strain 8081. In particular, a PilV-like 
adhesin, carried by the prophage YWA-4, may increase intestinal colonization of strain WA-314, 
as it has been shown for other Enterobacteriaceae (Bieber et al., 1998; Zhang et al., 2000). 
Curiously, the YWA-4 prophage occupies the same genomic region as the YGI-3 in strain 8081, 
between two tRNA genes. As demonstrated also by genome comparison of the whole YE 
species (section 4.2.4 and Figure 20), this region is highly variable and may be considered a 
“hot-spot” for the integration of genetic material acquired by horizontal gene transfer (HGT) in YE 
biotypes 1A and 1B. Genomic islands and prophages greatly contribute to inter- and intra-
species genetic variability and evolution of a variety of pathogenic bacteria (Dobrindt and 
Hacker, 2001), stressing the main role of horizontal gene transfer and mobile elements in 
shaping the genomic versatility of highly-virulent YE. Besides mobile elements, YE highly-
virulent strains 8081 and WA-314 differ in the presence and sequence similarity of certain gene 
clusters and protein-encoding genes. Strain WA-314 specifically possesses a xenobiotic-
acetyltransferase-encoding gene, a restriction modification system and a putative colicin cluster. 
Whether these proteins are efficiently expressed and functional in vitro and/or in vivo needs to 
be clarify. From an evolutionary perspective, being isolated from human, animal and 
environmental sources (Fredriksson-Ahomaa et al., 2006), YE serotype O:8 strains undergo 
numerous opportunities for exchanging genetic material. These flexible lifestyles make these 
bacteria be in contact with many microbial communities, and may therefore explain the genome 
plasticity as a result of continue adaptation for survival in different niches. 
5.1.2. New virulence factors for the highly-virulent phenotype 
Comparing and analyzing CDSs with low-sequence similarity between strains 8081 and WA-314 
allowed identification of new factors putatively involved in Y. enterocolitica pathogenesis. 
Autotransporters represent the largest protein family in pathogenic Gram-negative bacteria and 
perform heterogeneous functions, such as mediation of biofilm formation, bacterial aggregation 
and adhesion to epithelial cells. This functional diversity is due to the variable N-ter passenger 
domain, which is responsible for the pathogenesis of bacteria (Benz and Schmidt, 2011). Two 
orthologous autotransporters, showing only 32% sequence identity between strains 8081 and 
WA-314 (respective locus tags: YE3700 and YWA314_14949), contain dissimilar passenger 
Discussion  115 
domains, which may confer strain-specific adhesion properties. While this gene is conserved 
among all YE, even if with low sequence similarity (section 4.2.2), another adhesin is specific for 
YEE (locus tags: YE0694 and YWA314_00878), and may contribute to the highly-virulent 
phenotype of strains 8081 and WA-314. In addition, a biotype 1B-specific fimbrial operon with 
differences between strains 8081 and WA-314 (locus tags: YE1111-1114 and YWA314_11901-
11886) has been identified, and may also be considered a specific virulence factor for highly-
virulent strains. In fact, fimbriae (or pili) have demonstrated adhesion properties in different 
Gram-negative bacteria, leading to colonization of host tissues in the urinary, genital and 
gastrointestinal tracts (Proft and Baker, 2009). Genome comparison of two YE biotype 1B 
strains, therefore, allowed identification of yet unknown genes which may be involved in 
pathogenesis of this highly-virulent group of bacteria.  
5.1.3. Differences in the virulence plasmid sequences 
Considering the established virulence determinants of Y. enterocolitica (Table 3 and section 
1.2), significant differences between strains 8081 and WA-314 were found in certain pYV-
encoded proteins. YopM is a T3SS-dependent effector protein indispensable for full virulence of 
pathogenic Yersinia, even though its molecular functions still remain largely obscure. In 
Y. pseudotuberculosis YopM modulates virulence by interaction with two intracellular 
serine/threonine kinases, PRK2 and RSK1, involving the LRR6-LRR15 and the LRR12-C-ter 
regions, respectively (McCoy et al., 2010; McDonald et al., 2003; McPhee et al., 2010). Notably, 
YopM8081 is 367-aa long with 13 LRRs, while YopMWA-314 has 505 residues and 24 LRRs (Figure 
7). However, it is not clear whether the different number of LRRs in YopM proteins of strain 8081 
and WA-314 has different consequences on the virulence of YE in the mouse model. 
LcrV is one of the three translocator proteins which form the pore complex connecting the 
needle tip of the T3SS injectisome to the target host cell (Dewoody et al., 2013b). The 9-aa 
insertion identified in LcrVWA-314 has been previously observed in strain WA-314 and in other 
biotype 1B strains but is absent from strain 8081 and from weakly-virulent YE (Foultier and 
Cornelis, 2003; Roggenkamp et al., 1997). The role of this polymorphic region seems to be 
related to a humoral immunosuppression function, in that antibodies directed against Y. pestis 
LcrV are unable to block the T3SS-based virulence of YE strain WA-314 and strain W22703 
(serotype O:9) (Miller et al., 2012; Motin et al., 1994). Therefore, antibodies produced against 
LcrV8081 might not protect from YE strain WA-314 infections. However, the observed 
dissimilarities are independent from the amino acid polymorphisms in the LcrV sequence, but 
may be due to differences in injectisome assembly between Y. pestis and YE (Ligtenberg et al., 
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2013), suggesting that the different LcrV sequences of strains 8081 and WA-314 might not be 
involved in different virulence properties. 
YadA is an important adhesin involved in serum resistance and in mediation of adherence to 
epithelial cells and to extracellular matrix (ECM) proteins (Balligand et al., 1985; Heesemann 
and Grüter, 1987). The fundamental role of YadA for YE virulence has been demonstrated in the 
mouse infection model (Roggenkamp et al., 1995). The domains involved in these virulence-
associated functions are located in the N-terminal head region of the YadA protein (El Tahir and 
Skurnik, 2001); in particular, the amino acids 29 to 81 are important for neutrophil interaction and 
virulence in mice (Roggenkamp et al., 1996). Interestingly, YadA8081 and YadAWA-314 sequences 
possess six different amino acids at positions 53 to 67 (section 4.1.1, page 61). Whether the 
detected mutations alter neutrophil binding and/or virulence of YE strains 8081 and WA-314 
needs further investigations. 
YscP regulates the Yersinia injectisome needle length, which is directly correlated to the size of 
the YscP protein (Wagner et al., 2009). A minimal needle length is required for a fully functional 
injectisome, also in relation to the length of the YadA adhesin, providing optimal contact with the 
host cell (Mota et al., 2005). Yop translocation efficiency might be therefore reduced by shorter 
YscP proteins or longer YadA proteins. Sequence comparison of pYV8081 and pYVWA-314 
discovered a longer YscP protein in YE strain WA-314 compared to strain 8081 (Figure 8), due 
to three additional amino acid repeats. Since the length of YadA is the same, the longer YscP 
protein in strain WA-314 might improve the Yop translocation and, therefore, provide better 
virulence properties than strain 8081. 
Apart from differences in the YopM, LcrV, YscP and YadA sequences, YE WA-314 carries the 
ylpA gene, which is completely missing in pYV8081. This gene is conserved among the three 
pathogenic Yersinia species and encodes a lipoprotein related to the TraT protein. TraT is a cell-
surface-exposed lipoprotein carried by plasmids of Gram-negative bacteria. Probable roles in 
pathogenesis are supported by the observation that TraT confers serum-resistance in E. coli 
(Sukupolvi and O'Connor, 1990). However, no differences were found between YE strain 
W22703 and the corresponding ylpA mutant in terms of resistance to human serum (Balligand et 
al., 1985), nor in bacterial counts from organs of mice infected with these strains (China et al., 
1990). An implication of YlpA in YE strain WA-314 virulence is therefore unlikely. 
5.1.4. Different colonization properties of highly-virulent Y. enterocolitica 
Intra-species variation among Y. enterocolitica biotype 1B strains is evident from a genomic 
perspective, but is also confirmed by phenotypical diversification of strains 8081 and WA-314 
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during in vivo growth. In fact, these two highly-virulent strains demonstrated different virulence 
behaviors in a mouse model, especially in competition assays (section 4.1.3). A statistically 
significant number of mice were used for single strain and co-infection experiments via the intra-
peritoneal route, which was preferred to oral infection to avoid different dissemination efficiency 
from the intestine into spleen and liver, and to enable an accurate and controlled injection of the 
bacterial suspension. Nevertheless, two mice were not successfully injected with strain WA-314, 
while another mouse showed no bacteria in the spleen and low counts in the liver, probably 
because of a faster splenic clearance of bacteria. Overall, bacterial growth was more efficient for 
strain WA-314 than strain 8081, even though the loads were statistically significantly higher in 
the spleens and not in the livers. In co-infected mice, strain WA-314 outcompeted strain 8081, 
demonstrating improved colonization efficiency and adaptation to the host environment. YE 
mouse-virulent strains, therefore, seem to differ in invasion and proliferation in host niches, 
affecting their pathogenicity level. 
The genetic differences detected in strain 8081 and WA-314 may partly explain the higher 
virulence/fitness of strain WA-314. Apart from strain-specific prophages, which may carry 
hypothetical proteins with virulence-associated functions, adhesion proteins and known pYV-
encoded virulence factors showed significant differences between the two analyzed strains, as 
discussed in the previous sections. Moreover, a colicin operon has been identified in strain 
WA-314. Although its activity has not been proven, it can be postulated that this colicin confers 
additional advantage to strain WA-314 against strain 8081, by inhibiting growth of competitor 
organisms. Colicins from Yersinia species are known and activity against closely-related bacteria 
have been demonstrated (Bosak et al., 2012; Bosak et al., 2013; Ferber and Brubaker, 1979). 
The small differences observed in in vitro growth phenotypes (section 4.1.2) could also account 
for the in vivo behavior of YE strains 8081 and WA-314, independently of their virulence 
properties. However, the bacterial growth experiment was done in LB medium, at 27 °C and for 
some hours, in contrast to the in vivo growth rate, which was measured at the host temperature 
(37 °C) during a period of days. Most Yersinia virulence factors are not expressed at 27 °C but 
only at 37 °C, and, in general, the conditions of the in vitro growth experiment are totally different 
than the environmental conditions of mouse body-tissues and -fluids. Accordingly, differential 
expression profiles of metabolic pathways and virulence factors have been shown in Yersinia 
cultured in human plasma and in LB medium (Rosso et al., 2008). In conclusion, there are many 
factors that can determine the in vivo survival and growth of Yersinia, including nutrient 
composition and availability in the host niches, ability of the bacteria to gain access to the 
necessary nutrients, virulence factors and host defense mechanisms. 
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5.2. Y. enterocolitica subsp. palearctica genomics 
By comparison against the highly-virulent strain 8081, in recent works the genomic features 
involved in the low virulence of some Y. enterocolitica subsp. palearctica strains have been 
partly elucidated (section 1.5). In this study, comparison among genomic sequences of different 
YEP strains was accomplished taking into consideration the general mouse-virulent features 
discovered from the analysis of strains 8081 and WA-314 (section 4.1). In addition to significant 
differences in metabolic clusters, genes with putative disease-associated roles were identified. 
Importantly, the used genome sequences, which derived from both pathogenic and non-
pathogenic isolates, well exemplify the broad diversity of this species in terms of serotype, 
geographical origin and clinical relevance. 
5.2.1. Respiratory flexibility of Y. enterocolitica subsp. palearctica 
Utilization of N-acetyl-galactosamine (Aga) as carbon source has been demonstrated in 
Y. enterocolitica serotype O:3 and is related to the agaVWEF gene cluster (Batzilla et al., 
2011a), which is present in YEP but absent from the highly-virulent YEE. Since Aga is a major 
component of the pig intestinal mucin, the aga operon has been denoted as important fitness 
and host adaptation factor, especially for the pig-associated serotype O:3 strains. Similarly, YEP 
strains carry additional metabolic genetic clusters which confer respiratory flexibility, stressing 
the importance of anaerobic respiration in YE patho-adaptation and proliferation in different 
ecological niches.  
YE is a facultative anaerobic bacterium and, thus, can metabolize energy from oxygen, if 
present, or from other electron acceptors, by means of reductases. Nitrate is an important 
component of the nitrogen cycle and a source of energy during bacterial anaerobic growth. 
Nitrate and nitrite are commonly found in water, soil, vegetables and meat, even though nitrite is 
easily oxidized to nitrate, which is therefore the predominant compound in the environment. In 
many bacteria the nitrite generated from nitrate respiration can be further reduced to ammonium 
by nitrite reductases during the dissimilatory nitrate reduction (Richardson, 2000). Two 
independent pathways allow this process: the periplasmic respiratory nitrite reductase encoded 
by the nrf operon and the cytoplasmic NADH-dependent nitrite reductase encoded by the nirBD 
genes. The non-respiratory Nir pathway, which does not generate a proton motive force, 
provides a mechanism for detoxifying nitrite in the cytoplasm, while the electrogenic reduction of 
nitrite by the Nrf pathway offers a secondary source of energy during anaerobic respiration 
(Page et al., 1990). As discovered by genome comparison (section 4.2.1), YEP is equipped with 
both Nrf and Nir systems, while YEE only possesses the Nir pathway. This implies that the 
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proliferation of weakly-virulent and non-virulent strains in anaerobic ecological niches, such as 
food, the intestinal tract and tonsils, may be supported by nitrite as source of energy. For 
example, YE serotype O:3 can grow on raw pork packaged in modified atmosphere 
(Fredriksson-Ahomaa et al., 2012); as nitrites are used for processing and curing meat, the 
expression of the Nrf reductase may explain the ability of serotype O:3 strains to survive in these 
oxygen-deficient conditions. More importantly, Nrf has also demonstrated an activity in nitric 
oxide reduction during in vitro and in vivo growth of E. coli (Poock et al., 2002). This suggests an 
additional pathogenic role of this cluster in detoxification of the nitric oxide, which is produced for 
instance by macrophages as microbicidal agent (Murray and Wynn, 2011), encountered during 
YE invasion of the host. 
Likewise, YEP strains might be able to grow in anaerobic conditions by using dimethylsulphoxide 
(DMSO) as alternate electron acceptor, since a DMSO reductase system has been identified in 
this group of organisms (Table 25). DMSO is found in marine environments, in water surface 
layers, in fruits and vegetables (Griebler and Slezak, 2001), which are all specialized ecological 
niches for YE. Interestingly, impairment of the function of the DMSO reductase-encoding gene 
dmsA in Actinobacillus pleuropneumoniae, which is able to persist on respiratory epithelia, in 
tonsils, and in the anaerobic environment of encapsulated lung cells, causing porcine 
pleuropneumonia, resulted in reduced virulence (Baltes et al., 2003). The dmsA gene, moreover, 
is regulated by the HlyX protein, which is involved in persistence of this bacterium in pig lungs 
and tonsils (Baltes et al., 2005). A role of the DMSO reductases in YE serotype O:3 pig-
adaptation and tonsil colonization can logically be proposed. 
5.2.2. Virulence-associated factors in weakly-virulent and non-virulent strains 
Bacterial genome sequencing and comparative genomics are useful tools for discovering 
candidate virulence genes and for better understanding pathogenesis mechanisms. Virulence 
factors are not only involved in adhesion/invasion of the host and inhibition of immune 
responses, but also in successful proliferation and competitive advantage against other bacteria. 
Previous genome analyses of weakly-virulent strains have revealed several toxin-related gene 
clusters, including RTX-like toxins and colicins (Batzilla et al., 2011a; Wang et al., 2011). Despite 
the question whether these clusters are actively expressed in the host and able to exert 
pathogenic functions, toxins seem to have a relevant role for the whole species Y. enterocolitica, 
since also mouse-virulent biotype 1B and non-virulent biotype 1A strains carry genes belonging 
to RTX toxin and bacteriocin families. Apart from putative “classical” functions in virulence, toxins 
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more probably contribute to YE niche adaptation and defense against bacteria and fungi sharing 
the same environments. 
YE virulence is strongly dependent on the pYV-encoded adhesin YadA for adherence to host 
surfaces (section 1.2.2 and 5.1.3). Additionally, genomes of YEP revealed that other 
chromosomal-encoded proteins might play a role in efficient anchoring of these bacteria to host 
tissues or surfaces. Fimbrial adhesins and autotransporters appeared as newly discovered 
candidate factors for the high-virulence phenotype. Curiously, also weakly-virulent and non-
virulent strains carry specific fimbriae- and autotransporter-encoding genes (section 4.2.2). 
Surface fimbriae/pili are important for the colonization of many pathogenic bacteria and can also 
function as receptors for bacteriophages (Proft and Baker, 2009). Pili assembled by the 
chaperone-usher pathway, as the ones identified in YE, are commonly found in the family of 
Enterobacteriaceae, and require specific receptors exposed on the host cells, such as 
glycolipids, collagen proteins and integrins, which are recognized attachment sites for the YE 
YadA and Inv proteins (section 1.2). Therefore, the discovered fimbrial clusters may be 
additional adhesive structures for host recognition and adherence to receptor molecules on host 
cells and tissues and, in particular, for colonization of specific niches, such as pig tonsils and 
intestinal epithelial cells. 
Autotransporters are cell-surface-exposed or released proteins produced by a large variety of 
Gram-negative bacteria. Due to their virulence-related functions, they have been intensively 
studied, with their synthesis and secretion mechanisms being well characterized (Benz and 
Schmidt, 2011; Grijpstra et al., 2013). Their virulence-associated roles comprise invasion, 
adhesion, actin-nucleating functions, cytotoxicity and immune evasion. In YE, one of the major 
virulence factors, YadA, is a trimeric autotransporter, whose crystal structure has been 
elucidated, allowing identification of putative collagen-binding regions (Nummelin et al., 2004). 
The autotransporters specifically detected in different YE serotypes belong to the class of 
classical autotransporters, which consist of an N-terminal signal sequence for transport across 
the inner membrane, a passenger domain, and a C-terminal translocation domain that likely 
forms a pore in the outer membrane for the transport of the passenger part to the cell surface. 
Examples of classical autotransporters in pathogenic bacteria include the adhesin AidA of 
enteropathogenic E. coli, pertactin and BrkA of Bordetella pertussis and the cytotoxin VacA of 
Helicobacter pylori (Benz and Schmidt, 2011). Characterization of the YE newly detected 
autotransporters may bring new insights into their biological functions and putative implications 
in YE infection and/or adaptation to specific host niches. 
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Another important class of bacterial transmembrane proteins includes ABC transporters, which 
have a wide variety of substrates and a demonstrated role in virulence of several bacterial 
pathogens, for example being involved in export of toxins or import of nutrients (Lewis et al., 
2012). ABC transporters constitute a major part of the core genes (section 4.2.3) and the 
variable regions (section 4.2.1) of YE. In particular, YEP strains carry two ABC transport 
systems involved in acquisition of the branched-chain amino acids (BCAA) leucine, isoleucine 
and valine (LIV), while YEE only possesses one. It has been shown that the LivJHMGF ABC 
transporter is necessary for Streptococcus pneumoniae pathogenesis, even though the 
decreased virulence mechanisms related to the loss of BCAA are not clear (Basavanna et al., 
2009). BCAA limitation seems also to be involved in reduced virulence and survival of 
A. pleuropneumoniae in swine, as mutants unable to synthesize BCAA were attenuated in a 
porcine infection model (Subashchandrabose et al., 2009). The role of BCAA in YE 
pathogenesis, therefore, requires more clarification. 
Overall, disease-associated determinants in weakly-virulent and non-virulent YE serotypes seem 
to be strongly related to adherence and host interaction abilities, since autotransporters and 
fimbriae constitute the main findings. Moreover, being extracellular surface-exposed structures, 
pili and autotransporters may be used as effective recombinant vaccines and for YE diagnosis. 
5.3. A new assay for Y. enterocolitica patho-serotyping 
Serotype is one of the main characteristics of Y. enterocolitica, as demonstrated also by 
phylogenetic analysis (section 4.3.6), and may be useful for epidemiological and diagnostic 
purposes, especially because strains enteropathogenic for humans are limited to a few 
serotypes. The chemical structure of the O-ag, the LPS part which determines the serotypes, 
has been characterized for some YE serotypes, but the O-ag genetic clusters and their genomic 
locations are only partly known for serotypes O:3, O:8 and O:9 (section 1.1.1). The availability of 
YE genome sequences from strains of the major pathogenic serotypes enabled comparison 
among O-ag gene clusters and identification of serotype-specific genes, with subsequent 
development and validation of a PCR-based method for simultaneous identification and patho-
serotyping of YE. 
5.3.1. Newly discovered O-ag genetic clusters 
Y. enterocolitica heterogeneous genetic nature is also reflected in the genomic position of the 
genes involved in the O-ag biosynthesis. In contrast to Y. pseudotuberculosis and Y. pestis, 
where the O-ag clusters are located in the same chromosomal location in the hemH-gsk locus 
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(Bogdanovich et al., 2003), only serotype O:8 and O:36 O-ag clusters are found in this region. 
The O-ag genes of YE serotypes O:3 and O:9 share another location, whereas the genetic 
clusters of serotypes O:5,27 and O:5, despite their high DNA sequence similarity, are carried in 
different positions (Figure 24). Interestingly, no gene cluster encoding a second epitope related 
to the postulated O-ag factor 27 could be identified in the genome of YE strain Y5.27P, 
suggesting that factor 27 may not be of LPS origin. In fact, serotype-specific antisera are 
obtained against heat-stable antigens, which are mainly O-antigens (section 1.1.1). However, 
antisera may also recognize other specific surface-exposed molecules, which may account for 
factor 27 of serotype O:5,27. The uncommon chromosomal positions and the huge genetic 
diversity of YE O-antigens may be explained by recent inter-species lateral gene transfer, as 
demonstrated for other Gram-negative bacteria (Samuel and Reeves, 2003). Supporting this 
hypothesis, various transposase-encoding genes have been identified in the analyzed O-ag 
clusters. Further sequencing aimed at yet understudied serotypes may reveal new heat-stable 
antigenic gene regions and increase the scientific knowledge on YE serotype classification. 
5.3.2. Efficient and specific multiplex PCR assays 
A PCR-based test for simultaneous identification and patho-serotyping of Y. enterocolitica was 
established and validated in this study (section 4.2.8). The assay is able to identify YE strains at 
a species-level, distinguishing between the four clinically prevailing serotypes O:3, O:9, O:8 and 
O:5,27. It can also differentiate between virulent and non-virulent strains, detecting the genetic 
targets ail and ystB, respectively. However, recent epidemiological studies have shown that 
some YE biotype 1A isolates from pigs and pork products carry the ail gene (Bonardi et al., 
2013; Paixao et al., 2013b). Conversely, the frequency of YE biotype 1A clinical samples 
harboring the ail gene is not significant (Stephan et al., 2013). The identification multiplex would 
therefore correctly genotype as “non-virulent” biotype 1A human isolates, while a 
misclassification may occur when testing isolates from animals. Likewise, the ystB gene has not 
been detected in 27.6% non-virulent YE isolates from pigs (Bonardi et al., 2013), while in fecal 
samples from humans the ystB frequency is 95% (Stephan et al., 2013). The ail-positive and 
ystB-negative biotype 1A strains identified with this molecular scheme should, therefore, be 
further studied for presence of other virulence-associated factors. 
The corroborated identification and patho-serotyping method can be applied as diagnostic test, 
and avoid the low objectivity of the conventional agglutination test and the possible 
misinterpretation of the results. Enabling higher efficiency, sensitivity and specificity, this assay 
may be especially useful for typing YE isolates which have lost expression of the O-ag. Indeed, 
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validation of the assay was carried out also on 19 strains with unknown serotype, and 
demonstrated higher typing capacity than the conventional methods. 
The developed typing scheme is neither complete nor perfect, but can be used as starting point 
for further improvements. Availability of new genome sequences from YE strains belonging to 
less-common serotypes will allow a broader molecular serotyping, adding new targets to the 
present scheme. 
5.4. Genomic evolution of the Y. enterocolitica species 
The genome sequences of a number of Y. enterocolitica strains have been analyzed, providing 
not only an expanded view of the adaptation and virulence capacities (sections 5.1 and 5.2), but 
also presenting novel insights into the intra-species diversity and genome evolution of this 
bacterial species. Phylogenesis, pan genomics, core genomics, and singleton analyses revealed 
a high variability among YE genomes as entire species, with lower diversity in the biotypes 2-5 
groups. The results reflect the niche restriction of weakly-virulent strains in contrast to the wider 
ecology of the highly- and non-virulent groups. 
5.4.1. Open pan-genome of the species Y. enterocolitica 
Genome sequencing and comparison of ten strains allowed the description of the core and pan-
genomes of Y. enterocolitica, providing a glimpse of the genetic diversity within this species. The 
pan-genome of a particular species represents its whole gene repertoire and corresponds to the 
sum of the core and dispensable/unique genomes (Medini et al., 2005; Tettelin et al., 2008). The 
core genome includes genes that are present in all strains of a given species, thus including 
essential functions; on the other side, the dispensable and unique genes are absent in at least 
one strain or are present in single strains, and may confer selective advantages, such as 
adaptation to specific niches, stress resistance, and pathogenicity. Importantly, the calculations 
of the core and pan-genomes may be slightly biased by the use of draft genomes, since CDS 
prediction and, therefore, comparison are influenced by the gaps between contigs and by the 
quality of the assembled sequence. 
The analysis of the YE pan-genome using the EDGAR comparative genomics tool (Blom et al., 
2009) identified 8,102 CDSs, of which 3,090 are core genes, while 5,012 are dispensable and 
unique genes (section 4.2.3), thus showing a strong contribution of the non-core genes. YE 
demonstrated a large pan-genome, in comparison with other bacteria, such as the plant 
pathogen Erwinia amylovora, with 5,751 pan genes calculated on 12 genomes (Mann et al., 
2013), the swine pathogen Streptococcus suis, with 3,585 pan genes in 13 strains (Zhang et al., 
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2011), the human pathogen Listeria monocytogenes, having 4,052 pan genes in 26 genomes 
(Deng et al., 2010), and the human and zoonotic enteric pathogen S. enterica, with 10,015 
CDSs in 35 genomes (Jacobsen et al., 2011). In contrast, considering that the pan-genome of 
YE consists of 9,804 genes when calculated on 20 genomes using the Heap’ law function of 
Figure 18, the close relative E. coli demonstrated a bigger pan-genome (circa 13,000 genes in 
17 sequences) (Rasko et al., 2008). 
Nearly 74% of CDSs per YE genome are classified as core, meaning that a relatively high 
proportion of the genomes are conserved among the whole species. This is consistent with the 
analysis of the core genome development plot (Figure 17), which represents a decay function 
predicting the development of the number of core genes with an increasing number of genomes 
(Tettelin et al., 2005). Based on the 10 YE chromosomal genomes analyzed, the predicted 
number of core genes converges to 3,060 for an infinite number of sequenced genomes. 
Similarly, the slope for the singleton number approaches an asymptote, predicting the number of 
additional singletons (122) putatively retrieved by future genome sequencing (Figure 18). 
Together with the continuously increasing number of pan genes (Figure 18), such genomic 
structure indicates that the pan-genome of YE is open, meaning that the species is still evolving 
(Medini et al., 2005). Bacterial species with an open pan-genome are able to colonize multiple 
environmental niches, and gene gain and loss play a prominent role in the process of host 
adaptation, as well as in lifestyle changes (Medini et al., 2005). In fact, YE has been isolated 
from a variety of hosts, such as water, soil, vegetables and mammals, experiencing great 
opportunities for contacts with potential gene donors. This seems to be particularly true for the 
non-virulent biotype 1A and the mouse-virulent biotype 1B strains, which contribute to the 
species variability with a high amount of strain-specific features (> 130 genes), while the weakly-
virulent serotype O:3 strains add less than 50 singletons all together, suggesting a clonal-like 
behavior (Figure 19). Genes unique to each strain comprise a high proportion of the non-core 
genome (about 24%, corresponding to 1,183 CDSs), and mainly encode for hypothetical and 
mobile element-related proteins, supporting the hypothesis of genomic exchange and evolution 
by gene flow and horizontal gene transfer, a process which tends to involve a large number of 
hypothetical proteins (Hsiao et al., 2005). Finally, observing that uncharacterized genes are 
over-represented among the unique, strain-specific genes suggests the possibility that non-
essential genes are responsible for driving the evolutionary diversification among YE strains. 
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5.4.2. Y. enterocolitica phylogenetic relationships 
The species Y. enterocolitica is traditionally classified into 6 biotypes, more than 70 serotypes, 
and two subspecies (section 1.1). Observing the phylogeny obtained by using the whole core 
genome of the species revealed a main clustering according to the virulence degree of the 
strains, as the non-virulent biotype 1A and the weakly-virulent biotypes 2-5 (Y. enterocolitica 
subsp. palearctica), and the highly-virulent biotype 1B (Y. enterocolitica subsp. enterocolitica) 
form three distinct lineages (Figure 21). In contrast, no apparent grouping appears based on the 
subspecies classification, with biotype 1A strains being the progenitors and biotypes 2-5 the 
most recently diverged. Among the weakly-virulent group, clustering occurs according to the 
serotype of the strains, and the divergence is relatively low within each cluster. Serotype O:3 
strains show a particularly low genetic diversity, with short terminal branches. The long branch of 
strain W22703 is congruent with the high number of CDSs annotated in this genome, but may 
not really mirror the phylogenetic distance among serotype O:9 strains. In fact, a newly 
published phylogeny determined on 118 strains, which is strongly consistent with the one 
constructed in this study with 10 genomes, has shown a more prominent tight clustering among 
the weakly-virulent strains of serotypes O:5,27, O:3 and O:9 (Reuter et al., 2014). The authors 
have suggested that this may be due to ecological specialization events, which shaped the early 
evolution of these niche-restricted groups. This hypothesis is supported by the low number of 
unique genes in weakly-virulent strains, as obtained by the genome comparison and singleton 
analyses performed in this study (section 4.2.4). To note, the higher genetic variation of biotypes 
1A and 1B correlates with a broader metabolic capacity of these strains, in contrast to the 
metabolic restriction and low genetic divergence of biotypes 2-5 (Reuter et al., 2014). Having 
higher metabolic capability may supply biotype 1A and 1B strains with a competitive growth 
advantage in a variety of ecological niches, by using carbon sources that are not readily 
fermented. Overall, although the species YE possesses an open pan-genome and high genetic 
variability, it also includes discrete and genetically isolated clades, especially significant for 
strains of serotype O:3. 
5.5. Y. enterocolitica serotype O:3 microevolution 
Y. enterocolitica serotype O:3 is a typical zoonotic pathogen, in that it is frequently associated 
with food contamination, it is transmissible to humans and its usual host is an animal, the pig 
(section 1.4.2). As a consequence of their high genomic homogeneity, molecular methods have 
low sensitivity and discriminatory power in typing these trains, thus preventing a complete 
understanding of their epidemiology and evolution and, therefore, of the association among 
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clinical cases, of the reservoirs of infection and of the transmission vehicle. Further studies of YE 
serotype O:3 thus required a whole-genome approach. Comparative genomic analysis of 20 
isolates showed little evidence of recombination and adaptive selection, whereas microevolution 
of this group seems to be driven by high pseudogene frequency and, consequently, by loss of 
gene function. No clear differences between pig and human isolates were identified, while more 
recent mutational events appeared in the human strains. Together with the genetic isolation, this 
is consistent with the assumed role of pig asymptomatic carriers as the main reservoir of human 
infections by YE serotype O:3. Overall, YE serotype O:3 can be regarded as a genetically 
monomorphic group of bacteria, corresponding to a lineage within a species of greater diversity. 
5.5.1. Limited variation of serotype O:3 genomes 
According to extrapolations based on the pan-genomes, core genomes and singletons of the 
whole species Y. enterocolitica, serotype O:3 showed a more clonal-like behavior than the other 
lineages (section 4.2). To confirm this, it was necessary to capture as much variation as possible 
in the serotype O:3 population, based not only on three but on twenty genomes, including 
thirteen re-sequenced new strains. Since a previous phylogenetic tree of these subspecies was 
not available, the choice of isolates could not be driven by unbiased sampling from a reliable 
phylogeny (Pearson et al., 2009), but only on clinical phenotype, geographical origin and source 
and year of isolation. Spanning a time-window of almost 30 years and deriving from both 
European and Asian humans and animals, the selected strains provide a satisfactory starting 
pool of genomes. Moreover, due to the known low diversity of serotype O:3 strains, the read-
mapping approach was considered sufficiently valid for phylogeny reconstruction and 
comparative genomics, and preferred to the slower, more complex and memory intensive de 
novo assembly methods.  
Investigations into the core and pan-genomes of YE serotype O:3 revealed interesting clues 
about the genomic conservation of this subgroup. Indeed, in contrast to the whole YE species, 
which clearly possesses an open pan-genome, the small serotype O:3 pan-genome seems to be 
essentially close (section 4.3.3). The number of core genes reaches an asymptote in the 
development plot after adding 110 genomes, while the pan-genome slowly continues to grow 
with minor increase when adding additional genomes, though it does not arrive at plateau. If an 
open pan-genome is defined by having an increasing pan-genome and a decreasing core 
genome, the calculations obtained with YE serotype O:3 signify a weakly close pan-genome. 
This indicates that introducing new sequences in the serotype O:3 pan-genome does not 
significantly affect the general population homogeneity, confirming the relatively close nature of 
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these genomes. Whole genome comparison also supported this finding, as large-scale 
recombinational events are absent. In fact, all sequenced serotype O:3 isolates showed 
conservation in the GIYep-01 genomic island and in the prophage-like elements, with small 
differences (Figure 29). Additionally, in the recombinational hot-spot region corresponding to the 
genomic island YGI-3 in YE strain 8081, the analyzed serotype O:3 strains do not carry any 
alternative prophage or plasmid (Figure 20). Overall, it appears that horizontal gene transfer and 
gene flow do not play a relevant role in the evolutionary changes in YE serotype O:3 genomes. 
The incompleteness of the genomes, which are mainly composed of contigs or scaffolds, may 
have slightly affected the calculations in this study, especially in terms of genome size and gene 
prediction. For example, it cannot be excluded that the smallest genome size of the Philippines 
strain PhRBD_Ye1 is due to the highest degree of sequence fragmentation among the analyzed 
genomes (section 4.3.2 and Table 29), and not to a real genome decay in the Asian strains. 
5.5.2. Evolution of the genetically monomorphic Y. enterocolitica serotype O:3 
An understanding of the genetic structure of microbial populations provides a framework within 
which epidemiology of pathogens can be monitored and traced. To elucidate the structure of the 
serotype O:3 population and its microevolution, a variant-based comparative analysis was 
applied, capturing genomic differences of these very closely related strains. 
The performed analyses support the hypothesis of genetic isolation and drift in Y. enterocolitica 
serotype O:3, and provide new insights into its microevolution. Bacterial evolution may occur 
according to four processes: natural selection, mutation, gene flow/recombination, and genetic 
drift. Selection for greater fitness during adaptation seems to be the predominant mechanism for 
evolutionary dynamic under laboratory conditions (Barrick et al., 2009), and has also been 
observed in humans and natural bacterial populations, especially because of antibiotic 
treatments (Mwangi et al., 2007; Roumagnac et al., 2006). On the other side, signals of adaptive 
selection have not emerged in genetically monomorphic bacteria, which are characterized by low 
level of sequence homoplasy (mutation of a character found in other independent lineages) and 
rare recombination events (Achtman, 2012). In YE serotype O:3 there is a lack of evidence for 
adaptive selection, and the population appears to be genetically monomorphic (section 4.3.7). 
No genes contain multiple homoplasic variants, indicating low level of recombination among 
serotype O:3 isolates. Only one gene deviates from the Poisson distribution of the number of 
variants per gene, even though only 3 SNPs are nonsynonymous. Moreover, pseudogenes have 
a high frequency in YE serotype O:3, as confirmed by a bigger scale study on YE (Reuter et al., 
2014), being signal of host-restricted organisms (section 4.3.7). Together with the results 
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obtained by genome comparison, which proved the absence of genomic recombinational events 
(section 5.4.1), these findings suggest that evolution in these pig-adapted bacteria is dominated 
by genetic drift (random sampling of gene variants) and loss of functions instead of natural 
selection by recombination. Therefore, considering also the low genetic diversity, confirmed by a 
low mutation rate, YE serotype O:3 can be reasonably considered a genetically monomorphic or 
clonal microbial population, part of a more diverse species. The reduced genetic variation of 
serotype O:3 might be the result of a population bottleneck, due to transmission events and 
ecological specialization. Similarly, both Y. pestis, which typically colonizes fleas in order to be 
transmitted to mammals, and S. enterica serovar Typhi, a human-restricted pathogen, have 
been also designated as genetically monomorphic organisms (Achtman, 2008). 
The weak signal of selection can be also noticed by the lack of antigenic variation, defined as 
the diversification of mainly surface-exposed antigens for escaping the immune response 
mechanisms (van der Woude and Baumler, 2004). In fact, only few genes, which are 
metabolism and transport-related, have independent nonsynonymous variants in nearby amino 
acids (Table 32). Although metabolic and transport functions seem to be important for specific 
serotype O:3 antigenic proteins (section 4.4.3) and, therefore, the detected genes may represent 
cases of antigenic variation, the level of variability is low. The lack of evidence for immune 
evasion suggests that YE serotype O:3 is not under selective pressure from the human immune 
system, being humans not its usual habitat. 
The main source of YE serotype O:3 infections has been often suspected to be contaminated 
pork products, but the connection between human and animal isolates is not well established. 
Several DNA-based typing molecular methods have indicated an overall limited genetic diversity 
of these strains and a high similarity between human and pig isolates (Fredriksson-Ahomaa et 
al., 2006), supporting the hypothesis that asymptomatic pigs are the main reservoir for serotype 
O:3 strains. The SNP-based phylogeny obtained in this study seems to confirm this assumption. 
In fact, no SNPs allow a distinction between the two groups of pig/animal and human isolates. In 
addition, different phylogenetic ages are evident, with animal strains lying mainly on internal 
branches, because of old mutations, and the human ones on terminal branches, denoting recent 
mutations (Figure 32). The patterns of genetic drift, low level of recombination/gene flow and 
lack of antigenic variations may thus be explained by the fact that pigs are a restricted and 
persistent reservoir for YE serotype O:3 strains. Mutations occurring during a human infection 
might have no fitness advantage in the animal carrier condition and may not be maintained in 
the population. 
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Importantly, the representative strain collection used in this analysis has been chosen on the 
basis of multiple criteria, intending to maximize the amount of variation present in the YE 
serotype O:3 population. The depicted discernible diversity is thus limited by the selected 
strains, and some subgroupings may have been excluded. Nevertheless, it is unlikely that the 
variant calls and the identified phylogenetic structure greatly differ from the reality. Indeed, 
variant detection has been performed on the nonrepetitive component of the genome, thus 
excluding phages, insertion sequences and rRNAs, since assembly and mapping of short reads 
are unreliable in repetitive regions, and mobile elements may be under different selective 
pressure compared to the backbone genome. Only high quality variants have been used for the 
analysis, while indels have been omitted from the SNP-based phylogeny calculation, to reduce 
possible errors. SNPs, indeed, are the most valuable markers for studying phylogenetic 
relationships of isolates in homogenous pathogens, since they have relatively low mutation rates 
and are evolutionary stable (Achtman et al., 2004; Pearson et al., 2004). The discovered SNPs 
can be validated with genotyping approaches using a larger collection of strains, in order to 
develop a molecular SNP-based typing assay, capable of discrimination to the strain level. This 
may lead to an improved tracking of the spread of YE serotype O:3 between swine and human 
hosts. 
5.6. Gene expressed during Y. enterocolitica serotype O:3 infection 
Y. enterocolitica is able to respond to environmental stimuli by inducing or repressing genes, for 
example to optimize proliferation within the host during infection. Genes specifically induced 
during in vivo growth within the host may have a role in pathogenesis, being virulence or fitness 
factors. Techniques such as IVET (in vivo expression technology) and STM (signature-tagged 
mutagenesis) have been applied to the highly-virulent strain 8081 in order to identify novel 
virulence genes (Darwin and Miller, 1999; Gort and Miller, 2000; Young and Miller, 1997). In 
contrast, little is known about virulence factors responsible for the apparent adaptation to the 
swine of YE serotype O:3 and its ability to cause disease in humans. IVET and STM methods 
require an animal model, usually mice, which may not satisfactorily represent events during 
growth in humans or swine. To study serotype O:3 pathogenesis, the IVIAT (in vivo induced 
antigen technology) technique seemed to be a suitable alternative approach (Figure 33), and 
provided a portrait of possible mechanisms by which these bacteria can defeat host defenses 
and establish itself within the host. 
Applying the immuno-based IVIAT screening to the completely sequenced YE strain Y11 
identified 45 immunogenic antigens by probing sera from humans with serotype O:3 infections. 
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The detected IVI genes are mainly involved in metabolic and biosynthetic functions, similarly to 
the results from the IVET and STM studies with strain 8081, but also in “classical” virulence 
activities, such as motility and adhesion (Table 33). Overall, the IVIAT results largely confirm the 
conclusions drawn by the genome comparative analyses (section 5.2), emphasizing even more 
the importance of bacterial physiology during host infection. 
As suggested by genomic findings, growth in anaerobic conditions seems to play a major role in 
in vivo proliferation of YE serotype O:3, since genes belonging to cobalamin synthesis, nitrogen 
and sulfur metabolism pathways resulted as IVI antigens. The proposed function of BCAA in YE 
virulence (section 5.2.2) is supported by the LivK BCAA transporter, which was discovered by 
IVIAT. Being absent from the highly-virulent group, this protein might play a role in the host-
restricted phenotype of serotype O:3 strains. Future characterization of these metabolic-related 
IVI genes would be of great interest for developing efficient antibacterial strategies against 
Yersinia, as well as for better understanding how these bacteria compete for nutrients, using 
alternative carbon sources. 
Among the IVI antigens with known virulence functions in YE, the plasmid-encoded YscU 
undergoes an autoproteolysis which generates a C-terminal peptide responsible for correct 
regulation of Yops synthesis and secretion (Bjornfot et al., 2009). The antigenic region identified 
by IVIAT within the yscU gene corresponds to the C-ter domain, confirming the essential role of 
the pYV-encoded T3SS in Yersinia virulence and supporting the validity of the IVIAT screening. 
Notably, none of the other Ysc or Yop proteins has been detected, probably because of their 
expression in both in vitro and in vivo conditions, with consequent exclusion by the IVIAT 
approach. A large functional category of putative IVI virulence factors include flagella- and 
fimbria-associated proteins. These results are consistent with findings from various experiments, 
in which flagella appeared to be required for migration and initiation of host cell contact, for 
epithelial cell invasion and for virulence in a mouse model (Young, 2004). Even though the 
expression of flagella in YE is known to be decreased at 37 °C, temperature regulation seems to 
be primarily centered on repression of class III genes (Horne and Pruss, 2006). The detected IVI 
genes fliN, fliO, fliP and fliQ belong to the class I and remain expressed at the host temperature 
(Minnich and Rohde, 2007), confirming their role as immuno-antigens. The identification of Mrf 
fimbrial IVI antigens is also of particular interest, as genomic analyses have proposed a yet 
underestimated function in pathogenesis of these adhesion proteins (section 5.2.2). The role of 
MrfC in YE serotype O:3 infection is supported by the fact that both stbC and the adjacent stbD 
fimbrial genes have been involved in S. typhimurium  virulence (Chuang et al., 2008), and that 
four fimbrial proteins were identified by IVIAT in S. paratyphi (Alam et al., 2013).  
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In general, different IVI antigens discovered in YE serotype O:3 have similar function as genes 
previously detected in other IVIAT studies, reinforcing the validity of the method. For example, 
penicillin-binding proteins have been identified in the chicken-adapted S. pullorum (Li et al., 
2013) and in Bacillus anthracis (Rollins et al., 2008). Sensor kinases resulted to be IVI antigens 
in the EHEC E. coli O157:H7 (John et al., 2005), in the swine pathogen Streptococcus suis (Gu 
et al., 2009), in C. jejuni probed with chicken sera (Hu et al., 2014), and in S. pullorum. DNA 
recombination proteins, helicases and endonucleases have been detected in the zoonotic 
agents S. pullorum and C. jejuni and in E. coli O157:H7. 
In conclusion, IVIAT has been applied to identify proteins specifically expressed in vivo during 
both human and animal infection with a variety of pathogens. However, this technique has some 
limitations, such as (i) exclusion of potentially important antigens expressed both in vitro and in 
vivo and of non-proteic antigens; (ii) cross-reactivity with homologous antigens from other 
bacteria; (iii) variable expression due to the genomic library in an E. coli host. Determining the 
real roles of the detected genes in pathogenesis requires additional studies; however, the IVI 
genes, especially if located on the bacterial surface, may be used for development of diagnostic 
tests and vaccines.  
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6. Conclusions 
The species Y. enterocolitica contains a very heterogeneous collection of organisms. One end of 
the spectrum is formed by broad-host-range pathogens such as the highly-virulent biotype 1B 
strains, which are not only frequently associated with yersiniosis in humans, but are also isolated 
with water and rodents. At the other end of the spectrum there are pathogens of serotype O:3, 
whose ecological habitat is mainly restricted to humans and pigs. 
Whole genome comparisons provided clear evidences of the wide genetic variability within the 
highly-virulent group and the whole YE species, in contrast to the genetic isolation of serotype 
O:3 strains. Genomic insights into the microevolution of the YE serotype O:3 population showed 
their clonal-like nature and suggested the definition of “genetically monomorphic” for these 
strains. Recombinational events and adaptive selection play little role in serotype O:3 evolution, 
which is rather driven by genetic drift, while horizontal gene transfer seems to be the main 
evolutionary process for the entire YE species. These findings reflect the different degree of 
niche specialization of this heterogeneous group of microorganisms, and clearly demonstrate the 
host restriction of the pig-adapted serotype O:3. 
Both genome analyses and the IVIAT immuno-screening highlighted the putative essential role 
of anaerobic respiration abilities of the facultative anaerobic YE and, especially, of serotype O:3 
strains, during host colonization and/or pathogenesis. Despite the need of experimental proofs, it 
can be postulated that the capacity of growing anaerobically might bring an advantage to 
Yersinia for surviving and competing with microbial communities encountered in host niches 
(gut, tonsils) and in the environment (water, soil). Moreover, considering that anaerobic 
pathways are less efficient than the aerobic ones, they might be used by YE serotype O:3 more 
for survival and colonization than for invasion. This is also supported by the fact that the main 
virulence factors in the YE weakly-virulent group are fimbriae and transporters, having 
essentially functions in adhesion and contact with host cells. 
A thorough knowledge on the epidemiology of serotype O:3 isolates might unquestionably 
confirm the hypothesis that pigs are asymptomatic reservoir, with human infections being a mere 
consequence of contaminated-food consumption. Selection of informative SNPs evenly 
distributed through the chromosome and localized in core genes will allow the design of a rapid 
and cost-effective diagnostic scheme for strain genotyping.  
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